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AN APPROACH TO DEVELOP SUSTAINABLE MEDICAL 
DEVICES 
Abstract 
The development and commercialization of contemporary Medical Devices is 
inherently of a multidisciplinary nature. Consequently, they have to undergo a 
stringent regulatory compliance procedure in conformity with an ever 
increasingly fierce and competitive business environment. Throughout the 
product life cycle, medical devices would significantly consume renewable as well 
as non-renewable resources and as a result exert a substantial social, economic and 
environmental impact(s). 
Accordingly, it is imperative to consider the criteria of the aforementioned 
domains of sustainability in the initial phases of product development. The 
proposed conceptual multifaceted framework comprehensively explores a broader 
scope of sustainable product development, mainly from the pragmatic standpoint 
of systems engineering in comparison to the contemporary evaluation and 
development approaches. The underpinnings of the proposed framework 
encompasses the critical role of a decision model titled ‘Multi Criteria Hierarchical 
Model (MCHM)’ which is in fact an extensive revision of the Analytical Hierarchy 
Process decision modelling approach. The MCHM contains three tiers of pertinent 
criteria to attain overall sustainability. The structure of MCHM illustrates the 
tolerable level of sustainability in Tier 1, which is non-negotiable and compulsory, 
and the additional degrees of sustainability that increases from Tier 2 to Tier 3. 
Furthermore, the proposed framework elucidates the active participation of the 
MCHM in product design and development by conjoining with a wide spectrum 
of technical and conceptual tools. 
The research methodologies in the thesis are comprised of interviews, 
questionnaires and case studies that mainly involved active participatory 
observation. The objective of incorporating case studies in the thesis is to evaluate 
the effectiveness of the MCHM in an Industrial environment. In this doctoral 
research the contemporary medical devices explored during the case studies 
included a wide spectrum of materials and technologies that range from metal and 
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non-metal prosthesis (external and sometimes internal), instruments, advanced 
implantable devices and biodegradable scaffolds used in regenerative medicine. 
The research activities commenced with a thorough literature review that directed 
the researcher to the need for an exploratory study, accomplished by interviews 
with experts from academia and industry. These experts provided their feedback 
on the Sustainability related criteria outlined in the MCHM based on their 
expertise and knowledge of product development in diverse economic 
circumstances. The feedback was obtained in the form of assigning numerical 
scores during pair-wise comparison between two criteria at a time. The scores and 
recommendations were documented for being incorporated within the case 
studies. 
In the case studies, the MCHM was incorporated in the early stage of product 
development to prioritize bare minimum environmental sustainability and 
profitability in accordance with regulatory compliance. During the decision 
making process, the product design was investigated in order to simultaneously 
accomplish the aforementioned facets by way of incorporating the expert 
recommendations. Furthermore, these expert recommendations obtained in 
conjunction with business strategies and technical problem solving techniques, 
such as Case based Reasoning (CBR), Design by Analogy (DA) and Theory of 
Inventive Problem Solving (TRIZ) were considered for resolving conflicts between 
the criteria of Tier 1 and other Tiers. 
The thesis provides decision makers and the product development teams with a 
framework to gain a more holistic perspective on sustainable product 
development with respect to policies, technical/non-technical tools and business 
strategies. The goal is to enable these product development teams to implement 
pragmatic solutions for ensuring long-term competitiveness and the welfare of the 
Stakeholders. 
 
Keywords: Sustainability; Multicriteria Hierarchical Model; Medical Devices; New 
Product Development. 
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UMA ABORDAGEM AO DESENVOLVIMENTO DE 
DISPOSITIVOS MÉDICOS SUSTENTÁVEIS 
Resumo 
O desenvolvimento e comercialização de dispositivos médicos contemporâneos é 
por inerência de natureza multidisciplinar. Consequentemente, estes dispositivos 
têm que passar por um procedimento de regulamentação rigoroso, num ambiente 
de negócios cada vez cada vez mais acirrado e competitivo. Durante o ciclo de 
vida do produto, os dispositivos médicos consomem recursos renováveis, bem 
como recursos não-renováveis, o que origina impactos sociais, económicos e 
ambientais significativos. 
Assim, é imperativo considerar as diferentes dimensões da sustentabilidade nas 
fases iniciais de desenvolvimento do produto. O modelo conceptual proposto 
explora exaustivamente um propósito mais amplo de desenvolvimento de 
produtos sustentáveis, principalmente do ponto de vista pragmático da 
engenharia de sistemas, em comparação com a avaliação e abordagem 
contemporânea de desenvolvimento de novos produtos. A abordagem proposta 
suporta-se no modelo de apoio à decisão intitulado Multi Criteria Hierarchy Model 
(MCHM), que é uma extensão do modelo Analytical Hierarchy Process (AHP). O 
MCHM contém três níveis de critérios relevantes para alcançar a sustentabilidade 
global. A estrutura do MCHM reflete o que é obrigatório e não negociável no nível 
1, e ainda a importância crescente dos critérios de sustentabilidade do nível 2 para 
o nível 3. Além disso, o modelo proposto demonstra a relevância da inclusão do 
MCHM no design e desenvolvimento do produto em conjunção com um amplo 
espectro de ferramentas técnicas e conceptuais. 
As metodologias de investigação incluem entrevistas, questionários e estudo de 
casos que envolveram, principalmente, a observação ativa. A realização de 
estudos de caso teve como objetivo avaliar a adequação do MCHM em ambiente 
industrial. Os dispositivos médicos considerados durante o estudo de casos 
incluíram uma diversidade de materiais e tecnologias que vão desde próteses 
metálicas e não-metálicas (externas e internas), instrumentos, implantes e suportes 
poliméricos biodegradáveis usados em medicina regenerativa. 
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A revisão bibliográfica identificou a necessidade de desenvolver um estudo 
exploratório, suportado em entrevistas a peritos académicos e industriais. Estes 
peritos apresentaram a sua opinião relativa aos critérios considerados no MCHM, 
de acordo com a sua experiência e conhecimento sobre o desenvolvimento de 
produtos em circunstâncias económicas diversas. A comparação par a par dos 
critérios permitiu avaliar a sua importância relativa. Os resultados das entrevistas 
foram documentados para serem incorporados nos estudos de caso. 
Nos estudos de caso, o MCHM foi incorporado na fase inicial do desenvolvimento 
de novos produtos para garantir sustentabilidade ambiental e rentabilidade, em 
concordância com da regulamentação em vigor. Durante o processo de tomada de 
decisão, o design do produto foi analisado de modo a cumprir simultaneamente 
os aspetos acima mencionados e incorporar as recomendações dos peritos. Além 
disso, estas recomendações foram consideradas em conjunto com as estratégias de 
negócio e técnicas de resolução de problemas técnicos, tais como o Case Based 
Reasoning (CBR), Design by Analogy (DA) e Theory of Inventive Problem Solving 
(TRIZ) para a resolução de conflitos entre os critérios do nível 1 e dos outros 
níveis. 
A tese proporciona aos decisores e às equipas de desenvolvimento de novos 
produtos um modelo para obter uma perspectiva mais holística sobre o 
desenvolvimento de produtos sustentáveis, relativamente às políticas, ferramentas 
técnicas/não-técnicas e estratégias de negócio. O objetivo é capacitar essas equipas 
de desenvolvimento de novos produtos para implementar soluções pragmáticas 
que assegurem a competitividade a longo prazo e o bem-estar dos stakeholders. 
 
Palavras-chave: Sustentabilidade; Multicriteria Hierarchical Model; Dispositivos 
Médicos; Desenvolvimento de Novos Produtos. 
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Chapter 1 
Introduction 
Chapter 1 is the primary chapter that outlines the whole structure of the thesis in 
terms of the motivation and scope followed by methodologies considered to 
evaluate the proposed approaches and followed by the layout of the chapters. 
1.1. Motivation and Scope 
Medical Devices are a culmination of various scientific and engineering 
disciplines. Moreover, Medical Devices have although contributed to society in 
terms of development, based on the industrial revolution and quantum leaps in 
technological advancements. Nevertheless, in an economy in which whether the 
State plays either a dominant role (e.g.: Sweden/Denmark) or minimal role (e.g.: 
United States), they would still consume substantial magnitude of renewable and 
non-renewable resources. 
Furthermore, from a standpoint of complex theory, in which entities are strongly 
interconnected and intertwined between each other, the human civilization and its 
societies (especially their economies) are strongly inter-related with the 
environment. This implies that the consumption of resources and the undesirable 
generation of waste/emissions pose an imminent threat to the continuation of the 
biosphere and our human civilization (or stakeholders) (Hauschild et al, 2005; 
Parenti, 2011; Sutcliffe et al., 2009). In fact, the paradigm of Globalization, which 
transcends national and international borders via treaties, is quite contrary to the 
diffusion of socio-economic and environmental externalities as a result of 
unfettered economic growth (Parenti, 2011). These considerations have been 
clearly outlined and addressed by virtue of various initiatives and policy related 
mechanisms by countries across the globe under the aegis of the United Nations 
and other institutions of global reputation. For example, the United Nations report 
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titled “Our Common Future”, published in 1987, by the World Commission on 
Environment and Development (WCED). 
It is important to address the product development activities of medical devices 
within the aforementioned perspective of social, economic and environmental 
sustainability (or overall sustainability), especially in terms of a fiercely 
competitive business environment coupled with stringent regulatory compliance 
(Sobelman, 2008). 
Many research investigations in the past have illustrated that the commitment 
towards Sustainability by Enterprises and Institutions, both public and private 
have resulted in more stable ecosystems and improved income distribution which 
are necessary conditions for the perpetuation of commerce (D’Alessandro et al., 
2009). 
As a result, it is crucial to redefine the decision modelling and product 
development approaches with reference to the aforementioned domains of 
sustainability and the technical/non-technical tools utilized for commercializing a 
medical device. The endeavour to propose novel methodologies to incorporate 
overall Sustainability in this thesis emanates from the acknowledgement of a wide 
array of conflicts/synergies, which are a result of a multitude of specifications 
based on the criteria of overall Sustainability. Moreover, a series of conflicts and 
synergies which are embedded within each other should be resolved by the 
proposed prioritization based decision modelling approach discussed in this 
thesis coupled with business strategies and known problem solving techniques 
(Khomenko & Ashtiany, 2007). The prioritization based decision model titled as 
the Multicriteria Hierarchical Model (MCHM) is devised to execute trade-offs 
between certain criteria (and its corresponding specifications) in scenarios where 
the conflicts between them are irreconcilable.  Likewise, the MCHM in this thesis 
is re-structured to propose a novel product development approach that addresses 
the diverse facets of the products’ life cycles namely cradle-to-cradle/grave and 
business life cycle which begins from R&D to decline phase (Hauschild et al., 2005; 
Wejnert, 2002). 
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The thesis has committed a substantial number of pages to review existing 
literature in both decision modelling and product development approaches which 
either include or disregard overall Sustainability. During the literature review it is 
revealed that certain decision modelling techniques require exhaustive and cost 
intensive analyses, while certain product development approaches are profound 
enough to demand the assessment of the maturity levels of various technologies 
and sciences that forms the basis of the products’ functionality (Alexandre et al., 
2003). Therefore, the proposed models and approaches address the pragmatic 
impediments encountered by the Enterprises at the frontiers of their resources 
namely (but not limited to) time, managerial capacity, material properties and 
finance. 
In addition, the thesis does discuss the critical role of various technical tools for 
reducing the project timeline of a medical device under development which are 
specifically pertaining to life cycle management, knowledge based 
engineering/knowledge management and design engineering approaches (Patil, 
2010). Accordingly, a Multifaceted Framework that is proposed by acknowledging 
the utilization of these diverse technical and non-technical tools in conjugation 
with the proposed MCHM. 
Furthermore, the evaluation of the effectiveness of these proposed decision 
modelling and product development approaches was based on a case study 
approach which encompassed detailed interaction with participants and in some 
cases active participating to ensure that a certain degree of overall sustainability is 
attained during the initial phases of the product development (Yin, 2003). The case 
studies did entail interviews with experts from academia and industry who 
provided their wisdom and tacit knowledge with reference to the criteria in the 
MCHM and its corresponding product development models. As a result, the 
feedback was incorporated during the product development process of the 
Enterprises that were chosen for case studies. The goal was to ensure that the 
proposed models and approaches were evaluated in the scenarios for which it has 
been devised. 
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Towards the end of the doctoral research, the investigation revolved around 
comprehending the historical, policy centred and philosophical dimensions of 
technology development and sustainability. This final phase endeavour enables 
the product development teams to acknowledge the crucial role of policy and 
Government sponsored research projects and initiatives to foster mutually 
beneficial public-private partnerships. For example, the GeSI and StEP initiatives, 
outlined by the United Nations (2009), to enable public and private institutions 
with policy makers and other experts for developing as well as exchanging 
technologies for recycling electronic waste. This implies that private institutions 
are able to attain overall sustainability only up to a certain degree beyond which 
State sponsored involvement becomes necessary to actualize a more cost effective 
approach towards overall Sustainability. 
1.2. Objectives of the Thesis 
The core objective of the thesis is to deliver a holistic and a pragmatic approach 
towards decision modelling and product development for Medical Devices with 
the simultaneous incorporation of the three domains of overall Sustainability 
namely Social, Environmental and Economical. 
Concurrently, the research propositions are centred on the critical role played by 
the following paradigms in attaining overall Sustainability: product design, 
accessibility and utilization of Enterprises’ resources and the role of regulatory 
frameworks with socio-economic policies that could either promote or impede an 
Enterprise to incorporate a higher degree of overall Sustainability.  
The core objective is further elaborated as follows:  
a) Conduct a thorough literature review of existing product development and 
decision modelling approaches that include or exclude the considerations for 
overall Sustainability. The review is intended to unearth various shortcomings of 
the contemporary approaches followed by incorporating preliminary feedback by 
experts from academia and Industry to determine opportunities for improvement. 
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b) Proposing a novel approach towards decision modelling for developing 
Medical Devices with a substantial degree of overall Sustainability. The proposed 
decision modelling approach is titled as ‘Multicriteria Hierarchical Model’ 
(MCHM). The proposed decision modelling approach contains pertinent criteria 
encompassing overall Sustainability, which is devised to resolve conflicts that 
arise as a result of considering multiple criteria and its corresponding product 
specifications to attain a very high degree of Sustainability. Moreover, the role of 
contemporary problem solving techniques is to be explored for resolving conflicts 
during the evaluation of the MCHM within the case study approach. 
c) To propose a novel product development process based on the proposed 
decision modelling approach (MCHM). Furthermore, exploring the role of MCHM 
in product design optimization and to evaluate the effectiveness in pragmatic 
terms with respect to its implementation. 
d) To conduct interviews and discussions with experts from academia and 
industry in order to evaluate the co-relations between the criteria outlined in the 
MCHM. The aim is to accumulate wisdom, insight and tacit knowledge for 
executing decisions in substantially complicated circumstances that requires 
product development teams to simultaneously address multiple considerations 
pertaining to overall Sustainability. 
e) To conduct detailed case studies that entails discussions, interviews, 
questionnaires and in certain cases active participation in the Enterprises chosen 
for the case studies in order to evaluate the effectiveness of the MCHM and the 
novel product development process. Moreover, to determine the feasibility of 
incorporating the expert feedback during the early stages of product development 
during the case studies approaches. 
1.3. Methodology 
The aforementioned approaches for decision modelling and product development 
for the incorporation of overall Sustainability have been were devised for 
industrial application in the near future. This justifies the adoption of the case 
study approach that was conducted with 6 entities that comprised of research labs, 
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small-medium sized companies (SME) and large sized companies that develop 
and/or manufacture medical devices ranging from Class I to Class III categories. 
To clarify further, a single case study comprised of evaluating the proposed 
models and frameworks within a single entity. Therefore, 6 entities imply 6 case 
studies in this thesis.  
The case study approach provides substantial flexibility to consider a wide 
spectrum of data collection methods ranging from interviews, questionnaires, 
active participation/observation and reviewing relevant documentation. 
Although, the case study approach is most appropriate when the user can exert 
only a limited influence on the outcome of the process under examination (Yin, 
1994). However, in a few of the cases, active participation was considered to 
modify and improvise the existing product development process and product 
design approaches for the incorporation of overall Sustainability. Meanwhile, 
specific recommendations were provided for some of the cases after thorough 
observation of the product development process and reviewing opportunities for 
either incorporating or enhancing overall Sustainability.  In this thesis, due to 
more than one case is considered in terms of multiple enterprises with multiple 
units (i.e. decision modelling and product development approaches) under 
review. Hence, the most appropriate category of case study is this thesis is Type 4 
(Yin, 1994). The units of analyses were evaluated by the case study approach with 
respect to the three research propositions mentioned in Section 1.2. 
Moreover, the method of informal conversational interviews was considered for 
obtaining feedback and insights from the experts from academia and industry 
during the pair-wise comparison of the criteria outlined in the MCHM. The pair-
wise approach is adopted from the Analytical Hierarchical Process of decision 
modelling which has also been substantially restructured to devise the MCHM 
(Saaty, 1990). Moreover, the informal conversational interview approach is able to 
provide the flexibility of capturing the insight and tacit knowledge of the experts 
by co-relating more than one criterion simultaneously with reference to diverse 
economic circumstances. 
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The feedback from these experts was incorporated within those case studies that 
permitted active participation. Similarly, for the evaluation of the multifaceted 
framework, the interview approach was coupled with a questionnaire to focus on 
a few relevant questions without expending too much time while simultaneously 
gaining an appropriate degree of in-depth knowledge on the multifaceted 
framework from the Experts. 
Even though the case study method has been criticized for not being substantially 
rigorous in nature compared to other evaluation methods. However, as various 
medical device companies which develop/manufacture a wide array of medical 
devices ranging from syringes to neural prosthesis. As a result, it is crucial to 
consider a suitable evaluation methodology such as the case study approach that 
is flexible in nature in terms of the context of the medical device and the 
enterprises developing or manufacturing it.  
As the product development process of such diverse medical devices do possess 
their own idiosyncrasies with reference to opportunities for incorporating overall 
sustainability. Furthermore, the results of one case study within an Enterprise that 
develops medical devices cannot be necessarily be ‘literally replicated’ in other 
cases in which medical devices are manufactured either in a SME or a large sized 
company. This opens the case study approach towards the paradigm of theoretical 
replication in which different results are obtained based on specific circumstances 
of the medical device and the Enterprise under review (Yin, 1994). 
1.4. Organization of the Thesis 
The research was conducted according to the outlined objectives.  
Chapter 2 discusses the existing gaps and shortcomings of the contemporary 
medical device development approaches. As these devices consume substantial 
renewable and non-renewable resources that further instigate a series of 
interconnected social, economic and environmental impacts. The exhaustive list of 
criteria ranging from regulatory compliance, market competition and 
aforementioned domains of sustainability is overwhelming for an organization in 
terms of their human, financial and non-financial resources.  
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Moreover, the real-life challenges facing medical device development are rising 
healthcare costs in terms of allocation of Government funding and inclusion of 
more stakeholders with ever changing requirements. This justifies proposing new 
product development and decision modelling approaches to enable product 
development teams to exploit synergies and select suitable trade-offs in terms of 
cost effectiveness, quality and speed. In this chapter a contemporary product 
development approach is compared to a systems engineering based development 
approach in accordance with the quality systems requirements stated by the 
regulatory agencies such as the FDA. 
Based on the discussed challenges and limitations encountered during the 
incorporation of overall sustainability considerations within the design phase, the 
product engineers and managers require a comprehensive and simplified 
decision-making tool for governing their development process. The desired 
decision model should utilize prioritization of various sustainability 
considerations in accordance with the regulatory compliance and the desired 
degree of economic growth (Ambec & Lanoie, 2008; Vogel, 2005). The 
prioritization would facilitate the product engineers and designers to exploit the 
synergies and resolve the necessary trade-offs across products and product 
portfolios. 
In Chapter 3, the approach of delivering the utility (the desired outcome) of a 
medical device, in contrast of the actual physical good is exemplified. Moreover, 
the strategy of Product-Service System (PSS) is based on Systems Engineering and 
envisioned to accommodate a more modular structure for easier assembly, 
disassembly and even End-of-life options. This implies means that not all types of 
medical devices, which range from heart valve to wheelchairs, can be considered 
for the Product Service System (PSS) method. Even though savings in cost and 
energy/materials could occur by adopting the Product Service System approach 
and end-of-life options; nevertheless they may also incur their own opportunity 
costs and may not be always be accepted by the market/stakeholders. 
Furthermore, the medical device company should bear in mind the basic 
limitations they would encounter during product development in terms of time, 
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skills/knowledge of human resources, engineering tools, material properties, 
finance and regulation. These limitations may also pose an impediment for a 
medical device company to re-organize its value chain partners (such as suppliers, 
distributors and manufacturers) to counter uncertainties and mitigate undesired 
risks.  
The three tier multicriteria hierarchical model (MCHM) is introduced in this 
chapter that is inspired from Analytical Hierarchical Process (AHP) only in terms 
of its hierarchical nature of a wide spectrum of interconnected criteria. The 
decision model is called Multicriteria Hierarchical Model (MCHM). The AHP 
approach that forms the basis of the MCHM is considered to be simple and 
accounts for a wide spectrum of factors, criteria and indicators for decision 
making in a consistent manner with a common scale without any units. 
Furthermore, the MCHM aims to address complex product development and 
engineering scenarios, while concurrently maintaining the inherent simplicity of 
the AHP. The first tier is compulsory and non-negotiable with the minimal degree 
of sustainability, while the other two are additional degrees of overall 
sustainability that have to compulsorily comply with each criterion of the first tier. 
Moreover, each criterion is represented by one or more product specifications 
whose optimal values would be decided during preliminary engineering analysis 
in Stage 2-3 of the product development process in accordance with the product 
specifications of other criteria as well. The three tier approach which contains two 
main criteria namely, Regulatory Compliance and Economic & Business 
Performance does not only enable the senior management of a medical device 
company to select suitable projects for further development during stage gate 
process, but also assists product development teams to define the degree of 
effectiveness of the tools they need for their activities. In addition to the 
consideration of conceptual and technical tools for product development, a robust 
product life cycle management infrastructure with information technology system 
is crucial to synchronize a wide spectrum of exhaustive activities. 
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The chapter also simultaneously discusses the various decision modelling 
approaches used to addressing overall sustainability and their limitations. 
Especially for techniques such as Cost Benefit Analysis that considers 
substitutability between various impacts and denotes every undesired externality 
in monetary terms. However, assigning financial values has proved to be less 
effective and reductionist in nature, bearing in mind the closely interconnected 
relations between social structures, environment and economics. Moreover, in our 
globalized world almost every geographical region has diverse cultures and their 
own viewpoints in concurrence with on their livelihood that further complicates 
the geo-political scenario in which a medical device has to operate. Thus justifying 
the need of a comprehensive as well as simplified approach towards medical 
device development. 
This thesis explores the opportunity of the decision model MCHM inspired from 
AHP to be an actively participating entity within the product development 
process of a medical device as opposed to previous research investigations in 
which AHP has been mostly considered to select or reject alternatives. Moreover, 
the criteria of the AHP do not have a strong co-relation or co-dependency between 
each other, as opposed to circumstances in the real world. 
The interconnected nature of the criteria in the MCHM would enable the product 
development teams to define the sensitivity values of one criterion over the other. 
Moreover, outlining the sensitivity of one criterion over other criteria would also 
enable the product development teams to ascertain potential risks and even locate 
the source of undesired outcomes. Consequently, the elucidation of the 
interconnectedness between the criteria of the MCHM facilitates risk evaluation as 
well as planning suitable mitigation strategies throughout the life cycle of the 
product. 
In the subsequent chapters, the role of MCHM in medical device development 
would be discussed in detail. This would be materialized by incorporating the 
MCHM within a Multifaceted Framework that comprises of a wide spectrum of 
technical tools and conceptual approaches for product design and development. 
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Chapter 4 contains a detailed discussion on a wide spectrum of product 
development approaches that are utilized by the industry. These product 
development approaches encompass various forms of life cycles of the product life 
cycle management in order to attain sustainability. Moreover, these conceptual 
models are required to be integrated with technical tools for design, engineering 
and production in a seamless manner for streamlining both product development 
and commercialization. Therefore, this chapter explores the opportunities for 
incorporating the Multicriteria Hierarchical Model (MCHM) during the design 
phase of the product under development so as to enable the decision makers to 
select/reject suitable product design configurations. 
Furthermore, the chapter begins with the discussion of various conceptual 
product development approaches, which have illustrated an extensive focus on 
long term planning, product configuration and its underlying technologies and 
flexibility within the value chain to adjust for uncertainties. In this chapter, the 
most important facet of non-linearity of product development and design is also 
illustrated and discussed. In addition, the various technical tools in design, 
engineering analyses and product development planning are briefly outlined. 
Moreover, the critical role of identifying, storing and ensuring the accessibility of 
engineering and non-technical knowledge is ascertained to be crucial for adhering 
to the project timelines. Similarly, product development teams have to define an 
engineering analysis (or simulation) strategy to ensure that the evaluation of the 
virtual product is more comprehensive without expending excess of time and 
resources. 
Notwithstanding, the advantages of customizability of the proposed multifaceted 
framework for a wide array of medical devices, the product development teams 
would have to manually assign the values to each specification for every criterion. 
The arduousness of the customizability is governed by the complexity of the 
device that may or may not relevant to the pre-defined classes of the medical 
devices. Nevertheless, Knowledge Based Engineering applications can be 
incorporated for automating unproductive repetitive tasks to mitigate the 
aforementioned impediment. The proposed multifaceted framework has been 
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devised by considering the critical role of the MCHM for product design 
optimization by conducting an exhaustive literature research and validation by 
expert opinion. Furthermore, the literature review reveals that the coordination of 
a multitude of technical tools and computer-based systems could elucidate 
conflicts in terms of their data formats and programming structures. The objective 
of this chapter is to demonstrate the active participation of the MCHM Design 
Optimization Procedure. 
Chapter 5 details the research methodologies adopted in this thesis. 
Chapter 6 is divided into three exhaustive sections to provide in-depth discussions 
of the results pertaining to the methodologies adopted in Chapter 5 for evaluating 
the decision modelling and product development approaches in Chapter 2, 3 and 
4. The first section that discusses the one by one pair-wise comparison of the 
criteria outlined in the MCHM by the experts reveals that in pragmatic 
circumstances each criterion should be co-related with multiple criteria, 
simultaneously. Furthermore, the experts also pointed out that an Enterprise, 
which intends to incorporate overall Sustainability, should adopt novel strategies 
for product design, business operations and even interaction with relevant policy 
makers.  As the AHP approach requires pair-wise comparison on a one to one 
basis, while reality as stated by the experts is far more complicated to co-relate 
multiple criteria simultaneously and also consider the flexibility of disregarding a 
few irrelevant criteria (except Tier 1) to adhere to the project timelines. The second 
section discusses the feasibility of the multifaceted framework by using informal 
conversational interviews, questionnaires and literature review in accordance with 
experts from both Academia and Industry. 
The justification for considering expert opinion is because most of the conceptual 
frameworks, technical tools and optimization approaches have been 
comprehensively studied by both Industry and Academia for almost more than a 
decade.  
As per the experience of the experts, the multifaceted framework is suited for 
large sized companies with enormous research and development infrastructure. 
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Moreover, incorporating non-technical knowledge within design optimization, 
which is pertaining to socio-economics and business strategy, would reduce the 
effectiveness of the optimization activity, as it would require continuous human 
intervention. Concurrently, as concluded from the expert opinion, the 
effectiveness of the multifaceted framework in design optimization is determined 
to be entirely dependent on the complexity of the product configuration and the 
magnitude of design optimization required. In addition, the experts emphasized 
on the ability of the product engineering teams to address incompatibilities 
originating from the data formats and programming structures of the technical 
tools pertaining to computer design and engineering, ecological impact evaluation 
and regulatory compliance systems. 
The goal of the multifaceted framework is to evaluate the effectiveness of the 
MCHM and its ability to go beyond conventional decision modelling into design 
optimization at a comprehensive scale. Ultimately, it was concluded that the 
MCHM is most effective as a conventional decision-modelling tool for selecting 
suitable projects and even solving conflicts within product design as opposed to 
playing a critical role in design optimization. 
The third section discusses each entity (Research Lab, Small-Medium Enterprise 
and Large sized Enterprise) for which the case study approach was adopted to 
evaluate the effectiveness of the decision modelling and product development 
processes with reference to the previously mentioned research propositions in 
Section 1.2. This section provides the basic description of the Entity with the 
justification for its selection followed by relevant information on the data 
collection methods considered for the case study and the categories of case study 
approach which were applicable such as Explanatory, Exploratory and 
Descriptive. 
The final chapter of Conclusions and Future Research not only summarizes the 
preceding chapters but also co-relates it with certain pertinent concepts in 
Economics, especially the economic circumstances considered in the first section of 
Chapter 6 during pair-wise comparisons interviews of the MCHM criteria. The 
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conclusions from the case studies revealed that entities by themselves can 
incorporate overall sustainability only to a limited degree beyond which the role 
of State or State based Institutions play a more dominant role in defining policies, 
fostering partnerships and even providing subsidies or grants for developing 
robust technologies. 
To conclude, this thesis on decision modelling and product development of 
medical devices is unique owing to its strong co-relation with economic and social 
paradigms which not only leads to a successful medical device but even provides 
a justification in terms of need and market demand for a medical device to be 
commercialized. 
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Chapter 2 
Fundamentals of Sustainability with respect to 
the Development of Medical Devices 
2.1. Introduction 
Recent published work in academic journals has pointed out the need for more 
research on the identified gaps and shortcomings of the current strategies 
employed in the development of sustainable medical devices. The facet of 
sustainability comprises of social, environmental and economic considerations. 
This chapter discusses the existing gaps and shortcoming of contemporary 
medical device development. As these devices consume substantial renewable and 
non-renewable resources that further instigate a series of interconnected social, 
economic and environmental impacts. Consequently, these aforementioned 
categories of interconnected impacts would pose an impending threat to the 
continuation of an Enterprise that develops and/or manufactures Medical Devices 
across Class I to Class III.  Likewise, the chapter entails a detailed review of the 
contemporary product development processes from a business perspective as well 
as a systems engineering standpoint. 
The objective of this chapter is to illustrate the shortcomings in the existing 
product development processes of medical devices and in addition highlight their 
incapability to accommodate for the three domains of Sustainability. 
2.2. Basic introduction to Medical Devices and Sustainability 
The sector of medical devices comprises of products as simple as a tongue 
depressor (Class I) to complex and interdisciplinary devices as an implanted 
pacemaker (Class III) <http://www.fda.gov/MedicalDevices/default.htm>. 
Moreover, the development of medical devices is an extremely resource intensive 
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endeavour throughout its development and production life cycle, namely, at the 
frontiers of energy, materials, human (man hours) and knowledge (skills and 
expertise). 
The onset of globalization has placed immense pressure on both stringent 
regulatory compliance and business performance (Sobelman, 2008). Moreover, the 
medical devices sector similar to every other industrialized sector consumes non-
renewable energy and resources on a massive scale, especially single-use devices 
(Hanson & Hitchcock, 2009). Consequently, both regulatory agencies and 
governments across the globe have raised their concern for the continuation of the 
global scale Industrialization with reference to the current global socio-economic 
and environmental circumstances (World Commission on Environment and 
Development 1987) <http://www.un-documents.net/ocf-03.htm>. 
Meanwhile, the availability and accessibility of non-renewable energy and 
resources are gradually diminishing for every other business sector including the 
medical device industry, which intends to capture a larger global market share 
(Hanson & Hitchcock, 2009).  
These three facets of sustainability are social, economic and environmental 
sustainability, which are strongly interlinked and interdependent upon each other. 
Consequently, the environmental impacts initiate significant pressure onto the 
business performance and the dimensions of socio-economic welfare (Hauschild et 
al, 2005; Parenti, 2011; Sutcliffe et al., 2009). Thus making it imperative for the 
medical device industry to consider overall Sustainability (i.e. social, economic 
and environmental sustainability) within the initial phases of its development and 
throughout its life-cycle phases, namely, extraction, production, distribution, 
utilization, disposal and end-of-life (Hauschild et al., 2005). 
This thesis intends to simultaneously address the social, environmental and 
economic dimensions, following the Triple Bottom Line Approach (Sutcliffe et al., 
2009). The Triple Bottom Line Approach enables the product developers to 
develop tools and techniques (both conceptual and technical in nature) to identify 
and address various synergies/trade-offs during the early stages of the product 
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development cycle (Sutcliffe et al., 2009). For example, a new material for the 
external casing of a pacemaker is both environmentally friendly and compliant 
with FDA regulatory standards. On the other hand, surgical tools that require 
certain alloys owing to their strength and surgical performance could consume 
significant non-renewable resources for its production that results in large 
quantity of emissions. In such cases the medical device company can optimize the 
consumption of resources in order to minimize the release of the corresponding 
emissions. Furthermore, the company should consider replacing the alloy by a 
more sustainable material, provided it complies with the FDA regulatory 
standards <http://www.fda.gov/MedicalDevices/default.htm>. 
The exhaustive list of criteria for both regulatory compliance and sustainability are 
determined to be overwhelming, especially in terms of a fiercely competitive 
market, managerial capacity (e.g.: availability of time and human resources) and 
technological limitations (e.g.: limitations of modelling software and material 
properties) (Project Management Book of Knowledge, Project Management 
Institute, 2010).  
This scenario necessitates the need for establishing a priority based decision-
making and product development approach, to address various synergies and 
trade-offs. Therefore, the essential criteria would be prioritized in order to deliver 
a significant magnitude of sustainability without compromising the regulatory 
compliance and basic economic growth objectives that would result in a more 
profitable product.  
The core focus of this chapter is to discuss the importance of a priority based 
decision-modelling approach for governing the product development of a 
sustainable medical device. The subsequent chapters would outline and discuss in 
detail the structure of the priority based decision modelling approach and a novel 
product development approach for sustainable medical devices. Likewise, the 
thesis briefly discusses the other critical success drivers for developing sustainable 
medical devices, including the role of knowledge management and a robust 
Information Technology Communication infrastructure. The motivation to do so is 
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based on the significant presence of interdisciplinary research in medical devices 
that originates from diverse scientific and engineering disciplines. 
The priority based decision model is envisaged to enable product engineers and 
managers so as to implement sound decisions at the upper management level 
(e.g.: project selection of the most sustainable and economically viable project, out 
of a list of alternatives) as well as the level of critical engineering details in a 
product development endeavour. For example, the product engineers and 
managers can finalize the level of customization needed for a computational 
modelling tool to be considered for product design and simulation.  
The priority based decision modelling would be primarily based on the weights 
assigned to the pertinent criteria of the decision model. The assigned weights 
would be based on the degree of importance with reference to the regulatory 
compliance criteria, business growth criteria and relevant criteria pertaining to 
overall Sustainability. Moreover, in certain circumstances medical devices are 
exempted from adhering to RoHS compliance (Restriction of Hazardous 
Substances Directive). 
2.3. Challenges faced by medical devices companies 
The dynamics of the business, economic, political and regulatory scenarios exert a 
substantial influence on the innovation and product development strategy of a 
medical device company. The resultant impact would be the inability of a medical 
device company’s product development strategy to simultaneously address 
multiple and diversified challenges. Therefore, leading to the failure of the 
company or transformation of the company into a competitive market player.  
In this respect, Faniel (2011) has identified two challenges that medical device 
companies and other healthcare organizations would have to surmount in order to 
stay competitive: rising healthcare costs and its impacts on users, device 
developers and regulatory bodies and inclusion of multiple stakeholders and their 
ever-changing requirements. In the same document of Faniel (2011) mentioned 
that the recently published report by OECD (Organization for Economic Co-
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operation and Development) stated that nations invest around 10% of GDP on 
healthcare, which is expected to rise up to 16% at the same rate of growth by 2020. 
This has also resulted in the current inability of governments, citizens and 
institutions, such as insurance companies to afford rising healthcare costs. 
Furthermore, limited funds for a large number of patients subjects the medical 
devices to a much more rigorous evaluation procedure; thus leading to delays in 
time to market, delayed profits and eventually revenue losses. Meanwhile, the 
end-user and clients of the device desire a significant improvement in the medical 
device in order to justify their purchase. This is also applicable to medical device 
organizations that need to justify the expenditure of resources for the 
development, regulatory approval and marketing of a new medical device (Miller, 
2007). 
Accordingly with reference to the economic challenges, the medical device 
companies are required to consider various stakeholder requirements, which 
further leads to a higher degree of uncertainty in the product development 
process. For example, changing knowledge about various diseases, modifications 
in the regulations for insurance and reimbursement, competitive negotiation 
concerning the cost management objectives between the device developers and 
hospital purchasing departments. Additionally, identifying, developing and 
implementing of methodologies to maintain the equilibrium between the 
consumption of renewable and non-renewable resources versus its rate of 
replenishment (Cohen & Howard, 2006; Fiksel, 2006). 
As mentioned in the introduction that the above mentioned challenges 
encountered at the frontiers of environmental and socio-economic dimensions 
coupled with the demand for higher patient satisfaction, subjects the medical 
device companies to substantial pressure in their product development 
approaches and innovation strategies. However, these pressures both compel the 
medical device companies to identify pre-existing gaps and the newly created 
gaps in their existing methodologies.  
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The medical device companies are therefore required to implement methodologies 
and devise pertinent business processes for the identifying the relevant gaps and 
shortcomings in order to resolve conflicts and synergies between their business 
objectives and the various cross organizational boundaries pertaining in to their 
stakeholders (including end-users, regulatory bodies and insurance companies). 
These cross organizational boundaries pertaining to their stakeholders include but 
are not limited to environment, socio-economic domains, human resources, end-
users, patients, regulatory bodies, suppliers, distributors, manufacturers, 
development collaborators, shareholders, remote/distant communities, 
government(s), healthcare institutions and insurance companies (Charter, 1998). 
The inclusion of stakeholders within the business growth objectives results in a 
more holistic and sustainable approach towards product development. 
2.4. An insight into the best practices of the Medical Device 
Industry’s Product Development Process  
The utilization of certain business processes and best practices in collaboration 
with disciplined engineering efforts could enable medical device companies to 
identify the various gaps and shortcomings in their development methodologies 
for addressing the social, economical and environmental dimensions of 
sustainability.  
Accordingly, Vogel (2005) has enumerated a list of numerous facets in the product 
development process of medical devices that indicate the various 
gaps/shortcomings and the demarcation between successful market leaders in 
contrast to their contemporaries. 
Bearing in mind the previously stated challenges by Faniel (2011), medical device 
companies are working towards a shorter development cycle for enhancing their 
cash flow of revenues. Moreover, for a shorter product development cycle, a well-
defined engineering process embedded with regulatory controls serves the market 
needs with higher reliability and quality of performance towards the stakeholders. 
These are mainly, but not limited to Food and Drug Administration (FDA) for 
Device Regulation, International Organization for Standardization (ISO), 
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International Electro-technical Commission (IEC), European Standards (EN) and 
Directive on Waste of Electrical and Electronic Equipment  (WEEE). 
In addition, Vogel (2006) stated that the “Design Control” and “Validation” within 
the Quality System Regulations prepared by the FDA are nothing more than a 
collection of good engineering practices that a medical device company should 
consider in its product development programs (Vogel, 2001). 
The most crucial regulatory compliance procedure in itself provides the bare 
minimum social and environmental sustainability, in terms of safety standards for 
the end-users and minimization of environmental hazards, respectively 
<http://www.iso.org/iso/home/store/catalogue_ics/catalogue_ics_browse.htm
?ICS1=13>. Meanwhile, the profitability (also a part of economic sustainability) 
entirely depends on the medical device company and the external drivers to its 
business such as volatility in the price of raw materials. 
The objective to achieve a shorter product development cycle with the highest 
product quality and regulatory compliance, a medical device company would 
always encounter a complex relationship between the parameters of quality, speed 
and cost effectiveness. As a result, the medical device company would need to 
resort to exploiting the synergies and executing suitable trade-off between these 
aforementioned parameters (Almonor, 1998). The source for the trade-off usually 
is a result of the Pareto optimal frontier wherein one parameter cannot be 
improved without worsening the other (Zhao et al., 2010). Moreover, it is the role 
of the project manager to determine the appropriate balance between the 3 facets 
of sustainability based on the fulcrum of regulatory compliance (specifically FDA 
and ISO) so as to exploit the synergies and/or make the desired trade-offs. It is 
advisable for medical device companies to implement a disciplined mode of 
engineering and project management practices in order to actualize a continuous 
improvement of the business processes with minimal degree of any undesired 
inconsistencies. 
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Following are the facets of product development process and business practices 
that would enable medical device companies to determine the gaps and 
shortcomings in their product development methodologies:  
i. Defining the quintessential of Quality 
It is essential for the medical device company to primarily identify its criteria of 
quality, as various stakeholders of a medical device company perceive quality 
related criteria in their own perspective such as: 
•Regulatory agencies desire demonstrable evidence of performance, sustainability 
and safety. 
•Users perceive quality in terms of meeting the needs of cost, quality, 
performance and ease of use. 
•Sales department defines quality in terms of the device attributes that can be sold 
at competitive prices. 
•Service departments define quality in terms of devices that are low maintenance. 
•Engineers sometimes perceive quality in terms of the implementation of the 
latest technology with superior reliability. 
The project manager must establish the most appropriate degree of trade-offs so as 
to address the above needs with the highest priority assigned to the regulatory 
compliance requirements and bare minimum economic growth without which no 
medical device would be approved for commercialization.  
ii. The Speed of Development with respect to Allocation of Resources 
The pressures of a fiercely competitive market and the sustainability commitment 
to consume lesser quantity of renewable/non-renewable resources, drives the 
medical device company to compress the development schedules and squeeze the 
resource consumptions in order to deliver a profitable product. Enhancing 
communication between the project participants/stakeholders and streamlining 
the utilization of resources in a non-linear fashion can improve the development 
speed. Meanwhile, inconsiderate compression of the schedule without due 
diligence and paying less attention to the validation and verification steps such as 
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the General Principles of Software Validation, FDA (2002) 
<http://www.fda.gov/downloads/MedicalDevices/.../ucm085371.pdf> could 
result in a series of maintenance releases towards the end of the project. This 
would result in the service department being overwhelmed with multiple end-of-
the moment tasks to be completed. Therefore, the objectives have to be realistic in 
order to motivate the engineers, managers, and financers of the project to 
channelize their efforts, accordingly. Likewise, in terms of allocation of resources, 
sometimes multiple projects are squeezed into a limited set of resources, which 
results in the aforementioned detrimental effects. Both these facets if improperly 
addresses could negatively affect project schedules, product performance, 
reputation and safety related hazards 
iii. Regulatory Compliance: The Final Decision for the approval of a Medical 
Device 
The medical device company, as stated by the FDA should implement the 
business processes and design controls throughout the product development cycle 
in order to lower costs and improve product quality with a shorter development 
cycle.  
Regulatory compliance acts as the fulcrum of the interdependency between the 
factors of cost effectiveness, quality and speed.  It is imperative that throughout 
the product development endeavour, the regulatory compliance is to be 
maintained and the documentation should be regularly updated with the least 
possible time delay. Accordingly, Patil (2010) recommends the utilization of a 
robust information technology communication infrastructure as a key important 
driver for the comprehensive product life cycle management of medical devices. 
The advantages stated by Patil (2010) are the continuous iterative design and 
development of the medical device. Meanwhile, the IT communication 
infrastructure also permits the traceability and auditability of the tasks/activities 
involved. The IT Communication infrastructure also assists in automated 
updating of the regulatory documentation in order to prevent any project 
schedule overruns and errors that stem from manually handling the 
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documentation procedure. The end result is enhanced accuracy in the overall 
development process and significant savings in time/resources that can be 
focused on other essential parts of the project.  
A delayed regulatory approval, due to poor regulatory compliance during the 
initial phases of development, can result hamper the creditability and continuity 
of the medical device company. From a market share standpoint, the medical 
device company must bear in mind that each medical device product has a finite 
saleable time and consequently, each day in the Research and Development 
shortens the window of the sales period by one day. Furthermore, the shortening 
of the sales window implies that the company has much lesser time to sell its 
medical devices in order to gain a desired level of Return on Investment and 
unfortunately this could also increase the uncertainty concerning stakeholders’ 
requirements. Furthermore, delayed product launches leads to the competitors 
gaining advantage and also increases the probability of becoming out dated as 
practices and standards change at a rapid pace. The costs related to human 
resources, administrative and overheads can eradicate any profits expected from 
the market due to the additional costs of unused resources of sales, marketing, 
distribution, manufacturing and engineering. Therefore, finalizing the most 
suitable trade-offs for identified conflicts and exploitation of synergies is critical 
for the success of medical devices under development. Similarly, the application 
of comprehensive and simplified decision making tools and techniques are of the 
utmost importance. 
iv. Verification and Validation: According to the FDA regulations, verification 
and validation is of the utmost importance for developing a robust and reliable 
medical device. Verification comprises of evaluating the technical requirements 
that are translated from the user requirements. Validation is to assess the product 
based on its ability to address the overall user/stakeholder needs. The 
verification/validation activities should be conducted for both the software, 
hardware and all other associated systems/sub-systems of a medical device 
throughout the development cycle. The early identification of product deficiencies 
enables to improve quality, cost and decreased time to market.  
 25 
Sobelman (2008) recommends the verification and validation activities to be 
incorporated upstream into the design cycle, through virtual and rapid 
prototyping coupled with testing and user-environment evaluation. The early 
incorporation of validation/verification would enable the shortening of the 
development cycle without compromising any of its advantages.  
v. Traceability: The need to include numerous and diverse requirements of all the 
concerned stakeholders is overwhelming for any medical device development 
endeavour. Therefore the validation/verification stages require the inclusion of a 
strongly connected traceability network in order to enable the “tracking” and 
“linking” of the various higher level requirements (such as lower emissions of 
CO2) to the numerous lower level requirements (user safety such as visual 
indictors to inform elderly patients about the correct mode of use) and finally up 
to the exhaustive design related elements. The traceability assists the product 
development teams to determine the relevant the metrics for monitoring the 
project. 
Traceability has further roles and advantages enumerated as follows: 
•To identify the high-level requirements that have not been defined and 
implemented for designing. 
•To identify the design elements that do not trace back to lower-level or higher-
level requirements. 
•To enable the ease in maintenance of the overwhelming documentation 
pertaining to regulatory compliance, business processes and product 
development. 
vi. Risk Management: The ISO 14971 standard is applicable to systems, 
subsystems, hardware and software of medical devices 
<http://www.iso.org/iso/catalogue_detail?csnumber=38193>. The risks can 
range from schedule overruns caused by ineffective design simulation [to] 
erroneous use of a device by the user due to poor user safety design [to] health 
hazards caused by toxic waste disposal and emissions during the production of 
the medical device. 
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Risk Management is not the same as conducting a Failure Modes Effects Analysis 
and Fault Tree Analysis since it comprises of identification and analysis of various 
risks and designing of risk control measures. It is essential to devise and 
implement a Risk Management Plan throughout the Development Cycle since 
most of the failures that appear during the initial phase of development can be 
included within the “iterative” proactive risk management programme of the 
company and its collaborators. 
The project engineers and managers should encompass a systems level approach 
for their Risk Management Plan, as every medical device consists of independent 
and dependant systems and sub-systems that have to function in synchronicity 
with each other. For example, the assessment of the device software cannot be 
completed without the evaluation of the complete device performance in 
coordination with the functioning of the software.  
Therefore, a Systems Approach for Risk Management assists the managers and 
engineers to focus on engineering design approaches and the device validation 
activities in the higher risk as well as lower risks functional areas. Once the risk 
areas are identified, the development activities can be optimized and the 
validation procedures can be completed within a shorter time span which would 
further result in improving the development cycle time. 
The aforementioned facets and their associated business processes, demonstrates 
the role of effective and timely decision making for addressing the stakeholders’ 
needs and ensuring commercial success.  Therefore, the cost of the indecision of 
the manager should be considered as an additional cost, because it can result in 
schedule overruns. This includes extended time to make a decision or bad 
decisions that are made quickly without due diligence. However these costs are 
difficult to calculate as they express their negative impacts towards the later stages 
of the product development. 
This section concludes that a systems based approach utilized during medical 
device development would assist in early identification and management of 
risks/hazards relevant to the stakeholder’s requirements. Meanwhile, a 
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comprehensive and simplified decision making approach would be most suitable 
for such intensive product development endeavours so as to prioritize various 
criteria for addressing synergies, conflicts and trade-offs pertaining to the diverse 
set of stakeholders’ requirements. 
2.5. Product Development Process for New Medical Devices 
This section intends to explain the various activities and stages of the product 
development of a new medical device. 
Yang et al. (2006) discussed the various methods, tools and processes for the 
stages of product development, especially idea generation, concept definition, 
proof-of-principle, and conceptual design. The commercialization of a medical 
device requires systematic and disciplined investment of substantial resources (as 
stated in section 2.2). The endeavour requires in-depth expertise in the innovation 
process (including competition and marketing strategies), quality assurance, 
safety management and regulatory compliance in order to address the fierce 
competition brought about by large and small-medium medical device companies 
(Garnsworthy & Bell, 2004; Rainey, 2005). 
2.5.1. Introduction to the Medical Device Development Process 
Yang et al. (2006) proposes an iterative and integrated product development 
approach that incorporates strongly interconnected structures, activities, 
information flows and resources (see Figure 2.1). The aforementioned 
interconnected facets permit changes in the engineering design after 
inconsistencies are identified during the stages of prototyping, clinical testing and 
validation/verification stages. Moreover, the concept definition together with the 
engineering activities plays a key role in planning the manufacturing process.  
The mentioned approach as shown in Figure 2.1 systematically transforms 
stakeholders’ requirements as inputs into well-defined deliverables; thus, 
resulting into a product ready for commercialization. The product development 
process activities are outlined into various stages with in-between decision-
making gates, namely innovation (idea generation, concept definition, proof of 
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principle), creation (engineering design, prototype, testing), realization 
(manufacturing, clinical trial, validation) and launch. 
 
 
Figure 2.1. – Schematic representation of a widely used product development 
methodology for medical devices (Adapted from Yang et al., 2006; Borja et al., 
2000). 
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2.5.2. Critical Segments of the Medical Device Development Process 
Following are the stages that are carried out concurrently and in an integrated 
manner for shortening the development cycle:  
a) Assessing Market Opportunities 
It is essential for the medical device company to identify suitable market 
opportunities with respect to the corresponding stakeholders’ requirements. The 
medical device company should be capable of addressing the market 
opportunities through comprehensive investment analysis techniques (e.g.: cost-
benefit analysis) for determining the benefits and pitfalls. In relation to the device 
under consideration for development, the medical device company should be able 
to align its technological and human resources infrastructure with its business 
objective (Andrews, Foster Miller Inc. 
<http://thekenshogroup.com/docs/StrategiesforDevelopingandCommercializin
g.pdf> 
b) Idea Generation 
The identification of a lucrative market opportunity is followed by the idea 
generation phase that comprehensively attempts to address the desired market. 
However, ideas need to be filtered in terms of its feasibility and potential for 
success. 
Yang et al. (2006) have listed six techniques to obtain innovative ideas for medical 
devices, namely: interviews (with internal and external parties), brainstorming, 
literal benchmarking; theory of inventive problem solving (TRIZ), axiomatic 
design, clustering and ranking (Suh, 2001; Zlotin et al., 2000). The stakeholder 
needs should be categorized into essential needs and nice-to-have needs (using the 
Kano diagram preferably), which are required to be prioritized based on the 
technical and market feasibility, regulatory compliance and sustainability (Project 
Management Book of Knowledge, Project Management Institute, 2010). 
c) Concept Definition 
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The ideas generated must be defined for the creation of a tangible product that can 
be validated and transferred for production. Once the final set of ideas are 
obtained from idea generation phase, they are subjected to the evaluation criteria 
namely product attractiveness, fitness, cost, safety, overall sustainability, market 
potential, patent analysis and intellectual asset strategy. This phase usually 
experiences the utilization of the Quality Function Deployment (QFD) tool (Akao, 
1990). The QFD tool translates the user requirements into technical characteristics, 
which can be utilized to obtain the desired product features and its corresponding 
production controls/processes (also known as Concept Definition). 
d) Proof of Principle 
The product concepts need to be verified and validated as per their technical 
requirements and the ability to satisfy concerned stakeholders, respectively. The 
finalized product concepts are verified for their functionality, characteristics, 
features and limitations, using software or hardware based testing or both. For 
example, Yang et al. (2006) proposed a development approach of a blade type 
lancet. The product concept for the lancet had to incorporate a safety feature that 
is the automatic retraction of the lancet’s sharp blade after use without the use of 
any springs. The material properties and geometries of the lancet’s plastic frame 
were calculated to demonstrate the ability of the frame deformation to deliver 
sufficient restoring forces so as to actualize automatic retraction of the blade after 
removal. 
To add further, the device operability by the user is essential for minimization of 
user related hazards, which could originate from the erroneous use of the medical 
device. Edwards (2008) stated that the resources invested in medical device design 
and manufacturing must address the users’ operational convenience within their 
working environment. The Human Factors Engineering (HFE) features ensure 
product functionality coupled with minimal probability of hazards as a result of 
erroneous use. For instance, engineers need to design medical devices that address 
the needs of the various disabilities of the home-health care device users without 
consciously reminding them of their disabilities since that could result in 
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abandonment of the medical device (Gitlin, 1995). The approach is titled as 
Universal Design or Inclusive Design. The users include but are not limited to 
medical and nursing staff, medical doctors and engineers, clinicians. For example, 
Micromedics Inc. had developed a range of single use sterile surgical instruments 
for surgical incorporation of biomaterials that was accepted by surgeons and 
clinicians. However, only after consultation with the operating room nurses did 
the company include a kit of ancillary materials for delivering the surgical 
instruments into the hands of the surgeons in sterile condition (Miller, 2007). 
e) Patent Search, Analysis and Risk Management 
After the proof of principle stage it is imperative for the medical device company 
to conduct systematic intellectual property analysis for evaluating any possibilities 
of infringement on the previously filed inventions and other forms of intellectual 
properties rights (such as patents, copyrights, trademarks and trade secrets). 
Furthermore, the patent citations are assessed for the evolutionary path of the 
technology in order to identify prior/subsequent art. This enables the medical 
device company to design around the previously filed intellectual property in 
order to avoid any infringement lawsuits. It is also advisable to have access to 
intellectual property legal advice to address any potential or on-going 
infringement and conflict litigations (Andrews, Foster Miller Inc.) 
g) Competitive Assessment 
Similar to the patent search and analysis, the medical device company needs to 
conduct a business competitive assessment of its competitors and other market 
players. In the IV Catheter case discussed by Yang et al. (2006) in which the 
competition assessment was conducted primarily by identifying the companies 
(existing and new entrants) in the market followed by evaluation of their business 
performance, including Strengths-Weaknesses-Opportunities Analysis. 
Meanwhile, the pertinent end-users and stakeholders were identified for steering 
the product development process. 
h) Safety and Quality Compliance 
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Usually pertinent regulatory agencies require medical device companies to submit 
relevant design and compliance related documents. For instance, the Food and 
Drug Administration (FDA), USA demands a Design History File (DHF) that 
contains safety considerations for each individual device to be marketed in the 
USA. Similarly, the FDA also recommends the use of Quality System Regulations 
(QSR) frameworks (ISO 9001 or ISO 13485) for the Medical Device Development 
Organization to follow as good engineering and project management practices 
(Reliance Medical Consortium, Successful Medical Device Development: Critical 
Factors, <http://www.clinquest.com/Collateral/Documents/English-
US/med_device_critical_success_factors.pdf>; Vogel, 2001). 
i) Reimbursement and Payment 
The medical device company should be proactive in ascertaining potential 
impediments on the frontiers of insurance payments and reimbursement. The 
companies that fail to do so would result in a significant waste of resources and 
delayed product launch; thus, resulting in loss of market share. In countries with 
privatized medical healthcare such as the United States in which the use of a 3rd 
party payment system can pose paradoxical dilemma for the medical device 
company. In terms of the reimbursement and payment of medical devices in the 
United States; wherein the Centre for Medicare and Medicaid Services (CMS) 
cannot reimburse the medical device development company unless it obtains a 
request from the Insurance Company. However the Insurance Company would 
not put forward request unless it is confirmed that the CMS can reimburse the 
device. Furthermore, Miller (2007) recommends medical device companies hire 
competent consulting services to improve the odds in their favour. 
j) Animal Testing 
In some cases, medical devices under development have to undergo animal trials 
in order to confirm the performance and effectiveness, prior to human clinical 
trials. Under FDA regulations, animal testing should be carried out under Good 
Laboratory Practices and in accordance with Quality Management Systems to 
obtain evidence of safety and performance within a living system (Reliance 
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Medical Consortium, Successful Medical Device Development: Critical Factors). 
Any inconsistencies in performance would result in additional iterations of design 
changes and prototyping activities (including verification/validation) until the 
desired clinical effect is attained.  
k) Clinical Testing 
Once animal trials are satisfactory (if required), the medical device with additional 
evaluation can be considered for human clinical trials under strict medical 
supervision of the Institutional Review Board (IRB), especially for medical devices 
being developed for markets in the United States. The IRB is an independent 
committee made up of doctors, analysts, community advocates and others in 
order to ensure that the clinical trial protocol is ethical and the rights of clinical 
trial participants are protected. The IRB is empowered by the FDA and 
Department of Human Health and Services to monitor and approve the clinical 
trials (Spine-Health, <http://www.spine-health.com/glossary/institutional-
review-board>). 
The 510(k) and other recommendations devised by the FDA state that Medical 
Device companies should demonstrate efficacy and safety in both animal and 
human clinical trials and accordingly, submit the relevant scientific information to 
the regulatory authorities in order to obtain FDA approval (Food and Drug 
Administration; Reliance Medical Consortium, Successful Medical Device 
Development: Critical Factors). 
To elaborate further, the 510 (k) of the Federal Food, Drug and Cosmetic Act 
requires that the medical device company register in order to notify the FDA of 
their intentions to market a medical device that is equivalent to a pre-existing 
regulatory approved device, categorized in one of the 3 classes. Moreover, if the 
device is “substantially equivalent” to a pre-existing marketed and regulatory 
approved product before May 28th 1976, a pre-market notification is required. 
However, if the medical device is significantly different from a pre-existing 
marketed and regulatory approved product before May 28th 1976 in terms of 
design, material, chemical composition, energy source, manufacturing process, or 
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intended use, then a pre-market approval is required (Food and Drug 
Administration). 
l) Regulatory Filings 
All new medical devices are classified by the FDA as Class I e.g.: examination 
gloves (General Controls), Class II e.g.: infusion pumps (Special Controls), or Class 
III e.g.: cardiac pacemaker (Premarket Approval), according to the perceived risk 
they pose to patients and users (Food and Drug Administration; Miller, 2007). 
The product development teams must obtain access to expertise with in-depth 
knowledge of regulatory filings and interactions with the FDA, especially in 
challenging circumstances of Pre-Investigational Device Exemption. An 
investigational device exemption (IDE) allows the investigational device to be 
used in a clinical study in order to collect safety and effectiveness that is required 
to support a “Premarket Approval (PMA) application” or a “Premarket 
Notification (510(k)) submission” to the FDA. The IDE is quite a different scenario, 
wherein the IDE requires “clinical trials for supporting the PMA/PMN 
application”, as opposed to a regular scenario where “clinical trials are conducted 
to obtain PMN/PMA approval”. Therefore, the submission guidelines are far 
more stringent than non-IDE cases. Moreover, the medical device company’s 
development teams require thorough preparation for the pre-Investigational 
Device Exemption meetings in coordination with its collaborators (Reliance 
Medical Consortium, Successful Medical Device Development: Critical Factors). 
m) Supply Chain Structure 
A smooth flow of materials/resources for the development and production of a 
medical device into its commercialization phase requires an efficient and 
optimized supply chain structure. The supply chain structure can be devised 
during the iterative design phase based on the inputs received from the clinical 
trials, validation/verification and performance tests. Moreover, Krishnan and 
Ulrich (2001) state that the supply chain comprises both incoming and outgoing 
flow of materials, intellectual property and services. Hence, the supply chain 
decisions need to address the selection of the suppliers as well as the parties 
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associated with the product design, process development for production and 
configuring the distribution system. The overall sustainability can be significantly 
achieved if the suppliers and other associated parties are included based on their 
commitment to overall sustainability (Charter, 1998). 
n) Product Launch and Production Ramp-Up 
Post finalization phase and production eventually leads to the launch of the 
product for commercialization in order to be used by patients [or] end-users. 
Moreover, Krishnan and Ulrich (2001) state that post-finalization phase of the 
design with prototype testing and validation. The company needs to select the 
products poised for continuing the test marketing phase and/or commercial 
launch into the desired markets. The launch dates in accordance with the 
competition analysis and the product design would govern the production ramp-
up specifications and eventually the success of the product in the desired market 
space. 
The integrated and iterative correlation between the design phase and other 
subsequent phases is essential for the optimization and shortening of the product 
development life cycle without compromising regulatory compliance and safety. 
The next section would briefly discuss the phases of the product development 
cycle in the form of a project management process based on a systems engineering 
approach. 
The next section would discuss the systems engineering approach to the 
development of medical devices  
2.6. A Formal Systems Engineering Approach towards the 
Development of Medical Devices 
This section gives a brief description of the formalized product development 
process based on Systems Engineering Approach for medical devices which 
involves various phases of the product development life cycle and its decision 
making stages/gates. Jones and Masters (2008) devised the process for medical 
device development at Battelle MDS involving the utilization of Systems 
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Engineering (Systems Engineering Handbook version 3.2.2 2011, International 
Council on Systems Engineering). 
i. Definition and Introduction to Systems Engineering: A contemporary 
functional device is composed of multiple independent and dependent systems, 
sub-systems and assemblies. These entities are required to function with a high 
degree of synchronicity. Accordingly, the systems engineering approach is an 
interdisciplinary approach that enables the realization of successful systems. It 
focuses on defining customer and stakeholder needs with the required 
functionality early in the development cycle. Further, it proceeds with the design 
synthesis and system validation without ever loosing focus on the objective. 
Systems Engineering is also responsible for the integration of the pertinent 
disciplines and specialty groups into a coherent team effort; thus forming a 
structured development process that proceeds from concept to production and 
finally to utilization (Systems Engineering Handbook, International Council on 
Systems Engineering). 
The Jones and Masters Systems Engineering approach based product 
development is in compliance with international regulations and includes a Safety 
Risk Management process (as defined in ISO 14971:2007 and ISO 13485:2003) for 
Quality Management Systems. The aforementioned combination promotes 
scalability and customization with iterative design and development. 
ii. A Systems Engineering based Product Development Approach for Medical 
Devices 
The product development processes for the development life cycle of a medical 
device should be repeatable so that it can be applied consistently across varying 
scopes of development projects. The product development process should also be 
inclusive of the entire life cycle of a medical device. Therefore, the milestones and 
its corresponding validation processes need to be well defined and addressed 
accordingly (Robertson & Robertson, 2006). 
2.6.1. Life Cycle Phases of the Medical Device Development Process 
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The development process is composed of various stages with in-between gates for 
evaluation of the output from the preceding stage. Both the end-user/stakeholder 
and the medical device development teams need to acknowledge the ascertained 
risks and implement the mitigation strategies in order to align with the business 
objective (Hwang & Park, 2006). 
 
 
Figure 2.2. – Schematic representation of a Stage-Gate Process (Adapted from 
Jones and Masters, 2008) 
 
Following are the stages of the systems engineering based product development 
cycle: 
a) Feasibility Stage: The feasibility stage is defined as the ability of the medical 
device to perform its desired clinical action with the appropriate standards for 
safety, market acceptance and ease of operation. The technical and clinical risks 
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are evaluated in order to formulate a mitigation plan within the design stage. The 
outputs are as follows: feasibility concept, market needs assessment, identification 
of the technical risks with mitigation strategies, management buy-in or approval, 
return on investment, viability study, project proposal, and selection of a 
regulatory route to market (e.g. 510k for targeting desired markets in the United 
States). 
b) Design and Development Stage: The feasibility stage provides a list of 
constraints and opportunities; accordingly the engineering team must proceed 
with their design and development activities. This stage comprises the diverse set 
of requirements for the end-user/stakeholders satisfaction and regulatory 
compliance for translation into a verified/validated design. The output that is the 
verified/validated design is transferable to manufacturing stage in the form of a 
Design History File (DHF). The Design History File (DHF) documents all the 
design inputs and outputs. Moreover, the activities that comply with the required 
Design Controls are to be in accordance with Quality Systems Regulation, devised 
by the FDA (Vogel, 2001). 
The Design and Development Phase further contains the following sub-sections 
(Food and Drug Administration; Systems Engineering Handbook, International 
Council on Systems Engineering): 
i. Design Inputs: The Design Inputs comprise of the physical and performance 
requirements of a device that are used as a basis for device design. This phase of 
Design Inputs consists of identification of users, stakeholders and business needs 
followed by translating the needs into quantifiable requirements (the functional, 
ergonomic and aesthetic attributes). Furthermore, devising the device 
architecture/specifications leads to concurrently updating the regulatory 
documentation.  
The categories of Design Inputs with suitable examples are as follows:  
•User Needs (e.g.: inclusive of usability and human factors) 
•Business Needs (e.g. target market implications; business model) 
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•Regulatory Constraints (e.g.: device safety and effectiveness)  
ii. Design Review: This activity is conducted at the end of every stage and is a 
documented, comprehensive and systematic examination of a medical device 
design.  
The objective of the Design Review Phase is to evaluate the following: 
•The adequacy of the design requirements 
•The capability of the design to meet stakeholder requirements 
•To identify any problems and inconsistencies, pertinent to the design and 
stakeholders’ requirements. 
iii. Design Outputs: Post review and acceptance of the Design Inputs (with Design 
Review) is the Design Process and submission of Design Outputs. Design Outputs 
are results of a design effort at each design stage and at the end of the total design 
effort with the Device Master Record (DMR). The DMR is a compilation of records 
that contain the procedures and specifications for a finished device. 
The outputs of this phase are stated as follows: Device Master Records, 
Prototyping, Prototype Testing and Iterative Design Changes, Labelling 
Sterilization Protocol, Packaging Design, Transportation Testing, Cost Analysis, 
Test Development, Material Selection, Biocompatibility Testing, Accelerated 
Ageing Study, Part Inspection Plan, Design and Commission Inspection Jigs and 
Fixtures, Commission Production Tooling, Select Route to Market i.e. Clinical Trial 
or Evaluation Report Source Suppliers, Instruction for use and Design/ Process 
Failure Mode Analysis. 
iv. Design Verification and Design Validation: Starts at the end of Design 
Outputs, as discussed previously. 
c) Design Transfer Stage: The design from the research and development phase 
needs to be translated into a framework suitable for manufacturing. The 
information pertaining to the manufacturing of the device is appropriately 
documented and specified in accordance with a validated manufacturing process. 
The manufacturer is required to establish and maintain procedures to ensure that 
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the device design is correctly translated into production specifications, in 
accordance with the pertinent FDA guidelines for medical devices. 
d) Production Stage: Following the design transfer stage, the design outputs (a 
device with its details of manufacturability) have to be appropriately translated 
into production specifications and accordingly, the corresponding production 
process controls have to be defined. This phase confirms for the commercialization 
and sale of the device. Moreover, a clearance for 510 (k) pre-market notification or 
pre-market approval is essential before product launch. The details regarding the 
clinical and pre-clinical trials have already been previously addressed. 
e) Sustaining Engineering Stage: Following the production phase is the device 
launch phase, where the field results of sales and performance are thoroughly 
assessed. The provision of technical support, corrective and preventive actions, 
resolving regulatory compliance issues, production process optimization, addition 
or removal of certain features are conducted to achieve higher market acceptance. 
f) Device Retirement Stage: This is the stage when the sale of the device moves 
towards the end and is not supported by the medical device company, customers 
and regulatory authorities anymore (or even other pertinent stakeholders). The 
device can be subjected to a suitable end-of-life option, namely, removal, 
dismantling [or] recycling/reusing/remanufacturing (Nasr & Thurston, 2006; 
Pennsylvania Department of Environmental Protection, 2009). 
Moreover, Sobelman (2008) states that for any of the end-of-life options, the 
Design-reuse approach provides savings in time and monetary resources through 
reduction in testing time if only a few sub-systems are modified/changed. As 
described by one executives of a medical device company who was interviewed 
by Noel Sobelman (2008) “if the design is 20%new and 80% design re-use, we now 
test only 20% not 100%”. The company interviewed by Noel Sobelman (2008) 
utilized modular platform architecture with software automation tools to 
improvise archival access and retrieval of previous test/ design reports.  
Nasr and Thurston (2006) stress on the importance of product end-of-life such as 
re-manufacturing to ensure a closed loop of the material flows of every phase of 
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product life-cycle, to be considered as an integral part of the product design. This 
approach can lead to societal advantages of reduced energy with reduced material 
consumption and waste generation. Similarly, Pujari (2006) and Charter (1998) 
recommend the need of a strong alignment between new product development 
professionals, environmental specialists, suppliers, marketing expertise and 
product life cycle evaluation to be key factors for ensuring the success of 
sustainable products. 
Therefore, companies committed to sustainability require a comprehensive tool to 
implement informed decisions about the social impacts throughout the product 
life cycle in order to prevent their reputation from being tarnished.  
The relevancy of considering design reuse for a suitable end-of-life option such as 
reuse, recycling and remanufacturing is because it results in reduced waste 
disposal/resources consumption and thus contributes to sustainability. It is 
therefore concluded that a medical device can gain a significant magnitude of 
sustainability throughout its life cycle, especially when the sustainability 
considerations are included within the design and development phases (Hanson & 
Hitchcock, 2009). 
The inclusion of sustainability in the medical device development process would 
be discussed in detail, in the subsequent sections. 
2.7. Landscape of Sustainability Measures and Regulations 
Regulations and Legislations are essential for governing the sustainability related 
activities in the product development endeavours of every industrial sector. Both 
United States of America and the European Union have established legislations for 
promoting sustainability such as WEEE (Directive on Waste Electrical and 
Electronic Equipment), RoHS (Restriction of Hazardous Substances in Electrical 
and Electronic Equipment), REACH (Registration, Evaluation and Authorization 
of Chemicals), and the EuP regulations (Energy Using Products) (Kadamus, 2008).  
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Trotta (2010) identified some of the measures for promoting sustainability at a 
global scale, which has been initiated by some of the globally renowned and 
influential institutions: 
•The World Business Council for Sustainable Development (WBCSD) is to 
provide a platform for companies to explore sustainable development 
possibilities. The organization enables sharing of knowledge, technologies and 
best practices. 
•The United Nations Environmental Program (UNEP) has called for a “Global 
Green New Deal” in response to the financial and economic crisis for reviving the 
global economy, boosting employment and simultaneously counter climate 
change related crises, environmental degradation and poverty. 
•The European Union has developed the International Life Cycle Data System 
(ILCD) to encourage qualitative applications (in accordance with the international 
standards on Life Cycle Analysis ISO 14040/44) in business and the public sector.  
•Solving the E-waste Problem (StEP) is an initiative of United Nations with 
Industry partners, Governments, International Organizations, Non-Governmental 
Organizations and the Scientific Community. The objective is to address the 
electronic waste (e-waste) problem and facilitate approaches towards the 
sustainable handling and disposal of electrical and electronic equipment. 
As stated by Kadamus(2008), innovative medical device companies who believe in 
both complying with the newly established regulations and staying competitive 
would be able to accomplish lower long-term costs and defend their market 
leadership. Medical device companies can incorporate the contemporary product 
development tools such as Lean Manufacturing, Design for Six Sigma, Good 
Manufacturing Practices and Process Flexibility to incorporate sustainability 
within early phases of product development. Moreover, while adopting these 
tools, the definition of ‘value’ can include not only economic growth criteria such 
as profit/cash flows but stakeholder considerations and even environmental 
safety. Furthermore, the tools when combined with an exhaustive Life Cycle 
Management and Engineering framework would be in a position to synchronize a 
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wide spectrum of multiple activities to optimize the time to market (Patil, 2010). 
Organizations, implementing novel product development approaches are 
guaranteed to be in a position to address multiple trade-offs/synergies more 
effectively in terms of sustainability, device performance and economic growth. 
Moreover, the establishment of a continuously evolving and robust knowledge 
curve would ensure a stronger competitive advantage in comparison to their 
competitors (Kadamus, 2008). 
The interdisciplinary nature of medical devices requires materials, 
tools/machinery and expertise from diverse engineering and scientific fields, 
which by itself are always continuously co-evolving. As a result, the role of a 
knowledge management infrastructure for building and utilizing a knowledge 
curve is a critical driver for success in medical device development. For example, a 
pacemaker is composed of various engineered polymers, electronics coupled with 
mechanical parts and radio-frequency communication to communicate the patient 
data to the hospital server. This is viewed as a quantum leap advancement 
compared to its predecessors wherein the doctor/nurse would have to spend 
more time monitoring the patients’ heart rate with not as much accuracy as 
offered by the advanced version (Arntzen-Bechina & Leguy, 2007). 
Moreover, the utilization of sustainable business/product development practices 
to promote a win-win situation can be promoted through strong stakeholder 
interconnectivity by formation of conglomerates between medical device 
companies, government bodies, insurance agencies, public welfare institutions 
and hospitals (Kadamus, 2008). 
2.8. Role of Product Life Cycle Management for attaining 
Sustainability 
Product life cycle management for attaining sustainability employs systemic 
thinking and hence is capable of addressing the sustainability requirements 
throughout the life cycle of the product. For addressing sustainability, the product 
engineers and managers are required to utilize life cycle management coupled 
with systemic thinking tools and criteria for sustainability within the design stage 
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(Fiksel, 2006; Sutcliffe et al., 2009; Trotta, 2010). Accordingly, with the culture and 
capabilities of the participating organizations for both products and services, the 
sustainable design should address every stage of the production, the project 
management, the market and the usage life cycles (Trotta, 2010). The justification 
of incorporating life cycle related parameters and considerations for sustainability 
within the product design stage as opposed to the later stages of the life cycle are 
discussed in detail in the subsequent sections. 
Following are the facets of Product Life Cycle that are utilized for the systemic 
assessment and management of Product Life Cycle Management in order to 
achieve overall Sustainability throughout the life cycle of a product (Trotta, 2010). 
2.8.1. Life Cycle Systemic Thinking  
Sustainability assessment and implementation primarily begins with 
identification, followed by interlinking, tracing and articulation of the pertinent 
considerations with their corresponding indicators. These indicators are essential 
for evaluation throughout the life cycle (Dobbs & Cormican, 2007). 
2.8.2. Life Cycle Assessment (LCA)  
In combination with Life Cycle Systemic Thinking, the medical device company is 
required to conduct a comprehensive life cycle assessment. This tool is a 
recognized scientific methodology in accordance with Environmental Protection 
Agency (EPA) from USA. The life cycle assessment methodology is derived from 
Tool for the Reduction and Assessment of Chemical and Other Environmental 
Impacts (TRACI) (methodology studied by EPA, USA). LCA is also an objective 
and internationally recognized (ISO 14000). The tool assists engineers and 
managers to systematically identify and quantify the energy/materials consumed 
and the waste/emissions that are released in the environment.  
Some of the widely used proprietary LCA softwares are Gabi, SimaPro, Eco-it and 
Bounsted. These softwares consider the effects of material choices and 
manufacturing processes. Moreover, the tools perform graphical and numeric 
representations to assist the product development teams with their decisions 
during the design phase (Kadamus, 2008). 
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The life cycle assessment is carried out iteratively in the following sequence: 
•“Goal and scope definition” (ISO 14041): Planning of the analysis (identifying 
pertinent considerations of the product life cycle which are to be considered, data 
requirements, the geographical area, methodology to assign potential impacts). 
•“Inventory analysis” (ISO 14041): Data collection and calculation of inputs and 
outputs for each process involved in the life cycle (For example: the raw materials 
and their quantities). 
•“Impact Assessment” (ISO 14042): Evaluation of each inventory element with 
respect to environmental impacts (e.g.: the potential contribution to global 
warming and acidification by choosing Poly vinyl chloride plastic as opposed to 
Polyurethane plastic). 
•“Interpretation” (ISO 14043) combines the results and conclusions from the 
previous phases and devises recommendations to address the goal and scope 
definition. Furthermore, decision to modify the goal and scope definition and re-
initiation of another iteration can be pursued  
<http://www.basf.com/group/corporate/en/sustainability/eco-efficiency-
analysis/index>. 
The other tool that is less comprehensive as compared to exhaustive LCA for 
evaluating the ecological sustainability is the Eco-Indicator 99 by Pre Consultants 
BV. This tool addresses the environmental impact of products by breaking them 
down to elemental components, materials and processes. The Eco-Indicator 99 can 
be combined with the Eco-efficiency ratio that is the ratio of service provided by 
the activities with respect to its environmental impacts (Kadamus, 2008; Trotta, 
2010). 
2.8.3. Life Cycle Management (LCM) 
Life cycle management involves the utilization of engineering efforts and sound 
management decision making for ensuring long term overall sustainability 
through the utilization of Life Cycle Assessment and Systemic Thinking 
approaches (Fiksel, 2006; Hauschild et al., 2005). This also includes the 
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incorporation of a Total Product Life Cycle Management Infrastructure with 
information technology systems (Patil, 2010). 
The LCA tool can be utilized for taking decisions and implementing measures 
pertaining to overall sustainability. The LCA tool enables the product 
development teams to ascertain the critical processes in order to evaluate 
opportunities for optimizing the consumption of resources (e.g.: materials and 
machinery), waste disposal (e.g.: CO2 emissions). In addition, it can be used to 
evaluate suitable metrics for analysing the process performance and establishing a 
firm control to maintain the Organization’s position on its sustainability objectives 
(Almeida et al., 2005; Gonçalves et al., 2009). Once the product life cycle is well 
understood, the product design can be regularly updated (Annes, 2005). Thus 
resulting in product improvements and successful implementation of an 
appropriate end-of-life option. 
2.8.4. Life Cycle Engineering (LCE) 
Life Cycle Engineering is composed of engineering activities that are considered 
within the Life Cycle Management in coordination with Life Cycle Assessment 
and Systemic Thinking. It entails the application of technological and scientific 
principles to the design, manufacturing, and maintenance and end-of-life of 
products that promotes environmental welfare and conservation of resources, 
without compromising economic progress and simultaneously optimizes the 
product life cycle (Hauschild et al., 2005; Jeswiet, 2003; Wenzel and Alting, 2004). 
In order to initiate Life Cycle Engineering activities for incorporating 
sustainability, it is essential to develop a methodology that combines Life Cycle 
Assessment Tools with Computational Modelling Tools (such as 3-Dimensional 
Computer Aided Design/Engineering) in accordance with Sustainability 
guidelines (e.g.: EcoDesign guidelines) (Cappelli et al., 2006; Gaha et al., 2011). 
This would result in the interconnection of the environmental compliance 
parameters with the computational design approach. The sustainability of the 
environment is well known to promote the sustainability of the other 2 domains, 
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namely social and economical sustainability (Hauschild et al., 2005; Linnér & Selin, 
2003). 
Chang and Chen (2004) have identified the need of an articulate strategic 
approach towards sustainability-oriented engineering. These authors have 
devised the CAD Eco Design tool (a combination of CAD and Eco-Design 
guidelines). Their objective was to deliver technical support to the design 
engineers for developing products that address environmental sustainability 
through evaluation of components, materials and processes. Similarly, Capelli et 
al. (2006) also have proposed a novel approach to integrate EcoDesign and Life 
Cycle Assessment into a Virtual CAD Framework. 
Chang and Chen (2004) and Capelli et al. (2006) illustrate some reasons for 
considering CAD/3D design tools and Eco-Design Guidelines for building an 
integrated framework with Life Cycle Assessment. Firstly, modern CAD/3D tools 
are in a position to incorporate a higher number of parameters and provide 
significant savings in time for realizing a virtual prototype (Magne, 2010). 
Accordingly, Choi and Cheung (2008) had stated that a sophisticated virtual 
prototyping system could assist engineers and product managers to rapidly and 
iteratively optimize the product to obtain a desired trade-off between costs, 
product shape, manufacturability, profitability and reliability. The utilization of 
virtual prototyping minimizes dependency on multiple and expensive prototype 
development techniques so as to reduce the cost of failure and any potential user-
related hazards. Moreover, the virtual prototype designs can be sent via Internet 
to obtain feedback, especially concerning user-friendliness, production feasibility, 
supply chain and other essential facets of product commercialization and 
stakeholder requirements. The production feasibility assessment using virtual 
prototyping can even be extended to the cost effective design and modelling in 
terms of the shop floor controls, production process simulation, manufacturing 
planning, training, testing and verification/validation. 
Secondly, in order to conduct an environmental impact analysis via the Life Cycle 
Assessment technique, a designer must know the volume geometries, types of 
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materials used and their corresponding manufacturing processes. CAD/3D tools 
easily deliver this type of information. By using a Life Cycle Assessment, the 
environmental impact data for each part, sub-assembly and its corresponding 
process can be obtained to calculate an impact score (Goedkoop & Spriensma, 
2000). The integrated framework can also assist the designers to make the 
appropriate trade-offs and exploit synergies between efforts invested and time 
duration required for the entire development cycle (Bovea & Gallardo, 2006). 
Thirdly, EcoDesign guidelines are a set of best design practices, represented by a 
database of ecological challenges and questions with their most suited solutions. 
The authors of the database have categorized these solutions and questions 
through a collection of well-known standard design parameters. After a thorough 
survey of the occurrences of these parameters it is possible to determine the most 
suitable solution for improving the environmental impact (Capelli et al., 2006). 
On similar lines, Hanson and Hitchcock (2009) have utilized life cycle assessment 
and engineering for addressing the sustainability of a single use medical device 
namely a dialyzer. These authors improvised the sustainability of the dialyzer by 
optimizing the material (expensive and polluting petrochemicals) and energy 
utilization, within the design phase. In order to achieve their objectives, they 
obtained the statistics on the number of patients who undergo dialysis on a 
worldwide scale followed by determining the opportunity to significantly reduce 
carbon emissions through the reduction of the material quantity without 
compromising any aspect of functionality. Therefore, less material incorporated in 
the product resulted in significant decline in carbon emissions caused by 
incineration of used dialyzers. 
Hanson and Hitchcock (2009) carried out the LCA, through the using of software 
known as yED from yWorks Inc. The Life Cycle Evaluation provided the 
environmental impacts of the various parts and components of the dialyzer. 
Meanwhile, the functional assessments provided significant inputs for conducting 
geometric and stress analysis to identify suitable design structures in order to 
reduce the material required without compromising functionality, respectively. 
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For example, the LCA illustrated a substantial negative environmental impact due 
to polycarbonate, while functional analysis recommended the replacement of 
polycarbonate by another material with lower ecological impact in order to 
maintain the desired level of functionality.  
Furthermore, Hanson and Hitchcock (2009) studied the design of the dialyzer to 
determine the parts that do not come in direct contact with body fluids. The 
objective was to select the components which could be re-used and which survives 
the sterilization protocols. 
The need to shorten product development cycle time and address pertinent 
synergies/trade offs across a diverse spectrum of criteria for incorporating 
sustainability is discussed in the subsequent section. 
2.9. Balancing the Sustainability Objectives 
Addressing the various consequences of potential impacts on overall 
sustainability within the design phase of a product does have its own downside. 
Especially, negatively influencing the sustainability of one product by improving 
the sustainability of another product in a portfolio or across portfolios (Sutcliffe et 
al., 2009). As mentioned previously in Section 2.2 the crucial role of the Pareto 
optimal frontier comes into picture (Zhao et al., 2010). Therefore, it is critical to 
balance the product portfolio, through optimization of the resources consumed/ 
waste disposed in accordance with the regulatory compliance and the desired 
economic growth (Ambec & Lanoie, 2008; Vogel, 2005). Moreover, any number of 
decision models and product development frameworks devised to address 
sustainability has to maintain their focus as they offer insight to the product 
designers and engineers. It is important to note that these frameworks and 
decision models do not substitute for the critical and sound judgment of the 
product engineers and designers. The others constraints in addition to conflicting 
sustainability demands could be legal requirements, limited time for obtaining 
data or market dynamics pertaining to the product under development. The role 
of the designer and product engineer is to include as much sustainability as 
possible without compromising the essential aforementioned criteria. 
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The subsequent chapters would explore in detail the paradigm of prioritizing the 
pertinent criteria of overall sustainability with respect to the trade-offs to be 
executed and synergies to be exploited. 
2.10. Concluding Points 
This chapter discusses the existing gaps and shortcoming of contemporary 
medical device development. As these devices consume substantial renewable and 
non-renewable resources, which further instigate a series of interconnected social, 
economic and environmental impacts.  
As a result, the exhaustive list of criteria ranging from regulatory compliance, 
market competition and aforementioned domains of sustainability is 
overwhelming for an organization in terms of their human, financial and non-
financial resources.  
Moreover, the real-life challenges facing medical device development are rising 
healthcare costs in terms of allotment of Government funding and inclusion of 
more stakeholders with ever changing requirements.  
This justifies proposing new product development and decision modelling 
approaches to enable product development teams to exploit synergies and select 
suitable trade-offs in terms of cost effectiveness, quality and speed. 
In this chapter, a previously conducted case study by Yang et al. (2006) has been 
discussed to illustrate the contemporary product development approach of 
medical devices from a management. The development process entails idea 
generation and selection based on the company’s capabilities followed by 
assessing market opportunities wherein these capabilities and resources are 
evaluated with scrutiny to transfer the creation into a tangible product with 
compelling clinical performance. This would involve conducting proof of 
principle as well coupled with intellectual property evaluation and SWOT analysis 
towards the competitive forces. Moreover, the critical role of documenting and 
preparing the Design files in accordance with Quality System Regulations for 
regulatory approval should be conducted simultaneously (Vogel, 2001). The 
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marketing and regulatory compliance teams need to resolve the impediments 
concerning payment options in terms of Insurance and Government 
reimbursement. The company when considers the stakeholders early in the design 
phase is able to ensure its success in the post development phase. Hence, initial 
phases of test marketing and end-user trials are recommended.  
From a systems engineering standpoint, a medical device is perceived, as a system 
comprised of multitude of synchronized sub-systems, components, assemblies 
that are independent and dependent in nature. Systems Engineering, is also 
responsible for integration of the pertinent disciplines and specialty groups into a 
team effort, forming a structured development process that proceeds from 
concept, feasibility analysis, transfers phase to production and finally to operation. 
This approach reduces development cycle time and ensures reliability in terms of 
reusing the design in the future for innovations that are incremental.  
In this chapter, a contemporary product development approach is compared to an 
systems engineering based development approach in accordance with the Quality 
Systems Requirements stated by the FDA (Vogel, 2001). Based on the previously 
discussed challenges and limitations encountered during the incorporation of 
overall sustainability considerations within the design phase, the product 
engineers and managers require a comprehensive and simplified decision making 
tool for governing their designing process This utilizes prioritization of various 
sustainability considerations in accord with the regulatory compliance and the 
desired economic growth (Ambec & Lanoie, 2008; Vogel, 2005). The prioritization 
would assist the product engineers and designers to exploit the synergies and 
resolve the necessary trade-offs across products and product portfolios. In 
addition to the consideration of conceptual and technical tools for product 
development, a robust product life cycle management infrastructure with 
information technology system is crucial to synchronize a wide spectrum of 
exhaustive activities. 
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Chapter 3 
Decision Modelling and Sustainability in 
Medical Devices 
3.1. Introduction 
Medical Devices are required to comply with the most stringent regulatory 
requirements, while simultaneously addressing the economic growth of the 
Enterprise amidst the on-going volatile economic environment. The inclusion of 
criteria pertaining to overall sustainability poses not only a series of challenges, 
but even as a commitment towards stakeholders to ensure an extended 
continuation of an Enterprise’s business goals.  As a result, a major focus on 
decision modelling in conjunction with Business Processes and Design 
Engineering related activities is envisioned in the form of a coordinated 
framework to alleviate shortcomings of contemporary approaches in product 
development and decision modelling. Moreover, the anticipated exhaustive 
volume of data and information required to be processed and articulated for 
implementing sound decision demands a more simplicity and improvised 
accuracy for decision making and hence a simplified multicriteria based decision 
model is proposed and discussed in this chapter.  
Furthermore, Section 3.2 discusses the underpinnings of Sustainability and 
notwithstanding the advantages the section would illustrate the major 
impediments that are encountered while incorporating the considerations for 
overall Sustainability. As a result, not each and every criterion can be accounted 
for during the development of medical devices. Thus, justifying the need for a 
prioritization based decision-modelling approach in the form of a simplified 
multicriteria model. 
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3.2. The Underpinnings and Advantages of Sustainability 
The acclaimed United Nations report titled “Our Common Future” in 1987 
published by the World Commission on Environment and Development (WCED) 
had practically spearheaded the objective of overall Sustainability. Moreover, the 
renowned International Conferences including the Earth Summit of 1992 in Rio de 
Janeiro and of 2002 in Johannesburg have clearly postulated the emphasis on the 
commitment required by the Business, Regulatory and Political Institutions 
towards a worldwide approach for sustainable development (Vidal, 2012). Thus 
resulting in a “market” and “policy” oriented pressure on various institutions, 
which can bring about tangible transformation in the arena of Sustainability (Xu & 
Morrison, 2005).  
Ever since a few decades, businesses have demonstrated their commitment 
towards sustainability by implementing various measures such as carbon offsets 
projects (i.e. Clean Development Mechanism) for attaining sustainability (Buen, 
2013). Moreover, such measures are on the path for continuous improvements to 
resolve the criticisms that emanate from ineffectiveness and negative impacts onto 
stakeholders (Sutcliffe et al., 2009; Ambec & Lanoie, 2008). Nevertheless, as 
proposed by Xu & Morrison (2005), the consideration of Sustainability related 
criteria in the product development process and the corporate governance 
structure of the Organization, would ultimately result in the smooth transition 
between each of its product development phases and the extended continuity of 
the enterprise by virtue of active stakeholder participation. These authors have 
enumerated the advantages with which the companies could attain provided their 
business goals are effectively and efficiently aligned with the Sustainability 
objectives. The benefits are namely higher employee and stakeholder satisfaction; 
further strengthening loyalty; long term improvised financial performance and 
access to capital; reduction in cycle time for product development due to proactive 
risk management for addressing stakeholder requirements. 
As stated previously, the acute interdependency between the social, economic and 
environmental facets of sustainability determines welfare of the society as a whole 
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(Sutcliffe et al., 2009; Hauschild et al., 2005). For Example: The direct impact of 
health hazards caused by toxic emissions, leads to poor productivity of the 
population and ultimately affecting their purchasing power (Ding & Strong, 2010; 
Bhargava et al., 2001; Wilkie & Young. 2009; Linnér & Selin, 2003). This implies 
that an Organization should extend its Sustainability commitment beyond 
environmental compliance and accommodate other crucial social responsibilities 
pertaining to labour practices; transparency; human rights and fair business 
practices. These paradigms in our globalized world are increasingly becoming 
more obligatory in nature. The subsequent section would discuss a few real life 
cases of medical devices, which have attempted to incorporate overall 
sustainability (more environmental than social). 
The pre-existing stringent regulatory compliance and business performance 
requirements do pose a major impediment for companies to adopt sustainability 
(Faniel, 2011), notwithstanding the presence of critical market drivers including 
environmental sensitive consumers and cost savings brought about by 
environmental friendly materials. For example: Rollprint Packaging Products Inc. 
is a slow adopter for sustainability (Dodrill, 2010). On the other hand, companies 
can explore the opportunity to deliver the utility dimension of the medical devices 
to their customers by providing a portfolio of products; services; network of actors 
based on a supportive infrastructure, in contrast to the sale of physical goods 
similar to the Xerox Model (2003). This restructuring of the product value chain 
titled as “Product-Service-System” is an encouraging scenario for incorporating 
the underpinnings of Modularity and Platform/Derivative approaches in Product 
Design. This further facilitates the End-Of-Life Options for recovering the product 
value towards the end of its use phase (Filho et al., 2009; Goedkoop et al., 1999; 
Mont, 2000). End-Of-Life Options namely, reuse; remanufacture and recycle, 
nevertheless it should be noted that these options could consume significant 
resources during transportation and the limitations posed by product design for 
regulatory compliance and limitations of materials (Long, 2008) may hinder the 
possibility for utilizing the parts for multiple life cycles. This includes but not 
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limited to the hazards posed by contamination and limited opportunities for 
sterilization/reprocessing for the stated reasons (Kadamus, 2008). 
Following are two remarkable examples of incorporating Sustainability with 
Medical Device Design: 
a) ‘Syreen’, a revolutionary “green” pre-filled syringe developed by Cambridge 
Consultants Inc. ‘Syreen’ is a highly effective, safe, and easy-to-use drug delivery 
device for self administration. The device is designed to reduce the intensity of 
resource consumption and material wastage associated with traditional syringes. 
The ‘Syreen’ syringes are made with COP (cyclic olefin polymer) plastic, in 
contrast to glass and it does not require secondary packaging. The product design 
permits multiple syringes to be packed together conveniently without the use of 
any conventional wasteful fillers. These innovations reduced the packaging 
weight by 30 percent and volume by 50 percent in comparison to contemporary 
standard packaging. As a result, the fuel costs attributed to transportation are 
reduced (Cambridge Consultants, 2010)< 
http://www.cambridgeconsultants.com/news/pr/release/49/en>. 
b) Abbott targeted a 5% reduction in packaging for one of its products, through re-
design. The engineers at Abbott Labs redesigned one of its re-closable 0.24 litter 
plastic bottles in order to reduce the plastic used by 8.3% that resulted in savings 
of 1.65 million litters of annual fuel cost (Dodrill, 2010). 
These examples implies that although initially since the past two decades, the 
demand for sustainable medical devices has slowly gained momentum and 
accordingly, a few companies have resorted to design and materials engineering 
related innovation to accomplish at least environmental sustainability and their 
desired degree of profitability. 
3.3. Prioritized Decision Modelling: Function and Scope 
As identified previously, that one cannot attain an infinitely high level of overall 
sustainability with a desired degree of patient and user satisfaction, as it requires 
the inclusion of an exhaustive list of criteria and its corresponding parameters and 
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specifications (Zhao et al., 2010). Moreover, such an endeavour is identified to be 
overwhelming for a product development team of an Organization, which has to 
address a fiercely competitive market. The key sources of limitations are observed 
from the standpoint of managerial capacity (e.g.: availability of time and human 
resources) and technological limitations (e.g.: limitations of modelling software 
and material properties) (Wyatt et al., 2009; Tikare et al. 2005; Long, 2008). 
Following are the known sources of limitations that can presumably pose as an 
impenetrable impediment for satisfying every sustainability related criterion: 
a) Managerial capacity (e.g.: availability of time and human resources) (Project 
Management Book of Knowledge, Project Management Institute, 2010) 
b) Innovativeness and Intellectual acumen, Cognitive abilities, and Collaborative 
Strength (e.g.: skills, know-how and expertise) (Akgün et al., 2003a; 2006b). 
c) Properties and Accessibility of Materials & Energy Sources (Long, 2008). 
d) Organizational Infrastructure, Financial Capital and Value Chain Partners. 
e) Regulatory Frameworks, Socio-Economic Policies (e.g. Subsidies, Controls and 
Taxes). 
f) Technological feasibility of Engineering Tools  
i. Software:  
-Interoperability (Hu et al., 2006) between software and hardware platforms. 
-Limitations of modelling software to accommodate a majority of the life cycle 
parameters (Wyatt et al., 2009). 
-Need for customization and manual intervention for geometric processing and 
automation of meshing during CAD/CAE simulation (Shimada, 2011). 
ii. Hardware: Instruments/Machinery (e.g.: tolerances, accuracy, precision, 
flexibility of scope and capacity) (Kumar & Suresh, 2007). 
These sources of limitations are also in co-relation with the resources of the 
medical device company. 
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Therefore, it is imperative to establish a comprehensive ‘priority based decision 
making and product development approach’, to address the various key essential 
synergies and trade-offs while shortening the development cycle to attain higher 
economic growth.  
In this prioritization based decision modelling, the essential criteria would be 
prioritized in order to deliver a significant magnitude of overall sustainability 
without compromising any of the regulatory compliance and critical economic 
growth objectives. The advantages of a ‘prioritization based decision making 
approach’ is the attempt to be holistic in nature; wherein it would not only 
accompany the product development teams to implement sound decisions at the 
upper management level (e.g.: project selection) but even at the most vital 
engineering paradigms (e.g.: the level of customization of an existing design and 
simulation tool). This clearly points out that the aforementioned decision making 
approach does actively participate in the product development process.  
Meanwhile, during the incorporation of Sustainability criteria and executing the 
‘prioritization’; the product development teams need to undertake design 
engineering, project management and operations management endeavours for 
optimizing the consumption of resources and reducing the waste generation 
(Sutcliffe et al., 2009; Vogel, 2005; Ambec & Lanoie, 2008). In the attempt to 
conduct optimization, which is to address the underlying synergies/trade-offs, the 
product development teams would come across a scenario; wherein reducing the 
emissions pertaining to one facet of product design would result in producing 
higher emissions at another end (Hermann et al., 2007; Rebelo de Mira & Kroeze, 
2006; Brink et al., 2005). For example: While switching the materials from toxic to 
non-toxic would result in higher emissions and waste that is attributed to the 
procurement or production of the non-toxic material (Esposito, 2011). This 
scenario would remind the product development teams of the Pareto Optimal 
Frontier as mentioned in Chapter 2 (Zhao et al., 2010).  
In order to exemplify the relation between Medical Devices and Sustainability, Bill 
Evans, the founder and principal of Bridge Design Inc., USA stated that not a 
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single medical device could ever achieve a zero negative impact, despite 
employing any number of measures to minimize it. To explain further in the most 
humorous manner, during the Conference on Plastics in Medical Devices 2011, 
held on April 11-13 in Huron, Ohio, USA, he said “It shouldn’t be about emotions 
as You’re not going to start making bamboo surgical tools” (Esposito, 2011). 
The subsequent section will discuss the basis for a more comprehensive and 
simplified decision modelling approach based on the on-going interconnected 
facet of our human civilization, ecosystem and economics. Furthermore, the 
comparison of the contemporary decision models to the chosen technique of using 
a multicriteria approach is also discussed in detail. 
3.4. Decision Modelling for Sustainability 
3.4.1. Synopsis 
Today’s interconnected globalized world that involves diverse cultures and value 
systems results in a complicated political decision making scenario. This renders 
the ‘sole use of intuitive reasoning’ obsolete and demands a more comprehensive 
as well as a simplistic approach. Moreover, the sources for overall satisfaction and 
dissatisfaction in life do differ from region to region with respect to their cultures. 
This complexity is not free from a wide variety of disparities in terms of access 
towards resources and welfare related opportunities, in addition to the multiple 
layers of interdependencies between far and diverse geographical regions on the 
face of this planet. Therefore, it is imperative to account for the most essential 
criteria for attaining overall sustainability in order for a company whose obvious 
goal is to ensure its longevity (Ramjerdi, 2008). 
Decisions are made at Planning, Strategic, Tactical and Operational Levels. The 
differences in the levels are based on complexity, magnitude of uncertainty, nature 
of stakeholder involvement and the ability to make decisions transparent and 
equitable. Decision-making should be done in consistency with the Organization's 
values and objectives (Petrie et al., 2006). The approaches towards decision 
modelling are enumerated in the following steps from 1 to 9, which are cyclic in 
nature: 
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Figure 3.1. – Decision Modelling Approach 
 
The subsequent sections will discuss an overview of various decision modelling 
techniques used regularly in evaluating overall Sustainability followed by the 
explanation of the proposed multicriteria based decision model. 
3.4.2. The Fundamental Basis of Decision Modelling and its Implementation 
Decision making process for addressing overall Sustainability would entail the 
incorporation of various indicators and criteria that measure environmental 
sustainability in accordance with other social and economic impacts of outlined 
projects, plans and policies. The criteria, indicators and parameters deliver their 
own characteristic balance of constraints and opportunities throughout the 
product development process. 
There exists a multitude of decision making techniques to evaluate various 
alternatives pertaining to Projects; Products; Policies and Services and hence to 
name a few others in addition to the regularly used Cost Benefit Analysis or Cost 
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Eigen Vector Method, Compromise Programming, Sustainable Process Index and 
Best Practicable Environmental Option Index (The Royal Commission on 
Environmental Pollution, 1988). These evaluation techniques aid the decision 
maker and product development teams to estimate as well as monitor the 
consumption of natural resources with the corresponding generation of 
waste/emissions for the proposed alternatives. Acknowledging the complex 
interconnected relations between the social; economic and environmental domains 
of our eco-system poses an enormous impediment for decision makers (or 
decision model users) to clearly outline the social sustainability criteria. Previous 
attempts to assign financial economic values have been carried out (Van Erck, 
2003), notwithstanding the identified intrinsic challenges of improving the 
accuracy of the process (Jansen, 1992). 
Therefore, in this thesis, the utilization of a more qualitative approach towards 
decision modelling is discussed that simultaneously considers diverse set of 
criteria ranging from social; emotional; environmental; technical; rational; 
intuitive; economical and others with a substantial degree of consistency and 
simplicity, known as the Multi-criteria method. Furthermore, both qualitative and 
quantitative evaluation methods have been considered in the past in combination 
with subjective scale and guidelines for implementing informed decisions 
(Winpenny, 1991). For example, Labuschagne and Brent (2005) proposed the 
Sustainability Cost Accounting procedure. This technique accounts for various 
externalities (benefits and detrimental impacts), additional uncertainties and 
inventory of the resources consumed with their resultant environmental impacts. 
The results of the analysis are translated into financial terms for appraising the 
overall sustainability of an engineering project. 
To address the exhaustive complexities and gaps in Sustainability evaluation 
requires the utilization of sophisticated and interconnected computational systems 
that employ advanced modelling techniques. For example, the utilization of 
system dynamics and thermodynamic analysis in order to study the dynamics 
between various segments of eco-systems and institutions (public; profit; non-
profit; private). A few examples include but not limited to climate change and 
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extinction of flora-fauna of a certain region by virtue of in discriminate Industrial 
activity. The aforementioned approach towards the evaluation of complex systems 
and their interdependencies is titled as Systems Thinking (Fiksel, 2006). 
Notwithstanding the inundating nature of this approach, a partial insight is 
delivered that is considered sufficient by decision makers of large influential 
institutions, including Global Corporate Institutions (E.g.: Microsoft) or 
International Organizations (E.g.: UNO) and policy makers to invest in the most 
ecologically effective projects and account for possibly every long term impact on 
every stakeholder (near and far). 
During the execution of a comprehensive and a substantially complex evaluation 
procedure, it is imperative to map the decision making process which is further 
represented by the data and information flows emanating from various 
parameters; factors; drivers; criteria illustrated in the decision model. The goal is 
to determine the pertinent decision making nodes that adjoin the various impacts 
on the diverse set of stakeholders. This approach enables the decision maker for 
devising sound risk management plans and decision implementation strategies.  
The decision process mapping is conducted by installing robust computational 
systems. A known example would be the Structured Systems Analysis and Design 
Method (SSADM) that is capable of structuring, mapping and tracing the flow of 
data and information in conjugation with a reliable Information Technology 
System to promote interconnectivity between the systems under investigation 
(Ashworth and Goodland 1990; De Marco 1979). Ironically, the life cycle of the 
computational and IT systems generate an enormous environmental impact of up 
to 2% global CO2 emissions (Parliamentary Office of Science and Technology, 
2008). This factor is poised to stimulate innovation for devising improvised 
analysis models and techniques to optimize the computation with reference to the 
energy consumption. 
3.4.3. Multi-Criteria as a Prioritization based Decision Model 
As stated previously, the prioritization of the sustainability related criteria is 
crucial for acknowledging synergies and trade-offs encountered during the 
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Product Development process that intends to accommodate diverse and 
conflicting requirements, which are irreconcilable by any amount of feasible 
engineering design solutions.  
For instance: A medical device with multiple features that further corresponds to a 
multitude of sub-systems and components to satisfy a broad range of end-user 
requirements. The physical weights and the material properties would exert its 
ecological impacts. Moreover, in the case that overall ecological impact cannot be 
substantially reduced by feasible engineering solutions. Then it is advisable for the 
medical device company to mainly account for the Regulatory Compliance (e.g.: 
FDA, ISO, IEC) coupled with minimal environmental compliance (e.g.: RoHS) and 
the most essential end-user customer needs have to be prioritized.  
Also, care has to be taken to identify the Pareto Optimal Frontier for overall 
Sustainability in order to satisfy every involved stakeholder up to a tolerable level 
(Zhao et al., 2010). Therefore, in this thesis the prioritization of the sustainability 
related criteria are in accordance with two braid categories namely Regulatory 
Compliance and Economic and Business Performance. The Regulatory 
Compliance mainly encompasses Production; Performance; Safety and Ecological 
Considerations and the Economic and Business Performance include both socio-
economic axioms of Sustainability.  
The Multi-criteria Analysis (MCA) is both qualitative and quantitative; wherein 
the weights are assigned by participatory methods involving expert opinion in 
order to highlight their level of importance (or ranking) between the criteria. The 
unique feature of MCA is the possibility to address the aforementioned domains 
of Sustainability on a common scale of measurement without any standard units 
(Hermann et al., 2007; Ramjerdi, 2008; Zopounidis  & Doumpos, 2002). 
Above all, the ability of the MCA to unearth the explicit or hidden conflicts could 
eventually channelize the innovation efforts of the medical device company in the 
appropriate direction for its own longevity. The comparison of the regularly used 
Cost-Benefit Analysis technique to the Multi-criteria Decision modelling reveals 
that the only similarity between these 2 techniques lies in the prioritization of their 
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pertinent criteria. Meanwhile, unlike the multi-criteria method the Cost benefit 
Analysis method does consider the substitution between various impacts.   
The core reason for multi-criteria to not consider the substitution between various 
impacts is due to the pragmatic nature of inability to substitute monetary 
compensation for any remotely or even irreversible environmental or social 
damage. For example: The Gulf of Mexico oil spill in 2010 destroyed vast amounts 
of aquatic flora and fauna which eventually lead to the end of small business 
associated with local fishing activities. Although financial compensation could be 
provided to the victims but the irreversible damage done to the aquatic ecosystem 
is remotely or in fact irreparable. Unless, engineering processes are employed for 
cleaning the aquatic ecosystem under consideration, the probability of natural 
recovery is almost negligible. Nevertheless, the activity would again consume 
significant non-renewable resources, further contributing to environmental 
degradation either in the same vicinity or elsewhere (McConnaughey, 2013). 
One of the most remarkable advantages of the MCA is its ability to conjugate with 
various other evaluation methods; namely financial and/or environmental such as 
life cycle assessment and environmental performance index. The life cycle 
assessment technique in combination with an environmental management system 
conducts a comprehensive “cradle to grave” environmental evaluation throughout 
the product life cycle (Zobel et al., 2002). The evaluation encompasses the 
classification, characterization and normalization of the output data in the form of 
impact categories. For instance, global warming, acidification potential, 
eutrophication potential, ozone layer depletion and human health. Meanwhile, the 
multi-criteria decision making tool when applied to the exhaustive life cycle 
evaluation provides a singular overall index for illustrating the sustainability 
(Benoit & Rousseaux, 2003; Zobel et al., 2002; Pineda-Henson and Culaba, 2002a; 
2004b), despite the loss of certain information during the aggregation of data. The 
method of data/information aggregation; accuracy of data and decision makers’ 
perspective are the decisive drivers for the effectiveness of the decision model. The 
advantages of multi-criteria decision making is mainly due to the fact that the 
fundamentals of the technique has its foundations rooted in economics, including 
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welfare economics; utility theory; voting oriented social choice theory (Stadler, 
1979; Bouyssou, et al, 2000). 
Moreover, from the plethora of MCA tools available this research report utilizes 
the Analytical Hierarchy Process (AHP) as the foundational scaffold to devise the 
proposed multicriteria decision making model. The AHP technique possesses both 
the simplicity and the stated benefits of the multi-criteria method. In addition, the 
criteria (with their sub-criteria) of AHP are closely pertinent to the quintessential 
axioms of medical device development, which is further based on a systems 
engineering approach (Jones and Masters, 2008; Saaty, 1990a; 2006b; 2008c). 
Notwithstanding, the advantages of the Analytical Hierarchy Process, the 
methodology continues to be dependent to a certain degree on expert opinion for 
scoring in some way or the other, especially in a development environment 
affected by inadequate information on technology complexity and project 
uncertainty.  To minimize or even to eliminate this dependency, Halog (2002) 
devised a novel approach to include Quality, Environment and Cost Requirements 
of various stakeholders using a multi-attribute decision-oriented life cycle 
approach.  Accordingly, the framework utilizes the concept of Fuzzy linguistic 
approach to translate linguistic terms (in terms of natural language) of the 
requirements put forward by the stakeholders and product development teams 
into numerical codes for evaluation. 
The proposed MCA decision-making method in this thesis acts as a critical 
segment of a board multifaceted product development framework, which is also 
discussed in subsequent chapters. In contrast to the contemporary multi-criteria 
approach that does not explicitly permit optimization of the included criteria; the 
proposed multicriteria decision model in conjunction with the proposed 
multifaceted framework enables optimization of the criteria with reference to their 
corresponding product parameters/specifications. The optimization is conducted 
by virtue of continuous and comprehensive interaction between product 
development teams and their pertinent stakeholders in accordance with 
engineering based design optimization tools (Tzeng et al., 2002). 
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3.4.4. Versatility and Shortcomings of Analytical Hierarchy Process 
The conventional forms of AHP and MCA Methods have been in use for selecting 
the most suitable alternative out a given list of opportunities. The application case 
studies have spanned across a variety of sectors ranging from selecting suitable 
Information Technology Software to opting for an appropriate product 
development strategy suited for the Taiwan Semiconductor Industry (Tzeng et al., 
2006; Wu et al., 2009). Similarly, collecting customer preferences for pursuing a 
lean product design and evaluating the automobile competitiveness in the South 
East Asian region (Putri & Yusof, 2009; Venkatamuni & Ramakrishna Rao, 2010).  
The other innovative approaches for utilizing multi-criteria methods are in which 
fuzzy logic has been combined with AHP and the Delphi Participatory Process. 
One of the motivating factors for the researchers to choose a fuzzy approach is to 
identify the suitability of each available alternative with higher accuracy and less 
dependency on the weights assigned by expert opinion.  To explain further, the 
comparison matrix proposed in Saaty’s AHP ranges from values of 1 (equally 
important) to 9 (extremely important) and other intermediate values (Saaty 1990a; 
2006b; 2008c). As exhaustive evaluation requires more criteria and sub-criteria, 
which could further add to confusion while conducting pair wise comparison and 
even result in inconsistency. For instance, a project that is expected to increase the 
employment of members from the local community and simultaneously should 
also incur higher profits, although are considered critical for the sustainability of 
the enterprise; nevertheless these two criteria could be contradictory towards each 
other. Therefore, in place of scores ranging from 1 to 9, the research reports that 
discuss AHP with fuzzy logic have considered the membership equations to 
accurately address the weighting between the criteria. Nevertheless, Buyukozkan 
and Feyzioglu (2004) ventured a step ahead to ascertain and characterize the 
uncertainty factors in the new product development process for risk minimization. 
The concept of incorporating decision making should not be limited only to be 
application of decision models but also include other evaluation methods as well 
for overcoming its own limitations and aiding the user in the implementation of 
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an informed decision. For instance, Javadi and Dambatta (2008) devised an 
Analytical Hierarchy Process decision-making model to identify the most 
sustainable (social, environmental and economical) remediation strategy to 
counter the contamination caused by Petroleum processing. From their research 
they identified that the Monitored Natural Attenuation is the most sustainable 
option as compared to Enhanced Natural Attenuation and Soil Vapor Extraction. 
Nevertheless, the AHP Model without the inclusion of a comprehensive life cycle 
evaluation is handicapped to outline the potential drawbacks and environmental 
impacts caused by the remediation strategy itself, as the fundamental laws of 
thermodynamics execute no process without consumption of materials and 
energy. 
Similarly, the multi-criteria method has also been combined with other evaluation 
and application tools for user specific applications. Eshlaghy et al. (2011) utilized a 
multi-criteria method in conjunction with discriminate regression method for 
evaluating the most effective engineering process in order to maintain the desired 
level of adherence with the specified standards.  
In certain scenarios, the multi-criteria methods to which the AHP is a category, 
notwithstanding the effectiveness, could still possibly suffer from poor accuracy 
due to inadequate understanding. This would further demand additional 
modelling only possible by virtue of an exhaustive computational technique. 
Therefore, the computational modelling for both Systems and Processes is carried 
out to assign the weights to the Multi-criteria method and calculate the 
consistencies amongst the diverse range of criteria (Bouchard et al., 2010). 
In comparison to the conventional AHP proposed by Saaty (1990a, 2006,b 2008c) 
proposed in the early 1990s, significant modifications in the Analytical Hierarchy 
Process have been justified in order to address Comprehensive Product 
Development Requirements that further demand a more effective decision 
modelling approach. Accordingly, Yang et al. (2009) instead of considering AHP 
as a decision making model for evaluating various technologies for coating car 
wheels, have used a multi-criteria hierarchical matrix method. Their conclusion 
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purports that the hierarchical multi-criteria matrix model provides a flexible and 
practical approach to define overall sustainability of manufacturing processes.  
Furthermore, they have also used a comparative evaluation of various criteria and 
the alternatives by engaging the domain participants and potential users quite 
closely in the evaluation phases. Their studies further reveal that in comparison to 
powder coating, the sol-gel coating delivers better technical, economical and 
environmental sustainability. 
At the moment, pertaining to the interdisciplinary nature of medical devices and 
other dimensions of developing and delivering healthcare, the authors have 
identified a limited number of studies on the application of Multi-criteria decision 
methods. One of them was a review report published by Liberatore and Nydick 
(2008) discussed the suitability of AHP decision-making process in the field of 
medical and healthcare. The duo reviewed around 50 research articles from 1980s 
onwards and identified a surge in AHP utilization for decision-making since 1997, 
particularly in the areas of joint decision-making between patient and doctor, 
evaluation and/or selection of therapies/treatments and the evaluation of health 
care technologies & policies. 
The authors of this research have not come across significant research articles 
related to the application of Analytical Hierarchy Process actively participating in 
the Medical Device Development. Although such attempts have been made in 
other engineering industries namely aerospace, automobile and defence, which 
involve interdisciplinary product design, that is largely prevalent even in the 
Medical Device sector. 
Cho &Kim (2003) have utilized only the Analytical Hierarchical Process (AHP) for 
assessing and ranking a list of selected medical devices, to receive funding from 
Korean Ministry of Health and Welfare. In their research investigation, due to 
budget restrictions on healthcare expenditure by the Korean government, Cho 
&Kim (2003) established priorities to select the most relevant medical devices for 
receiving funding. The goal was to satisfy the needs of the stakeholders that are 
include people, medical institutions, government and patients. Moreover, the 
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authors implemented the basic principles of ‘exclusiveness,’ ‘marketability’, 
‘technology applicability’, ‘public benefits’, ‘completeness’ and ‘optimum size’, 
while identifying their evaluation criteria and the hierarchical structure on the 
basis of the presumption that the criteria independent of each other.   
Acknowledging the customized modifications of the Analytical Hierarchy Process 
and conjugating the methodology with a variety of evaluation and product 
development strategies, a Multi-Faceted Product Development Framework was 
devised. In this multifaceted framework a novel and modified Analytical 
Hierarchy Process is proposed whose participation is assured throughout the 
Product Development Cycle of a Medical Device.  
The novel (or modified) AHP approach in this would be hereafter titled as 
“Multicriteria Hierarchical Model (MCHM)”.  
3.5. Structuring the Proposed MCHM 
The proposed MCHM in this thesis is envisioned to participate actively in the 
product development endeavour, in addition to the conventional project selection 
and evaluation role of the contemporary multi-criteria methods such as AHP.  
As illustrated in Figure 3.2, the Model comprising of 2 main criteria namely 
Regulatory Compliance and Economic and Business Performance that are further 
divided into 3 Tiers. The Tier 1 consists of the most critical sub-criteria without 
which no medical device can be qualified by the FDA; ISO and other Regulatory 
Bodies. Satisfying the criteria is Tier 1 results in a attaining a acceptable degree of 
overall Sustainability from the perspective of regulatory agencies and the senior 
executives of the medical device company.  
As safety considerations of all the involved stakeholders (e.g.: Environmental 
Protection Agency (EPA); ISO) and the minimal environmental compliance (e.g.: 
ROHS; REACH; WEEE) in conjunction with reasonable profitability satisfies the 
bare minimum threshold after which the company can chose to increase its overall 
Sustainability by satisfying Tier 2 and 3 as per their own preferences. However, 
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the product development teams should not violate any of the criterions in Tier 1 to 
satisfy any other criterion or criteria in Tier 2 and Tier 3.  
As these criteria in Tier 2 and Tier 3 are negotiable in nature and dependent on the 
company’s profitability, for instance charity and employee housing are addressed 
mostly by investing financial resources. The Medical Device Regulations, 
Mutually Beneficial Labour Practices and Safety Norms are assigned the highest 
priority compared to environmental compliance (ROHS; REACH; WEEE). As in 
certain cases these ROHS; REACH; WEEE regulations could be irreconcilable with 
Product Specifications critical for the medical device functionality and regulatory 
compliance. Therefore, in certain cases medical devices are exempted from these 
ROHS; REACH; WEEE related regulations and accordingly, the company is 
responsible to execute the necessary due diligence to obtain the required 
certifications and exemptions.  
 
 
 
A. Regulatory Compliance  
 
TIER 1 (Non-Negotiable) 
Stakeholders: Supply Chain, Personnel, Patients, End-users  
 (Direct/indirect interaction with the ecological system) 
i) Medical Device Regulations (Eg: FDA, ISO, IEC): 
Function, Reliability, Clinical Evaluation, Human Factors 
Engineering, Ergonomics &Manufacturability. 
ii) Environment (RoHS, REACH, WEEE) 
>25% Minimization waste & emissions and non-renewables.  
>25% Increase the use of renewable resources.  
iii) Social Factors: Health and Safety of Stakeholders . 
 
TIER 2 
i) Environment  
30%-50% Increasing Renewables; Decreasing 
Waste/Emissions  
30%-50% Decrease in waste & emissions 
(End-Of-Life) Remanufacturing, Reuse and Recycle. 
Modularity, Platforming and Standardization  
Of Parts, Components and Sub-Assemblies. 
ii) Social: Employment and Growth in Income Distribution.  
 
TIER 3: Social Sustainability 
Employee  Housing and Community Welfare. 
>50% Increasing Renewables; Decreasing Waste/Emissions  
>50% Decrease in waste & emissions. 
B. Economic & Business Performance  
 
TIER 1 (Non-Negotiable)  
i) Competitive Edge and Knowledge Curve.  
ii) Strong Team Collaborative Strength. 
iii) Supply Chain: Superior Planning and Logistics. 
iv) Adequate Access to resources/infrastructure:  
such as Engineering; Material; Financial and 
determining their limitations  
v) Market Acceptance with maintenance services  
and Stakeholder Satisfaction. At least 25% increase  
in cost-effectiveness for 10% price increase.  
vi) Robust IT Communication Network with  
Customizability and Interoperability. 
iv) Payment and Reimbursement  
(Government/Insurance). 
v) Competitive Shorter Time to Market.  
vi) Return on Investment:   
(1) Adequate profit for a 3 year no-growth period [or]  
(2) Two year growth period of 2%. 
 
TIER 2: Growth in Market Share (~2-5%) and  
50% increase in cost-effectiveness for 20% price rise. 
 
TIER 3:Corporate Expansion. 
>70% increase in cost-effectiveness for price rise > 30%.                      
Mergers and Acquisitions. 
 
 
Figure 3.2. – Multicriteria Hierarchical Model 
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Nevertheless, the company can still improvise its environmental sustainability 
quotient by adopting lean product development and sourcing practices to 
minimize wastage and consumption of resources (Kadamus, 2008). Since the last 
decade, research endeavours to recover precious materials from semiconductors 
and treatment of industrial emissions/ waste have achieved a quantum leap in 
their ingenuity (Cui and Zhang, 2008; Pubule, 2011). 
The known concept of Value Engineering can also be employed with the MCHM; 
wherein the focus is on identifying the “Value” of a developmental and/or 
production process. The “Value” can be elucidated by the attainable magnitude of 
product functionality; safety; business performance (e.g.: profits and 
administrative cost effectiveness); regulatory compliance and overall 
Sustainability. The “Value” of each process is not necessarily additional in nature 
in combination with other processes as it can be exponential, compounding or 
even inversely co-related if the Pareto Optimal Frontier is encountered (Zhao et 
al., 2010; Hede et al., 2011). 
Each Criterion of the proposed MCHM is in fact composed of one of more Product 
Specifications, which embodies the objective of attaining the criterion under 
consideration. Moreover, the instead of compelling the users of the MCHM to 
assign scores for any particular criterion in Tier 1 and End-of-Life/ Modularity of 
Tier 2; the authors suggest the usage of the “maximum achievable and minimum 
acceptable values” associated with the pertinent specifications.  
For example, the Criteria of Functional Performance and Reliability are dependent 
upon the specifications of ‘uninterrupted cycles of operation’ and ‘mean time 
between failures (MTBF)’ respectively. The “maximum achievable and minimum 
acceptable” range values for the two specifications are (100-1000 cycles per 
minute) and the MTBF is 300-1000 hours, respectively. In due course of time 
during the conceptual design phase and design engineering activities, the product 
development teams can finalize the most optimal values. Nevertheless, the teams 
would have to conduct a preliminary investigation to ascertain the range of 
values, deduce the feasibility to incorporate multiple life cycles/product 
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modularity and ultimately, unearth any underlying conflicts and synergies. Under 
no circumstances, the modularity and end-of-life options should be considered if it 
is identified to be irreconcilable with the Tier 1 criteria. Therefore, these two sub-
criteria are placed in Tier 2. The fundamental concept behind the justifying the use 
of specifications for each criterion is based on Quality Function Deployment. The 
aim of the stated conceptual tool was to transform user requirements into the 
quality of product design and recommend approaches for achieving thereof. 
For clarification purpose, the stakeholders in the proposed model are the people, 
societies and ecosystems that are both directly and indirectly affected by the 
company’s business practices. For example: The 2010 Gulf oil spill not only 
affected the aquatic ecosystem and the livelihood of local industries on the coast, 
but in fact threatens to pollute other geographical regions in the coming future 
(McConnaughey, 2013). Also, in today’s modern globalized world, the medical 
device development starting from the design to production and sale is conducted 
across various continents. Therefore, the stated example is also applicable towards 
the safety, labour laws, welfare/benefits, sourcing, development, exports and 
imports of medical devices to countries with regulatory compliance frameworks 
quite different from the parent country of the medical device manufacturer. In line 
with this, the organization titled as the “Global Harmonization Task Force” has 
been conceptualized in 1992 by the regulatory authorities of European Union, 
United States, Canada, Australia and Japan for establishing a higher degree of 
uniformity between the various national medical device regulatory systems. 
The Tiers of criteria in the MCHM as denoted in Figure 3.2 are also categorized 
with respect to two more categories in Figure 3.3. The first one is the “Design 
related criteria” (e.g.: Human Factors; Safety; Functionality; Clinical Evaluation 
and others), which can be incorporated as a part of the Product Design. The 
second category is the “Non-design related criteria” that although is closely 
related to Product Specifications but not necessarily can be modified by the design 
engineering activities directly, namely Aesthetics in terms of market acceptability; 
Finalizing the Payment/Reimbursement options; Ability to execute advanced 
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technology/product development processes and Knowledge Management; 
Information and Communication Technology Infrastructure and Management. 
The aim of Figure 3.3 is to enable the users of MCHM to allocate suitable human 
resources and the appropriate magnitude of effort in terms of man-hours to 
monitor those criteria that regularly require human intervention. For instance, the 
reliability of a component in terms of Mean Time Between Failures can be 
addressed by using suitable automated design engineering optimization tools 
with limited human supervision. However, challenges pertaining to payment and 
reimbursement demands continuous interaction between the pertinent employees 
of the medical device company and the regulatory agencies, which cannot be 
substituted by an automated system. This implies that the product development 
teams have to plan the logistics/operations between designs related engineering 
activities and business process related activities in order to shorten the product 
development life cycle.  
Design related criteria: 
 Performance, Reliability, Clinical Evaluation, Emissions, Human Factors Engineering 
and End-of-Life. 
 Regulatory Compliance 
 Minimization of emissions and waste 
 Safety, Cost and Time to Market 
Non-design related criteria: 
 Market Acceptance (such as Aesthetics and Selling Price) 
 Policies of Payment and Reimbursement by the Government and Insurance 
Companies. 
 The medical device company’s infrastructure to uphold safety standards and execute 
advanced technology/product development.  
 Information & Communication Technology (ICT) Infrastructure. 
 Strong Team Collaborative Strength. 
 Economic & Business Performance criteria in Tier 2 and Tier 3. 
 Employment and Growth in Income Distribution (Tier 2 of Regulatory Compliance) 
 Employee Housing and Community Welfare (Tier 3 of Regulatory Compliance) 
Figure 3.3 – Categorization of the Criteria in Multicriteria Hierarchical Model 
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As described previously, the pertinent criteria are structured into three tiers; 
wherein Tier 1 is compulsory and non-negotiable and Tier 2/Tier 3 are negotiable 
in nature and hence medical devices companies can chose certain design 
candidates. In conventional AHP terms the design candidates can be considered as 
Alternatives, out which the most suitable one has to be selected. 
Following is a description of each criterion of Figure 3.2 and the numerical values 
in terms of emission reductions. The cost effectiveness was provided by the 
Experts (from Industry and Academia), which were interviewed to conduct the 
pair-wise comparison of the Tier 2 and Tier 3 (negotiable Tiers). The discussion of 
the methodology and results of the pair-wise comparison have been outlined in 
Chapter 5 and Chapter 6, respectively. 
TIER 1 (Non-Negotiable) (Left hand side A. Regulatory Compliance) 
The crucial regulations pertaining to FDA, ISO, IEC and others are necessary for 
the product to be qualified to enter the market. There are also additional policies 
by the government to prevent any safety related hazards and even human rights 
related issues that a company must comply before commercializing its 
products/services. 
i) Medical Device Regulations (e.g.: FDA, ISO, IEC): 
Function, Reliability, Clinical Evaluation, Human Factors Engineering, 
Ergonomics & Manufacturability. 
These facets are to be conducted in a concurrent manner on the basis of the 
configuration of the medical device and the knowledge curve (in addition to other 
resources outlined in Section 3.3) of the medical device company. 
ii) Environment (RoHS, REACH, WEEE) 
>25% Minimization waste & emissions and non-renewables.  
>25% Increase the use of renewable resources.  
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iii) Social Factors: Health and Safety of Stakeholders. 
The medical device should not engage in any engineering process as a part of its 
design, development or production, which could harm local or distant 
stakeholders. For instance, indiscriminately dumping toxic waste in rivers and not 
adopting safety standards pertaining to waste disposal. 
Once the company is in a position to attain the Tier 1 criteria, they can consider 
any one or few or all criteria of Tier 2/Tier 3. These criteria are capable of adding a 
strategic value to the company for its future prospects. As commitment to 
incorporate criteria such as end-of-life options and increase in employment within 
the business practices of an Industry have demonstrated long term success via 
improvement in income distribution (D’Alessandro et al., 2009; Nasr and 
Thurston, 2006). The facet of cost effectiveness and increase in price gradually 
increases as we go from Tier 1 onwards to Tier 2 and 3. The objective is to 
recommend companies for delivering ‘better value for their money’ in order for 
them to stay competitive in the long run (Xu and Morisson, 2005). 
TIER 1 (Non-Negotiable) (Right hand side B. Economic & Business 
Performance) 
i) Competitive Edge and Knowledge Curve.  
A medical device company’s products should possess substantial competitiveness 
compared to its competitors. This is in addition to the company’s organization in 
terms of leveraging its resources (financial/non-financial) to produce new 
products/services. The knowledge curve which is a key decisive factor for 
commercializing robust customer centric products at lower costs (Corallo et al., 
2009). 
ii) Strong Team Collaborative Strength. 
A team that is able to collaborate effectively and exchange their knowledge as well 
as expertise are able to develop superior products with a smoother process of 
product development (Akgün et al., 2006). 
 76 
iii) Supply Chain: Superior Planning and Logistics has proven to be a strategic 
factor in access to raw materials and delivery of finished goods/services to 
pertinent consumers in the most effective manner. This enables the company to 
gain better product feedback and provide maintenance services, so as to 
demonstrate better customer services and maintain customer loyalty (Marra et al., 
2011) 
iv) Adequate Access to Resources/Infrastructure: such as Engineering; Material; 
Financial and determining their limitations (refer Section 3.3). 
The properties and limitations of materials (e.g.: steel is strong and heavy so 
higher fuel costs for transportation) are crucial in determining the scope of 
application of the medical device, which uses a certain combination of materials to 
lower costs and provide the desired utility to the end-user. For instance, certain 
polymers cannot be used as implants owing to their eventual fragmentation and 
disintegration, which can result in allergies; nevertheless metals can be expensive 
as well as heavy. Thus resulting in higher costs (Nag & Banerjee, 2012). 
v) Market Acceptance with maintenance services and Stakeholder Satisfaction: 
At least 25% increase in cost-effectiveness for 10% price increase.  
The Experts (from Academia and Industry) recommended that the medical device 
company adopting the MCHM should consider at least 25% increase in cost-
effectiveness in terms of customer satisfaction for a 10% increase in price, in order 
to increase profit margins and add more value to their customers who choose to 
pay more. 
Similarly, the same Experts (from Academia and Industry) recommended 
additional degrees of cost effectiveness for increase in product price in Tier 2 and 
Tier 3 of the Economic and Business Performance.  
These two are the most crucial criteria, which are considered before ‘killing a 
project’. As the market interest in terms of demand (and buying power of the 
relevant customers) and the support from the stakeholders are critical for the 
device to be made accessible or even justifiable (including end-users, regulatory 
bodies and Insurance companies). This includes support of local and distant 
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communities who are directly and indirectly affected by the company’s actions 
(Pacelli, 2004). 
vi) Robust IT Communication Network with Customizability and 
Interoperability.  
IT (Information Technology) communications network enables a more agile 
continuous iterative design and development of the medical device by virtue of 
improved traceability of the tasks/ activities involved. This includes the 
automated updating of the regulatory documentation for minimizing the risk of 
any project schedule overruns (Patil, 2010). 
iv) Payment and Reimbursement (Government/Insurance). 
As mentioned in market and stakeholder considerations, this criterion is crucial 
for the utilization and sale of the medical device, especially in scenarios where 
Insurance companies and Governments require substantial time for 
reimbursement (Miller, 2007). 
v) Competitive Shorter Time to Market.  
The activities of product development of a medical device should never fall 
behind the time to market plan of the competitors. However, a late entry can be 
strategically considered to incorporate better features after learning from 
competitors’ failures, which creates a need on the market for a better product. This 
is the reason the criterion is labelled a ‘competitive’ shorter time to market.  
vi) Return on Investment:   
(1) Adequate profit for a 3-year no-growth period or (2) Two year growth period 
of 2%. 
The criterion of minimal profitability is critical to filter out design candidates that 
although meet certain advantageous aspects such as recycling, nevertheless may 
not provide the desired rate of profit for the medical device company. Moreover, 
this criterion should not violate the crucial regulatory compliance requirements.  
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TIER 2 (Left hand side A. Regulatory Compliance) 
i) Environmental Sustainability 
30%-50% Increasing Renewables; Decreasing Waste/Emissions  
30%-50% Decrease in waste & emissions 
End-Of-Life: Remanufacturing, Reuse and Recycle. 
Usually the End-Of-Life comprises of a systems based approach of a product 
configuration namely Modularity, Platforming and Standardization Of Parts, 
Components and Sub-Assemblies to name a few. In Chapter 5 and Chapter 6, this 
sub-criterion of End-Of-Life is renamed as End-Of-Life and Modularity as they are 
closely inter-related (Nasr & Thurston, 2006). As it become easier for pair-wise 
comparison related interviews with the Experts (from Industry and Academia). 
ii) Social Sustainability: Employment and Growth in Income Distribution (in 
terms of benefits, perks and incentives). 
Both these sub-criteria have been considered for pair-wise comparison pair-wise 
comparison related interviews with the Experts (from Industry and Academia). 
TIER 2 (Right hand side B. Economic & Business Performance) 
Growth in Market Share (~2-5%)  
50% increase in cost-effectiveness for 20% price rise. 
TIER 3 (Left hand side A. Regulatory Compliance) 
Social and Environmental Sustainability 
Employee Housing and Community Welfare. 
Activities pertaining to community welfare in terms of Corporate Social 
Responsibility and providing any suitable form of support for productive as well 
as deserving employees not only leads to boosting employee morale with 
commitment for a higher degree of productivity, but also eventually contributes 
towards income distribution (D’Alessandro et al., 2009). Moreover, both these sub-
criteria i.e. Employee Housing and Community Welfare have been considered for 
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pair-wise comparison pair-wise comparison related interviews with the Experts 
(from Industry and Academia). 
>50% Increasing Renewables; Decreasing Waste/Emissions  
>50% Decrease in waste & emissions. 
TIER 3(Right hand side B. Economic & Business Performance) 
Corporate Expansion. 
>70% increase in cost-effectiveness for price rise > 30%. 
Mergers and Acquisitions (M&A) of Organizations is one of the approaches 
towards the economic growth objectives of a company. However, in certain cases 
when companies face bankruptcy they could opt for an M&A (Denning, 2012).  
In Chapter 5 and Chapter 6, the sub-criteria of Business Growth is considered 
instead of Mergers and Acquisitions, as Business Growth can be attained by 
increasing sales, M&A, entering new businesses as well as corporate expansion. 
Hence the sub-criterion of Business Growth is more holistic in nature and ensures 
that the pair-wise comparison activity with the Experts (from Industry and 
Academia) becomes less exhaustive without losing the scope of the thesis. 
Meanwhile, the sub-criterion of Market Share is still considered as a separate sub-
criterion as market share growth does not necessarily indicate the other 
aforementioned business growth related facets. 
With respect to the brief description of each pertinent criterion outlined in the 
three tiers, the product development teams should take note of a few important 
points that for any development endeavour, the key important resources with 
their corresponding properties and policies/regulations have to be in place for the 
company to attain mutually beneficial relationship with its stakeholders. 
Accordingly, the role of the ICT infrastructure is critical in attaining a 
synchronicity and assures traceability between project management; knowledge 
management and interdisciplinary engineering activities (Patil, 2010). The product 
life cycle management also encompasses ‘Digital Manufacturing’ to integrate the 
shop floor activities and equipment so as to actualize product-related information 
 80 
between design and manufacturing activities in a computerized virtual 
environment. The virtual environment can model the incorporation of Tooling, 
Assembly Lines, Work Centers, and Facility Layout, incorporation of Ergonomics 
and optimal use of resources 
(SIEMENS<http://www.plm.automation.siemens.com/en_us/>). The 
advantages of a coordinated networking of activities are including but not limited 
to cost savings, minimizing expensive downstream modifications and reduce 
time-to-market.  
A robust and interconnected company would always move faster in the learning 
curve and disseminate knowledge throughout its organizational structure to stay 
competitive. As the ICT systems efficiently transfer knowledge pertaining to the 
complex engineering data/information generated during the design phase for 
product and production processes of components and sub-assemblies. The 
knowledge transfer processes can be conveniently correlated with the automated 
updating of regulatory documentation such as FDA or environmental compliance 
e.g.: WEEE, FDA and ISO. The product development and ICT systems have to 
coordinate with other information systems by way of interoperability to 
communicate with activities pertaining to other phases of the product life cycle, 
namely supply chain; distribution; maintenance and end-of-life. For example: The 
Enterprise Resource Planning Systems; Quality Management System; Product 
Data Management; Portfolio Management; Laboratory Information Management 
(LIMS); Document Management System (DMS); Clinical Data Management 
System (CDMS); Submission Management and Publishing; Inquiries and Adverse 
Event Reporting (AERS); Learning Management System (LMS). (Patil, 2010; 
Parametric Technology Corporation (PTC), 2008). 
One such remarkable example of product life cycle management is from 
SIEMENS, who have developed a software based digital platform to provide its 
clients with single, easily configurable and open/flexible source of Product, 
Business and Production Process Information. The Open/Flexible architecture 
enables introduction of additional business processes while minimizing undesired 
complexities that arise during integration, implementation and interoperation. The 
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SIEMENS software based digital platform permits integration of leading 
engineering systems from other vendors such as SAP, Oracle and Microsoft 
(SIEMENS <http://www.plm.automation.siemens.com/en_us/>).  
The other functional paradigms of ICT systems are enumerated as follows (Filho 
et al., 2009; Goedkoop et al., 2000; Mont, 2000): 
a) The Innovation Management Component embraces Innovation Strategic 
Planning and with Portfolio Management through a stage-gate process. This 
business process involves assessment of trends in the market and technology of 
products and services. 
b) The Configuration Management (ECM) is related to engineering oriented 
modifications across the product life cycle that also assists in maintaining the 
complete information and knowledge of the involved PSS (Product Service 
System). The Configuration Item (CI): A collection of all components and sub-
systems that form the PSS and the Configuration Document (CD): the complete 
information that characterizes the CIs (Ekos International <www.ekosi.com/>). 
c) Business Process Management (BPM) is sector that builds and evolves 
knowledge, which is obtained through the intersection between management and 
information technology. This sector includes various methods, techniques and 
tools that are crucial to design, control, and analyse operational business processes 
involving humans, organizations, applications, documents and other sources of 
information (Van der Alst et al., 2003). 
The additional advantages are traceability of work activities to the compliance of 
each system element with the validation standards for addressing stakeholder 
considerations. Traceability monitors the progress and actively materializes risk 
mitigation objectives by enabling the product development teams to identify, trace 
and rectify the source of failures and accordingly, monitor the resultant 
consequences to the company (Wysoki et al., 2000; Wilde Analysis 
<wildeanalysis.co.uk>). Simultaneously, the Product Design and Optimization 
Phase enables graphical modelling of the requirements, behaviour and 
functionality of both the systems and software. Graphical representation permits 
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iterative assessment, testing and validation, throughout the development process. 
The results can be automatically transferred into a production quality code, which 
would be evaluated in accordance with Manufacturing Process Management 
(MPM). The MPM would further enable communication with the value chain 
partners through the attributes of the Enterprise Resource Planning (ERP) Tools. 
Moreover the visual models facilitate the teams’ understanding of the 
interdisciplinary project and enables better communication to its engineers and 
stakeholders.  
The Validation of IT Communication Software Systems for Medical Device 
Industry is stated in the Quality System Requirements (QSR) put forward by the 
FDA (Vogel, 2001). The QSR demands validation of the software solutions 
implemented for the new product development in the medical device industry. 
The QSR states that if “computers or automated data processing systems are used 
as part of production or the quality system, the [device] manufacturer shall 
validate computer software for its intended use according to an established 
protocol” (see 21 CFR §820.70(i) Code of Federal Regulations) (Sobelman, 2008). In 
addition, Sobelman (2008) has determined that Companies who purchase their 
enterprise software systems from vendors, who also provide a validation protocol 
for the base-line implementation state of their software systems, save around 50% 
of time and cost for the validation procedure. The discussed QSR requirements 
are: Traceability (820.65), Production and Process controls (820.70), Process 
Validation (820.75), Device Master Records (820.181), and Device History Records 
(820.184). These aforementioned Code of Federal Regulations are located in the 
CFR - Code of Federal Regulations (2012) Title 21, PART 820 of the Food and Drug 
Administration 
<http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpa
rt=820>. 
Furthermore, notwithstanding the drawback of the proposed decision making 
approach pertaining to its capital intensive nature and demand for due diligence 
throughout the development path.  The model does deliver the advantage of 
customization subjective to each medical device, although substantial effort is 
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needed for preliminary investigation as stated before for ascertaining the optimal 
values for the product specifications. The proposed MCHM and its criteria can 
also be considered as a ‘Benchmarking Tool’ and a ‘To-do List’ as it elucidates the 
position of the Organization from a competitive standpoint and encourages the 
development of a reliable roadmap for the “overall” success of the Organization 
(Damelio, 1995). The approaches for design optimization and strategies for 
reconciling conflicts objectives and constraints would be discussed in detail in the 
subsequent sections of this thesis. 
3.5.1. Project Selection 
If one observes the list of criteria with close observation, then the proposed 
MCHM is capable to acting a decision model to choose suitable medical devices 
for development. The proposed MCHM for Project Selection is demonstrated in an 
example. In this example the choice to pursue development has to be made 
between a Pacemaker, a Syringe and an Infusion Pump for injecting fluid 
intravenously and the decision modelling steps are outlined as follows: 
STEP 1: Identify the magnitude of commitment desired for each criterion 
pertinent to the shortlisted candidates of Medical Devices. For example, A 
Pacemaker would have more stringent regulations than a Syringe and hence 
requires more expertise for design and manufacturing.  
STEP 2: Identify the magnitude of financial and expertise related commitment that 
can be invested by the Organization for each criterion in order to achieve the 
desired results.  
STEP 3: If the medical device company determines substantial impediments 
pertaining to addressing regulatory compliance, knowledge curve and monetary 
resources then the company is advised to “Reject” the particular Medical Device 
under evaluation. Nevertheless, if the Organization has access to relevant 
expertise, resources, partners, and leadership and marketing strategies for 
leveraging a successful market entry, then the option can be “Selected”.  
STEP 4: Post selection, the product development teams have to identify the 
pertinent specifications of the device. For example: For a pacemaker to perform for 
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4 year life-span, then the mean time between 2 failures should be around 20,000 
hours.  
STEP 5: Deduce a list of “minimum acceptable and maximum achievable” values 
for each criterion and especially for the specifications pertaining to of Reliability 
and Material Properties for ensuring an End-Of-Life Option namely, 
Remanufacturing, Reuse and Recycling.  
For the illustrated example in Figure 3.4, it is to be inferred that the company is 
sufficiently capable of commercializing a Syringe from an engineering standpoint 
as compared to Pacemaker.  Nonetheless, the market competition for the Syringe 
is the highest due to a multitude of pre-existing players. Moreover, the company 
through additional investment of expertise, resources, partners, leadership and 
marketing strategies, is in a stronger position to launch an Infusion Pump that lies 
between the extremities of a Syringe and Pacemaker. Meanwhile, for a Pacemaker, 
the investment and challenges would be much larger, and therefore a thorough 
internal and external assessment is required before the option is pursued for 
development. 
 
Figure 3.4 – Multicriteria Hierarchical Model in Project selection 
High 
Medium 
Low 
Regulatory Compliance  Knowledge &Expertise Market Competition 
Syringe Pacemaker Infusion Pump            Company’s capabilities 
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Notwithstanding the technical and project related challenges that the development 
teams would encounter, the Business Management dimension of the medical 
device company has to face its own share of insurmountable challenges. To begin 
with, once the patient benefits are accounted for in the medical device design, then 
it is recommended by Miller (2007) to launch medical devices that offer a higher 
degree of cost effectiveness (and savings) to the healthcare service provider such 
as a Hospital.  
Moreover, the healthcare service providers sign “group purchasing contracts” 
with renowned medical device vendors and pharmaceuticals and accordingly, 
buying a better product that is cost effective with enhanced patient satisfaction but 
not “under contract” is a major impediment for business (Miller, 2007). The 
regulatory hurdles and payment/ reimbursement options are the most critical for 
the success of the product development endeavour as confirming a third party 
payer (e.g.: Insurance Company) could turn out to be impossible unless there is a 
decision for reimbursement by the healthcare policy of the nation and vice versa. 
The involvement of sound expertise for guiding the regulatory and 
reimbursement procedure is vital throughout the development activity. Similarly, 
other pragmatic challenges a medical device company would encounter is during 
identification and collection of ergonomics/human factors engineering 
requirements from the patients; medical personnel (doctors; nurses; staff) and 
healthcare providers. Although these pertinent stakeholders are always occupy 
and not readily available for prolonged interactive discussions. The Medical 
device companies do not necessarily possess the prerequisite facilities and 
expertise to scout for all the explicit/latent needs of their stakeholders and 
accordingly simulate them to be incorporated into their products. However, 
medical device companies can hire the services of consultants who specialize in 
the aspect of human factors engineering. 
3.5.2. Comparison between contemporary AHP and the proposed MCHM 
The three tier multicriteria hierarchical model was introduced in this chapter, 
which is inspired from Analytical Hierarchical Process (AHP) only in terms of its 
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hierarchical nature of a wide spectrum of, interconnected criteria. The AHP 
approach is identified to be simple and accounts for a wide spectrum of factors, 
criteria and indicators for decision making in a consistent manner with a common 
scale without any units. It is noted that AHP has undergone substantial 
modifications to address complex product development and engineering 
scenarios: 
1) The contemporary AHP does not necessarily address the complexity of the 
inter-relationships between the Criteria of the uppermost hierarchy with the 
Criteria of the same hierarchy and its sub-criteria levels (Saaty 1990a, 2006b, 
2008c). Moreover, in the conventional AHP each criteria needs to be addressed, 
while the proposed MCHM demands that only the first Tier be satisfied and the 
other tiers to be optional in nature.  
2) The contemporary AHP is more focused on choosing a certain alternative out of 
a list of other Alternatives. This although is applicable only for the “Idea Screening 
Phase”. Meanwhile, the proposed MCHM participates in addressing 
conflicts/synergies and highlighting the limitations elicited by the Organizations’ 
and their Value Chain Partners for selecting a Project of interest for stakeholder 
satisfaction. The proposed MCHM includes by default the holistic assessment of 
the Balance Score card and Strength; Weaknesses; Opportunities and Threats (Hill 
& Westbrook, 1997). This is unlike the Analytical Network Process that also 
elucidates the co-relation between various criteria (Saaty, 2009). For example: 20-
30 years ago, when new applications were encountered for the field of Micro-
Electro-Mechanical Systems (MEMS). MEMS are systems in which micron sized 
parts are fabricated using modified semiconductor fabrication processes. The 
major impediment for innovation in MEMS was that the existing industrial 
electronics industry was not well equipped to accommodate the new sector in a 
cost effective manner. Thus, resulting in a time delay of a few decades to launch a 
simple and robust accelerometer (Baltes et al., 2008). 
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3.5.3. The Role of Multicriteria Hierarchical Model for Addressing the End-Of-
Life Options  
Optimizing the consumption of materials and waste/emission generation without 
compromising the facet of regulatory compliance and bare minimum economic 
objectives of the company can incorporate the Sustainability quotient in a product 
design. Alongside, the product development teams should include end-of-life 
options namely Recycling; Remanufacturing; Reuse; Reconditioning for products, 
which have longer life spans, coupled with higher reliability and short market life 
cycles. The “flow of materials” can be transformed into a closed loop. Thus, 
reducing the dependency on energy and extraction of raw materials (Nasr and 
Thurston, 2006; Scharnhorst et al., 2006; Stahel, 1982). 
Similar to Stahel (1982) the illustration of the length of the loop for each End-Of-
Life option in Figure 3.5 proportionally corresponds to the consumption of time; 
monetary; human expertise/labor and material resources. Moreover, when the 
company opts for any one or all of the End-Of-Life options it also has to accept the 
ownership and responsibility of its products and services through the life cycle(s) 
for satisfying its Sustainability objectives towards its stakeholders.  
 
Figure 3.5 – Multicriteria Hierarchical Model for Addressing End-Of-Life Options  
Resources 
 
Testing Production and Processing Use Assembly Disposal to Landfill 
Recondition Repair 
Design for Remanufacture 
Design for Reassembly Design for Disassembly 
Compliance with Tier 1 
YES 
YES 
NO NO 
Design for Manufacturing and Assembly (DfMA) 
Recycling 
Design for Recycling 
Criteria for End-If-Life are available at the web resources of Systems Realization Lab of Georgia Institute of Technology. 
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As stakeholders desire a utility delivered by a product and not necessary the 
possession of a physical product. For example, consumers desire a cell phone for a 
long distance conversation but not necessarily need to permanently own one 
owing due to the rapidly evolving cell phone alternatives available (Parlikad et al., 
2005). Consequently, the company can provide the consumers with a combination 
of products and services with warranty and take-back benefits constituting the 
product-Service-System (PSS) Model. The inclusion of end-of-life requires the 
products to be Modular in nature; wherein they can be disassembled into distinct 
elements (such as sub-systems, sub-assemblies, components and parts). For 
example, components, parts and sub-assemblies that can be either easily repaired 
or replaced with new ones for either Reusing or Remanufacturing (Hammond et 
al., 1998; Ijomah et al., 1999; King and Burgess, 2005; Sundin, 2004). According to 
Figure 3.5, the product development teams should ensure that during the 
incorporation of disassembly and reassembly mechanisms in the product design 
(Active Disassembly Research Inc., 2005). Moreover, while incorporating 
disassembly and reassembly mechanisms, as stated previously that not a single 
criterion of Tier 1 of MCHM should be violated, under any circumstances.  
The concept of Modularity in product design permits the division of a system into 
its constituting and distinct system elements, namely sub-systems; sub-assemblies; 
components and parts (Sundin, 2004; Ijomah et al., 1999; King and Burgess, 2005; 
Hammond et al., 1998). For instance, an X-ray machine can be sub-divided into its 
constituting modules (system elements) as opposed to an intricately inter-
connected components of a heart valve or a even a stent graft (Aguwa et al., 2010; 
Nair et al., 2003; Fenlon & Walton, 2000). The modules (or systems elements) can 
be interchanged and combined with (less or no-modification) to obtain product 
derivatives from a particular Platform Architecture (Aguwa et al., 2010; 
Chandrasekaran et al., 2004). 
As observed in the medical device sector irrespective of class; the devices such as 
Heart Valves possess a low potential for modularity and end-of-life options as 
compared to X-ray machines and pacemakers that are composed of multiple 
interconnected system elements (Fenlon & Walton, 2000). The prospective users of 
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the MCHM model can choose to modify the project selection process to suit their 
own subjective requirements.  
Also, whenever the company is unable to reconcile the end-of-life objectives with 
Tier 1 criteria, then by default the product should be considered for recycling 
(Weiss and Karwasz, 2005). Nevertheless, it is of utmost importance that the 
paradigm of modularity and platform-derivative approach should not be 
“misused” by launching multiple range of products with nearly cosmetic 
modifications (i.e. planned obsolescence) that although would increase the 
economic sustainability of the Medical Device company, while simultaneously 
jeopardizing the other two domains of sustainability (Packard, 1963; Fishman, 
Gandal & Shy, 1993). 
The advantages of end-of-life, as stated by Sobelman (2008), is that for re-using the 
design by accessing the design archives by using specialized software tools 
ensures substantial savings in time and resources. For Example: Most probably, if 
a design is 20% new and 80% reused, then the testing and evaluation would be no 
more than 20%.  
Moreover, Remanufacturing is known to preserve the embodied energy of the 
elements for their first life cycle. According to Lund (1985) a remanufactured 
product requires only 20-25% of the energy/resources consumed for its first life 
cycle, which begins from extraction up to disposal/end-of-life (Hauschild et al. 
2005). Moreover, a comprehensive learning curve in product development can 
reduce the consumption of energy/resources even further (Lund, 1985). 
Furthermore, if the resources invested are optimized for utilizing the materials 
and elements for multiple life cycles is always preferred by Industry in terms of 
cost savings when compared to manufacturing the product from scratch up to 
recycling/disposal.  
Also, Bras & McIntosh (1999) identified that product recovery by any one of the 
end-of-life options contributes to additional profits by cost savings and 
improvised understanding of the reliability and durability of the product. 
Therefore, further contributing to the learning curve of the Organization for 
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developing better products at a faster rate with competitive prices (up to 60% in 
some cases). Product Designers who intend to incorporate End-Of-Life options 
may have to choose product elements, materials; production methods and design 
candidates which although would last for multiple life cycles could 
simultaneously consume more resources and generate more higher 
emissions/waste usually in the first development and production cycle. For 
instance, certain robust reusable plastics or high strength alloys would require 
more non-renewable fuels such as coal and petroleum for their production; 
nonetheless these materials would survive for multiple life cycles and may 
consume only a fraction of resources for reuse or recycling. While, as stated in this 
example, the product elements or materials in subsequent life cycles are envisaged 
to consume much less resources. Hence bringing about an overall reduction is 
usage of resources and generation of waste.  
Likewise, as explained using the first law of thermodynamics that energy and 
materials cannot be created or destroyed but can be transformed from one form 
(useful) into another form (recyclable or waste).  
The second law states that more energy would be required for carrying out the 
transformation and therefore, low entropy materials that are procured in the 
beginning of the life cycle as starting elements, undergo significant modifications 
during the life cycle phases of production; distribution; use and disposal 
(Hauschild et al. 2005). As a result the entropy (which is denoted as disorderliness 
in this thesis) proportionally increases towards the end of the product’s life cycle. 
Consequently, more energy is required to rectify the “high entropy material” 
(high disorder and low embodied energy) which is in the form of waste/ 
unwanted product to transform into a desired “low entropy material” (low 
disorder and high embodied energy). The disorder or entropy is highest for 
materials and products suitable for recycling. Similarly, the entropy is lower for 
materials and products suitable for remanufacturing and much lower for reusing. 
Thus, exemplifying the Stahel (1982) model for depicting End-Of-Life scenario. 
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Notwithstanding, the benefits of end-of-life, neither of the End-of-Life options is 
free from their own idiosyncratic challenges that range from access to expertise, 
technical infrastructure and resources to design related impediments for both the 
Remanufacturer and the Original Equipment Manufacturers (OEM). The 
restructuring of the conventional supply chain and logistics to a reverse logistics 
approach for “closing the materials loop” has been considered as one of the most 
severe stumbling block. As significant non-renewable resources are expended in 
transportation; recovering the product value and opportunity cost incurred while 
rectifying more damaged components as compared to components in better 
condition (Marques et al., 2004; Barker & King, 2007).  
The impediment is further propagated by lack of assuring incentives and conflicts 
of interest with the Remanufacturer, specifically pertaining to the risk of losing 
foothold of the intellectual property to the other clients of the Remanufacturer and 
the loss of brand value as the “brand conscious” market may reject the product as 
“second hand”. Nonetheless, the increasing awareness and sensitization of 
consumers towards Sustainability has diminished this ‘second hand’ drawback to 
a much larger extent. The demand forever increasing level of sophistication in 
medical devices in combination with competitive pricing results in a significant 
increase in structural complexity pertaining to the product design; development 
and compatibility/interdependency between the diverse product elements in 
terms of the product architecture.  
These potential impediments towards attaining End-of-Life options are accounted 
into Tier 1 in the form of criteria such as Market Acceptance, Stakeholder 
Satisfaction and Competitive Edge. For instance, a product design which is able to 
attain regulatory compliance and remanufacturing; nevertheless, could become 
less competitive in the market and may not be accepted by the end-users. 
Consequently, the design candidate would be rejected and would undergo further 
iterations.  
The fluctuations in the dynamics and logistics of the Value Chain Partners (e.g.: 
Increased prices of copper) of the Life Cycle and Stakeholders (e.g.: demand for 
 92 
more eco-friendly products) results in uncertainty. The uncertainty is minimized 
by overcoming limitations posed by streamlining the access towards resources 
namely materials; expertise; tools and technologies (as mentioned in Section 3.3). 
This is achieved by establishing strong agreements between the value chain 
partners and stakeholders that have to be regularly honoured. Furthermore, the 
policies and legislations (e.g.: tax benefits and subsidies) in accordance with the 
company’s business practices for continuous innovation are essential for 
overcoming the aforementioned sources of uncertainty. 
Taking the discussion of uncertainty and complexity a step further is where a 
medical device company’s commitment to its overall Sustainability is absolutely 
inseparable from its Risk Management measures (FDA, 2000). The degrees of 
anticipated risks are based on the magnitude of undesirable or uncertain events, 
which can further lead to other undesirable consequences, eventually threatening 
the welfare of the Organization and its stakeholders. 
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Figure 3.6 – Interrelation between Criteria of the Multicriteria Hierarchical Model 
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Therefore, the proposed MCHM does outline the co-relation between the criteria 
that are quintessential for ensuring sustainability in the first Tier in relation to the 
other two. Accordingly, the criteria in the MCHM are re-arranged to exemplify the 
inter-relations between them as shown in Figure 3.6. Moreover, through the inter-
relations, the repercussions (or impacts) of any uncertainty or other unintended 
consequences can be traced throughout the Organizations’ activities and its value 
chain. 
The Figure 3.6 is able to illustrate the possible changes in the magnitude of risk 
from one criterion to another and provide a relatively in-depth insight to the user 
of the MCHM. Furthermore, in order to benefit from the proposed MCHM criteria 
inter-relations, the company is responsible to ascertain the sensitivity of the co-
relation to compute the impact of any modification of one criterion on the rest. The 
company in order to do so can incorporate a well-known Systems Engineering 
based technique known as the Design Structure Matrix that explicitly outlines the 
‘extent’ of interdependencies between various system elements (parts; 
components; sub-assemblies) of a product and various other business processes 
pertaining to product development <http://www.dsmweb.org>. 
The product development teams can accordingly devise suitable product designs 
which are adaptable; product development approaches and commercialization 
strategies which are most suited for addressing the interdependency of the 
outlined criteria in Figure 3.2 and Figure 3.6. Moreover, the rectifications required 
towards the later stages would be comparatively less expensive and less probable 
(Malhotra et al., 1996, Trotta, 2010).  
The extent of risk is closely dependent upon the project complexity encountered 
during product development and the effectiveness of the expertise possessed by 
the product development teams under the aegis of the senior management of the 
company. The importance of the interdependences and interrelations will be 
discussed in the design optimization section in the subsequent chapter of this 
thesis. 
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The criterion of Competitiveness basically encompasses the company’s ability to 
deliver highly cost effective products within the suitable time frame into the 
market, which would further satisfy the end-user and patient requirements. 
Competitiveness also accommodates the company’s ability to be flexible and 
leverage negotiations with its value chain partners in order to significantly reduce 
the product development cycle time. The aptitude to be competitive is by virtue of 
a strong and disciplined project management and operations strategy which can 
continuously identify, capture and leverage their knowledge resources of the 
company (and its collaborators) so as to devise the most suited products/services 
for their desired market. In order to do so, the company needs to closely study the 
trends of its target markets and build an inference so as to mobilize all of its 
resources as outlined in Section 3.3 of this Chapter. The criterion of 
Competitiveness is closely related to every other criterion of the proposed MCHM. 
To summarize in one sentence, the model demonstrates a strong alignment 
between the Upper Management; Product Development Teams and the 
Technological Infrastructure of the medical device company. 
The success of a product development endeavour elicits a higher degree of 
assurance in terms of product quality, optimal resource consumption and reduced 
development cycle time by implementing a sound and redundant project 
management methodology. The project management approach with suitable 
templates should clearly define the list of deliverables in accordance with the 
stakeholders’ requirements (Jerrad et al., 2008; Wiegers; Davis, 2002; Sutcliffe et al., 
2009). Moreover, the strategic goals and business processes have to be aligned 
without stifling innovation by incorporating a certain degree of flexibility within 
the Organization. During the execution of the deliverables, the product 
development teams have to conduct their due diligence for each deliverable and 
for their co-relation with other deliverables in order to establish a proactive risk 
management approach. Moreover, sourcing the appropriate human resources in 
terms of skills and knowledge as well as providing access to effective training 
programs for improving useful tacit and explicit knowledge is also considered as a 
key driver for success.  
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The company must possess the relevant expertise and infrastructure to leverage 
“Knowledge” as a vital driver for innovation and development. Robust 
communication coupled with strong leadership and answerability is instrumental 
to coherently articulate the project activities. Meanwhile, the project management 
should encompass the marketing strategy as a part of its executive agenda to 
obtain feedback from stakeholders and value chain partners at every critical stage 
for a “go/no-go” decision as outlined in section 3.5.2 of Project Selection via 
MCHM. 
The stakeholder involvement aids the development teams to identify areas of 
improvements and/or rectification early on and deploy operations for ensuring 
adherence to the desired objectives at an early stage (Trotta, 2010; Sutcliffe et al., 
2009). Thus, avoiding expensive end moment modifications; nevertheless, the 
company’s expertise and process flexibility should permit later stage 
modifications without undergoing detrimental economic consequences. For 
Example: A modification in product specification, just one month before launch 
could be resolved inexpensively, if the company has tools and expertise to 
establish a strong co-relation between their design and production facilities with a 
high product-production process flexibility to incorporate any anticipated 
alterations which were accounted during the product conceptualization phase 
(Yang et al., 2006).  
Finally, the company should always bear in mind its economic objectives would 
be satisfied in terms of its access to credit lines and frequency of cash flows only 
through successful product development endeavours reinforced by stakeholder’s 
satisfaction (Malhotra et al., 1996). 
For implementing any of the End-Of-Life options it is imperative to determine the 
threshold limit of the Reliability of the Product and each of its elements 
(Anityasari and Kaebernick, 2008). Anityasari and Kaebernick (2008) devised such 
a methodology to aiding manufacturers to minimize the risk of disassembling 
products that may possess minimal or no reusability. Moreover, their approach 
could assist engineers in identifying the most appropriate take-back time of the 
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product in addition to selecting the most suitable end-of-life option for products 
with less known reliability. The authors recommend manufacturers to select a 
suitable reliability threshold limit during product design phase, which is 
compatible with the Tier 1 criteria, and also ascertain a suitable degree of trade-
offs between the warranty cost and remanufacturing cost.  Furthermore, the 
products recovered for the end-of-life option (which may or may not possess a 
lower degree of reliability) can also be considered for secondary markets as 
proposed by Gallo et al. (2010). For Example: A computer robustly designed with 
extended durability for military use, can be remanufactured and sold to the low 
durability computer market. The PUSH (namely technology) and PULL (market) 
dynamics have to be balanced with the supply-chain of the products submitted for 
an end-of-life option.      
Meanwhile, during the product development endeavour the development teams 
will require an adjuvant analysis methodology to support the proposed MCHM 
for addressing synergies and trade-offs that would be less exhaustive compared to 
Systems Thinking Approach. One such analysis method is the Markov Decision 
Process and Sloan (2006) devised a decision making model based on the Markov 
Decision Process to assess the trade-offs and engage in a fruitful debate between 
the environmental, legal end-of-life options, safety, reliability, failure penalty, 
device cost and financial viability. The methodology enables the decision maker to 
conduct rough-cut analysis and confirm his/her intuition to ascertain the 
indifference point between an end-of-life device and a new device. For Example: 
Class I items such as Syringes (High Risk) that are less capable of being re-
sterilized and Class I items such as Saw Blades that can be reprocessed. The 
methodology would assist the device manufacturer to propose a suitable price and 
contribute to the savings of the medical practitioner with respect to the 
reimbursement policy.  
With reference to the criterion of reducing overall emissions and waste 
throughout product life cycle of a product designed for a single (No end-of-life) or 
multiple life cycles (with end-of-life) is evaluated by conducting a thorough life 
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cycle energy analysis. Boustani et al. (2010) conducted life cycle energy analysis 
pertaining to the utilization phase and end-of-life options for common residential 
appliances, namely refrigerators, dishwashers, and washing machines. 
Consequently, Boustani et al. (2010) deduced that the remanufacturing end-of-life 
option as theoretically identified earlier by King et al. (2006) by using the 
principles of Thermodynamics is in fact a net-energy expending end-of-life option. 
Furthermore, Boustani et al. (2010) recommend that global organizations (E.g.: 
UNO) and Policy Makers of developed as well as developing nations provide 
incentives to OEM for incorporating end-of-life options so as to be cost effective 
for the customer and other stakeholders (including the value chain partners).  
These constraints for developing an interdisciplinary product with its adjuvant 
services need to be addressed in order to provide a desired combination of 
features to a variety of target market segments. Consequently, the parameters such 
as cost; quality; reliability; environmental impact; end-of-life can be 
simultaneously improved and optimized until the Pareto Optimal Frontier is 
reached. The aforementioned frontier is a limit wherein an improvement in one 
parameter worsens the other and consequently, beyond this frontier trade-offs 
have to be initiated (Zhao et al., 2010). To resolve such challenges Zhao et al. 
(2010) have used a genetic algorithm in conjugation with a multi-attribute utility 
model for a case study in personal computers to determine the Pareto Optimal 
Frontier with respect to price; environmental impact; choice of an end-of-life 
option; number of life cycles; take-back time and reliability to meet the 
dynamically changing needs of divergent markets. Furthermore, once the Pareto 
optimal frontier is ascertained with reference to certain criteria pertinent to the 
medical device and the company’s objectives and regulatory obligations, the 
frontier can also act as a starting point of innovation in the sources of limitations 
outlined in Section 3.3 of this Chapter. 
3.6. Concluding Points 
The decision modelling approach towards the incorporation of overall 
sustainability within the early phases of product development is crucial to 
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minimize expensive modifications in the downstream segment of product 
commercialization. Moreover, such an exhaustive modelling approach requires 
being in a coordinated framework to connect with Business Process Operations 
and Design Engineering activities. As a result, a medical device company always 
desires a simplistic and a comprehensive decision model.  
The medical device companies are advised to venture beyond the bare minimal 
sustainability basic stakeholder safety and ecological compliance to encompass 
additional degrees of stakeholder welfare and substantial decrease in 
emissions/waste. In certain cases, companies who have invested in their 
stakeholders’ welfare and the environment by virtue of renewable energy projects 
and conservation of natural resources such as water have substantially 
contributed to the income distribution of the region, which is known to further 
improve the economic growth.  
The approach of delivering the utility (the desired effect) of a medical device, in 
contrast for the actual physical good. This strategy of Product-Service System 
(based on Systems Engineering) would have to accommodate a more modular 
structure for easier assembly, disassembly and even End-of-life options. As a 
result, not all types of medical devices that range from heart valve to wheelchairs 
can be considered for the PSS method. Even though savings is cost and 
energy/materials could occur by the PSS and end-of-life options, they may also 
occur their own opportunity costs and fewer acceptances by the 
market/stakeholders. Furthermore, the medical device company should bear in 
mind the basic limitations it would encounter in terms of time, skills/knowledge 
of human resources, engineering tools, material properties, finance and regulation. 
These limitations may also pose an impediment for a medical device company to 
re-organize its value chain partners (suppliers, distributors and manufacturers) to 
counter uncertainties and mitigate undesired risks.  
This chapter illustrates the role and importance of an Enterprise subscribing to a 
simplified multicriteria decision modelling approach, namely MCHM that is an 
extensive revision of the Analytical Hierarchical Process. It is imperative for the 
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decision model to be an integral segment of the Business Process Management and 
Engineering Process Frameworks in an Enterprise. The review of previous 
investigations in the domain of Decision Modelling and Sustainability, including 
the other multicriteria methods have been discussed with respect to their 
limitations, especially in their ability to address complicated scenarios that entail 
multiple stakeholders and a diverse set of criteria for overall sustainability. Thus, 
justifying the motivation to substantially redefine the Analytical Hierarchy 
Process, without eliminating the core concept of hierarchical arrangement. As a 
result, the proposed MCHM can be used to eliminate certain criteria that are 
irreconcilable with the most crucial criteria for a medical device to provide bare 
minimum sustainability to the company and its stakeholders. 
The interconnected nature of the criteria in the MCHM would enable the product 
development teams to define the sensitivity values of one criterion over the other 
and in cases of undesired circumstances would be able to trace to the source. As a 
result, enabling sound risk evaluation and planning of mitigation measures 
throughout the life cycle of the product. 
In the subsequent chapters, the role of MCHM in medical device development 
would be discussed in detail. This would be materialized by virtue of being 
included in a Multifaceted Framework that consists of a wide spectrum of 
technical tools and conceptual approaches for product design and development.  
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Chapter 4 
Product Development Approaches in 
conjugation with Decision Modelling for 
Medical Devices Design 
4.1. Introduction 
This chapter contains a detailed discussion on a wide spectrum of product 
development approaches that are utilized by the industry. These product 
development approaches encompass various types of product life cycle 
management in order to attain sustainability. Moreover, these conceptual models 
are required to be integrated with technical tools for design, engineering and 
production in a seamless manner for streamlining both product development and 
commercialization. Therefore, this chapter explores the opportunities for 
incorporating the Multicriteria Hierarchical Model (MCHM) during the design 
phase of the product under development so as to enable the decision makers to 
select/reject suitable product configurations. 
Section 4.2 would discuss in detail about the contemporary product development 
approaches with their shortcomings, followed by a review of the computational 
tools that play a crucial role in materializing the product development 
deliverables into a robust product and the recommended approach to incorporate 
sustainability within product design. Meanwhile, Section 4.3 provides a detailed 
discussion of the proposed Multifaceted Framework and the role of the MCHM 
onwards Design Optimization. Furthermore, the method to evaluate the 
framework would be discussed in Chapter 5 and the outcomes of the evaluation 
are discussed in Chapter 6. 
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4.2. Sustainable New Product Development 
4.2.1. Review of New Product Development Methodologies 
The significant feature of any Product Development Model is to outline the role of 
various drivers, factors, players, tools and methodologies and their corresponding 
interdependencies throughout the product life cycle (Suomala, 2003). The objective 
of these product development models is to enable the product development teams 
to gain a reasonable insight into the critical interwoven intricacies of their 
organizations’ alignment with its sub-divisions, strategic business units 
(internal/external) and value chain partners. 
Product Development Models act as the initiation step for a thorough readiness 
assessment of the Organizations’ resources for launching a robust product/service 
in coordination with other comprehensive decision models. The goal is to ensure 
that the appropriation of the resources is executed in the most effective manner to 
ensure the best interests of both the shareholders and stakeholders. As the models 
represent a layout of the most essential resources (technical, non-technical and 
human), especially the product development tools. Therefore, it is important for 
the company to harmonize the developmental activities of its products and 
services that entail a substantial degree of interdisciplinary engineering, as 
correspondingly each discipline possesses its own synergistic and conflicting 
idiosyncrasies. 
The role of Product Innovation is quintessential for the upholding an 
Organization’s competitive edge in its desired markets and also acts as the 
modality to address the needs and welfare of its stakeholders. A products’ 
performance is complemented by the service it provides in synchronicity with a 
wide spectrum of services that actively support the product throughout the life 
cycle (e.g., the maintenance, billing & payments and take-back). Therefore, 
Kindström & Kowalkowski (2009) recommended a strong harmonization between 
product development and its complementary services. 
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The project deliverables vary from stage to stage of the product development 
process (Krishnan & Ulrich, 2001). For example, the variation could be in the 
functional reliability in the feasibility phase of the product development process 
and the entire product life cycle. This can be further explained by co-relating the 
functional reliability with the importance of the raw material yield during the 
extraction phase as well as variation in product quality during the production 
phase. Mallick and Schroeder (2005) proposed an integrated conceptual 
framework to elucidate the complex relationships between the diverse set of 
metrics considered during product design (Finger & Dixon 1989a and 1989b), 
production (Krishnan & Ulrich 2001) and marketing activities (Griffin & Hauser 
1996) and their overall influence on successful interdisciplinary Product 
Development (Tatikonda & Montoya-Weiss 2001). 
Once the Medical Device Company acknowledges the acute inter-relations 
between the product development criteria and metrics, then it is incumbent upon 
the company to devise a long-term sustainable business strategy. Vickers and 
Boyle (2008) advocated the application of scenario network mapping to chart out 
the present and future trends of the desired markets. The scenario network 
mapping is envisioned to assist companies to devise roadmaps for a business 
horizon that comprises of decades, instead of years. The goal is to minimize 
unpredictability associated with new to the world and radical innovations that are 
further founded on the advancements of interdisciplinary research. 
It is important for the product development teams to address the dynamics of the 
on-going business trends (e.g.: regulatory modifications and customer 
preferences). As a result, the product design would undergo numerous re-designs 
that would range from incremental to major modifications. This would compel the 
development teams to incorporate a substantial degree of operational and design 
flexibility in order to address the prospective dynamics and unexpected outcome 
of events throughout the product life cycle. For instance, the design should be 
robust enough to sustain its structural integrity despite unexpected fluctuation in 
raw material supply. 
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Since the growth of the Industrial Age, the world has experienced an exponential 
increase in resource consumption, especially non-renewable which is much larger 
than the rate of replacement by renewable resources within the regenerative 
capacities of the ecological dynamics (Daly & Cobb, 1989; Goodland, 2002). The 
impacts of a resource intensive economy on the ecosystems and socio-economics 
engender a series of undesired fluctuations in its dynamics (Hauschild et al., 2005).  
Moreover, the rise is interdisciplinary dimension of modern products and services 
continue to unearth other limitations in the previously described new product 
development approaches. As a result, the product development approaches 
require a substantial evolution for a company to adopt in order stay competitive. 
McCarthy et al. (2006) published a report with multiple case study inferences to 
reinforce their perspective on New Product Development, as a process that is 
governed by the fundamental underpinnings of Complex Adaptive Systems. In 
their study, they propose that the diverse product development processes are 
composed of systems whose elements (known as agents) are interconnected to a 
certain extent and also function as independent decision-making points. 
Moreover, the rules, interactions, overlaps, feedback loops and outcomes of these 
agents result in non-linearity of the product development endeavour. These 
paradigms are not explicitly identifiable within the contemporary linear product 
development models. In addition, these quintessential axioms of complex 
adaptive system that comprises of adaptability, flexibility, informality, feedback 
and autonomy are known to promote innovation; thus contributing to the 
company’s future (Clark & Fujimoto, 1991; Dougherty, 1992; Griffin, 1997). 
Concurrently, Alexandre et al. (2003) devised a hierarchical framework that co-
relates product development approaches and its corresponding technological and 
scientific origins, respectively. Moreover, the role of society with the stakeholder 
institutions and corresponding ecosystems play a strategic role in the success of 
the product development endeavour by materializing these scientific discoveries 
and technologies. The framework highlights the role of explicit and latent needs of 
the stakeholders while engaging cross-functional developmental activities for 
designing products and their respective variants. The lower tier of their 
 105 
hierarchical model entails the knowledge domain, followed by the 2nd Tier of 
functionality and efficiency. The 3rd tier is comprised of technology capability to 
devise building blocks for designing a product or a service. For example, a cardiac 
pacemaker requires a small sized power supply, miniaturized electronic circuits 
and biocompatible electrodes. Therefore, technologies pertinent to these sub-
systems have to be robust in nature with a higher degree of functional reliability. 
Similarly, these sub-systems should be fortified by the mandatory industrial 
quality assurance standards such as ISO, IEC, FDA, and others. The final 
uppermost tier comprises of a spectrum of products and services requirements 
that satisfy the stakeholder requirements, in addition to the concerned customers 
and end-users. The study developed by Alexandre et al. (2003) ultimately 
concludes that factors and behaviours that lead to any form of disobedience of the 
hierarchical model would eventually lead to a risk of high failure. Meanwhile, 
continuous improvement of the model would enable the medical device company 
to strategically allocate its limited resources to reap successful products and 
services. To clarify further, the hierarchical structure of the MCHM as discussed in 
Chapter 3 is quite unique compared to the hierarchal structure of product 
development proposed by those authors. 
Every product development endeavour is fundamentally based upon the 
utilization and accessibility of resources namely in the domains of expertise, 
human labour, tools and techniques, monetary and materials (including energy 
resources) (outlined in Section 3.3 of Chapter 3). A self-sufficient organization or 
organizations in joint ventures can carry out the utilization and accessibility with 
each other forming an extended enterprise (Dyer, 2000; Jagdev & Browne, 1998). 
Accordingly, Barragan et al. (2003) have devised a four step decision making 
process for implementing informed decisions pertaining to sourcing their 
resources in a business environment wherein product life cycles are demanded to 
be short and product complexity is desired to be higher than its preceding 
generations to address the dynamically changing needs of a globalized market. 
This further compels organizations to engage in developmental and sourcing 
partnerships with institutions across the world so as to guard existing markets 
 106 
and aggressively enter new markets. Barragan et al. (2003) recommend the 
product development teams to closely associate the financial metrics and the 
factors governing stable and long term competitiveness, not to mention the overall 
sustainability. Therefore, it is important for the product development teams, in 
coordination with other functional areas of the company, including procurement, 
human resources, engineering and production be simultaneously engaged in the 
finalization of sourcing strategies. The sourcing approach is recommended in the 
form of three edges of an equilateral triangle, namely, product architecture 
knowledge, business process management and supply chain coordination. The 
collaborations could range from short-term contracts, call options, long-term 
contracts, joint developments, partial or complete ownership. The increasing 
degree of complexity in today’s products and services compels medical device 
companies to source product development expertise in entirely new areas of 
knowledge in accordance with enhanced access to all forms of resources in order 
to accelerate the time to market. Moreover, companies are recommended to 
engage in a slow transformation from their operational approach to a more 
strategic approach towards product development. 
During the transformation towards a strategic approach for sourcing, the 
company would be in a position to attain its sustainability objectives by 
persuading its value chain partners (or supply chain partners) to closely consider 
their stakeholders simultaneously during the planning and implementation 
phases of their business practices. The company should acknowledge the 
regulations for promoting ecological considerations (e.g.: ROHS; REACH; WEEE) 
and communicate them accordingly so as to establish itself as a member of a larger 
social-ecological-industrial system. The “best practices” of supply chain activities 
have to be reconfigured concerning the depletion of natural resources and the 
ecological impact of globalized industrial activities. Accordingly, Pagell et al. 
(2005) these “best practices” could be Mass Customization, Large Scale 
Outsourcing, and Modular Product Design for incorporating End-Of-Life options, 
Dispersed Global Manufacturing and Sourcing, Collaborative Partners for Design 
and Development. The reconfiguration would entail learning, implementing 
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previously acquired knowledge and adaption of business processes (Hart, 2005; 
Purser, 1995; Shrivastava, 1994a, 1995b). 
It is highly recommended for companies to collaborate with research institutions 
(private/public) or other companies to pursue innovation in new sustainable 
technologies and renewable sources of energy/materials (Massachusetts Institute 
of Technology, 2013 <http://web.mit.edu/newsoffice/2013/mit-eni-renew-
energy-partnership-0213.html>) 
Despite the availability of various renowned product development tools that are 
theoretical (e.g.: Stage Gate, QFD), mathematical (e.g.: Complex Theory) and 
technological (e.g.: Toyota Manufacturing Method). Some of the commonly 
encountered problems in product development are enumerated as follows: 
 Marketing failure up to 90% and above 
 Budget and timeline failures up to 70% and above. 
 The above two coupled with several re-plans and reorientation of 
resources. 
Although, the product development teams are aware of the pre-existing tools and 
techniques namely Stage-Gate, Design for Six Sigma, Toyota Product 
Development Systems, Open Innovation and Outcome based Development, they 
need to ask themselves the fundamental questions about the applicability of these 
tools and techniques pertaining to their specific scenarios to prevent further loss in 
performance. In order to benefit from any of the existing or newly introduced 
tools for product development, the medical device company should understand 
its shortcomings originating from its own expertise and ability to organize and 
utilize its resources effectively. Furthermore, the medical device company should 
incorporate better guidance coupled with a well-defined focus towards a certain 
target market and the ability to incorporate desired level of flexibility pertaining to 
scope of the product development activities and the scale of commercialization 
(Malhotra et al., 1996). These endeavours should be supported by a robust and 
efficient risk contingency plan in conjugation with the willingness to learn at a 
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faster rate than their industrial contemporaries. For example, a product 
development team dedicated to developing a new pacemaker should possess 
substantial willingness and expertise to incorporate additional features that 
deliver a higher degree of cost effectiveness to its end-users. In addition, during 
the design phase the team needs to account for a production method that can scale 
up significantly in a short period of time to address growing market needs. The 
product development teams which account for the most precious resource for a 
medical device company require their adequate supply of ‘organizational fuel’ 
comprising of team development; motivation; communication; training and 
conducive culture to promote innovation. Mr. Parendo Perry of Perry’s Solutions 
(2011) stated that critical thinking and rational approach towards product 
development demands an in-depth understanding of the conceptual frameworks 
in order to elucidate the co-relations and interdependencies between the diverse 
vital facets of an organization and its product development infrastructure. This 
approach would ultimately result in shortening the timelines as opposed to 
directly engaging tools and techniques for obtaining a myopic and short-term 
problem solving options <http://www.perryssolutions.com/index.php>.  
Human and knowledge resources are the vital drivers for innovation in a medical 
device company. Moreover, social cognition acts as a vital methodology for 
comprehending human social behaviour in order to investigate the mental 
processes that occur during interaction between people and systems. Accordingly, 
Akgu et al. (2006) investigated the role of socio-cognitive theory of learning within 
product development teams and their organizations that influence the success of 
new product development endeavours. Moreover, Akgu et al. (2006) devised an 
iterative process model for assessing the team learning phenomenon that includes 
the core components of social cognition namely, information acquisition, 
information dissemination, information implementation, unlearning, thinking, 
intelligence, improvisation, sense-making and memory. The investigation 
concluded that team intelligence resulted in a positive impact on the team 
information processing which further stimulates a rise in product development 
performance. 
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The life cycle perspective illustrates the co-relation of various facets of product 
development. In order to address sustainability oriented business practices, the 
product development endeavour does require interactions between the various 
life cycles (Labuschagne & Brent, 2005), namely project life cycle, product life 
cycle, asset life cycle and process life cycle. For example, during the product 
development stages in which the prototypes are being evaluated using a certain 
manufacturing technology or machine. The same technology/machine could be 
also applicable for the industrial scale production process. This situation 
demonstrates the interdependency and interaction between production life cycle 
and project life cycle (e.g.: product design) with the asset life cycle (e.g.: machining 
tools) in terms of optimum conditions or declining conditions of the asset. 
Likewise, would be in the case of production process life cycle that varies from 
prototype to final commercial product. 
Sustainability oriented product development and commercialization, from a life 
cycle standpoint, starts with Life Cycle Design and Engineering (Herrmann et al., 
2007), follow by Product Life Cycle Management and finally Product End-Of-Life 
Management (Ohlendorf, 2006). These three Life Cycle approaches require robust 
communication and consistent coordination of engineering and business 
processes. Herrmann et al. (2007) have devised the Braunschweig Framework of 
Life Cycle Management that is inspired from the ideas of the Viable System Model 
and the “concept of integrated management”. The framework proposes a systemic 
and life cycle oriented framework to deliver a comprehensive perspective on 
products and their corresponding processes. 
The Viable System Model entails normative (regulatory and legal requirements), 
strategic and operational management. The normative and strategic management 
are the basis for governing the constraints for the operational management. 
Engineering and management activities, in every phase of the product life cycle, 
lead to the commercialization of the product. This is accomplished by the support 
of structures that are governed by the behaviour and expertise of the senior 
management and its associated personnel (Akgu et al., 2006). There are diverse set 
of interactions between the normative, strategic and operational management 
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dimensions in coordination with the life cycle phases of products, processes and 
assets. Moreover, the spatial (size and intensity of tasks), organizational and 
temporal (time) separation of the personnel associated in the product 
development endeavour poses a significant challenge for the streamlined 
execution of the life cycle phases. 
Synergies have to be ascertained and exploited, while conflicts have to be resolved 
and optimized during the integration of diverse life cycle perspectives of each 
system element and paradigm (e.g.: people and processes) of the medical device 
company. For example, the primary product of an automobile manufacturer is a 
car that is designed and produced by the manufacturer within its production life 
cycle, after the development cycle has been successful. The manufacturer also uses 
a secondary product namely a machine tooling unit for the production of the 
primary product that is present within its own usage life cycle. The production life 
cycle of the car [product] and the usage life cycle of the machine-tooling unit 
[asset] are further dependent on the life cycle of the production process, which 
also has a beginning and end [process]. Therefore, the three intersect and exhibit 
the functional and organizational interdependencies. The changes in the 
regulatory framework would demand rectifications in all the three life cycles. 
Furthermore, to incorporate those modifications, the usage life cycle of the 
machine tooling unit and the effectiveness of the process life cycle should be 
consistent with the new regulations. 
4.2.2. The Role of Computational Modelling Tools in Product Development 
The innovations in the domain of devising modern interdisciplinary and robust 
product developmental models have to be complemented with more technical 
methodologies that embrace scientific principles and mathematical models 
(Dankwort et al., 2004). The objective of acknowledging the design engineering 
and modelling facet of product development is to both qualitatively and 
quantitatively illustrate the potential outcomes for a given developmental 
approach. 
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Computational simulation and modelling tools have been extensively utilized in 
design intensive engineering activities. The interdisciplinary nature of certain 
medical devices that needs to satisfy stringent regulatory requirements for which 
certain advanced computational tools and modelling approaches play a crucial 
role in shortening the developmental cycle. For instance, pertaining to the 
utilization of Finite Element Analysis (FEA) for design optimization of the leaflet 
size and geometry of a bio-prosthetic tissue heart valve in order to attain the 
desired blood flow hemodynamic with long lasting durability (Denton & Ford, 
2009). The bio-prosthetic tissue valve was identified to be more biocompatible 
with improved hemodynamic activity and low incidences of thrombosis. 
Nevertheless, this valve was not as durable as mechanical valves. Therefore, an 
optimal design structure was required for minimizing the limitations without 
compromising the benefits. The FEA involved subjecting the design of the bio-
prosthetic tissue heart valve to various forms of loads in order to simulate the 
product performance in its actual environment of operation. The FEA entails a 
complex methodology of points and grids called nodes and meshes, respectively. 
Each mesh contains material and structural properties that are further 
programmed to illustrate the reactions when subjected to certain loading stress 
conditions. The concentration, arrangement and multitude of nodes are 
distributed in the design according to the anticipated stress levels of that region. 
For instance, the regions of the design expected to encounter significant stress 
would be densely populated with nodes as opposed to the regions with lower 
levels of stress. The FEA in the case of the bio-prosthetic tissue heart valve was 
equipped to evaluate the leaflet geometry, tissue thickness, leaflet mismatch and 
consequences of non-concentric valve deployment and fluid structure interaction 
analysis to elucidate the long-term results as a result of fluid flows. The FEA 
simulations enables the designers to gain an in-depth in-sight into the crucial 
failure modes and durability of the proposed design recommendations by 
evaluating varying magnitudes of the in-plane and compressive leaflet stresses, 
conduit stresses, deformation under loading and magnitude of suture forces. As a 
result, FEA was also considered for determining improvised design 
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recommendations. The valve was designed in ProE 2.0 and the finite-element 
models were generated using HyperMesh, (Altair HyperWorks 
<www.altairhyperworks.com>) in combination with the Abaqus standard version 
6.5-3 as a general-purpose nonlinear solver. The run times were approximately 1.4 
hours on a 64-bit Linux 2-node cluster. 
To exemplify further from a pragmatic standpoint as the Product Development 
Teams rely on sophisticated computational tools including Finite Element 
Analysis and Computational Fluid Dynamics, which can extensively impact the 
flow and timing of the development activities, in addition to the no. of re-designs 
required to clear the validation phase. Accordingly, Isaksson et al. (2000) have 
devised a mathematical approach using Signal Flow Graphs in order to compare 
alternative computational simulation strategies with respect to the impact on the 
project lead time, activity cost and project success probability. As knowledge of 
utilizing computational tools is insufficient without incorporating a modelling and 
simulation strategy that further could be sourced from the company’s knowledge 
infrastructure, project team involvement and third party consulting services. The 
computational simulation activity provides a more realistic insight concerning the 
definitive capabilities of the organization as a whole and identifies the occurrence 
of threatening weak links in the developmental process. Consequently, a medical 
device company should not only know on “how” to conduct computational 
modelling but also “how best to conduct computational modelling”.  
In addition, to mathematical techniques such as Signal Flow Graphs there are 
other known approaches such as Data Envelopment Analysis (DEA) which is a 
linear programming methodology to measure the efficiency of multiple decision-
making units (DMUs) in an organization that entails a multitude of processes with 
their own characteristic inputs and outputs (Chiang et al., 2008). Similar to the 
Signal Flow Graphs, this mathematical approach leaves as much as less room for 
dependency on the experience and intuition of the product development teams, 
which is unfortunately prone to subjectivity and errors in terms of schedule 
overruns and wastage of resources (Issakson et al., 2000). 
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Another step further would be in the case of Bayesian network that is a 
probabilistic graphical modelling approach that represents a set of variables and 
their probabilistic dependencies between various facets of the Product 
Development Process. For example, effectiveness of computational modelling 
tools and project lead times (Jensen, 1997). This approach is able to represent 
complex relationship amongst various elements and is able to emulate human 
reasoning (Ren et al., 2007). 
From a Systems Engineering viewpoint of devising co-relation between various 
system elements to develop Products and Services, Andersson et al. (1998) have 
stated that ‘A problem in systems engineering is a deviation between the 
arbitrarily little known system of objectives and a chosen arbitrarily vague object 
system, linked with the partially unknown operating system from objectives to 
object.’ Likewise, Albers et al. (2005) have proposed a unique problems solving 
approach within the domain of Systems Engineering, which is titled as SPALTEN 
-methodology (i.e. to split, decompose) of problem solving in Product 
Development. The SPALTEN -methodology attempts to evaluate the problem 
with respect to the problem type, the boundary conditions, situation, time, person, 
information and complexity. The evaluation based on the SPALTEN -
methodology is carried out in accordance with the scope of objectives and the 
impacts of various activities on the stakeholders and ecosystem. Moreover, the 
SPALTEN -methodology considers the actual state (final system to be defined) 
with the target state (object system to be achieved) and the operating systems 
(pathways involving labour, materials and actions to transform actual state to 
target state). 
The systems elements are required for being modelled in order to simulate the 
performance of the product design candidate devised by the development teams. 
Nevertheless, unlike the computational simulation conducted in Finite Element 
and Fluid Dynamics that is far more exhaustive in nature, the product architecture 
simulation delivers insight on the coherent functionality of the pertinent system 
elements, which eventually builds into a complete System. During the conceptual 
design stage, the geometric, parametric and procedural information are not easily 
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available. Therefore, Wyatt et al. (2009) identified only those modelling languages 
with the ability to provide a schematic component layout to illustrate the 
parameters that embody Product Life Cycle (Subrahmanian et al., 2006). 
Moreover, Wyatt et al. (2009) evaluated the capability of various product 
architecture-modelling languages (e.g.: Bill of Materials, SimuLink and MOKA) to 
address various life cycle objectives that include environmental compliance, 
logistics and assembly. For example, to address the life cycle objective of 
“Assembly”, the chosen metric was Boothroyd-Dewhurst Design for Assembly 
(Boothroyd-Dewhurst Inc. <http://www.dfma.com/>) and the data items of the 
metric were the “parts geometry” and “parts weight”. Therefore, the ability of 
SimuLink, MOKA and Bill of Materials to provide the necessary information on 
the product’s “part geometry” and “weight” was evaluated and compared. Wyatt 
et al. (2009) concluded that the MOKA Modelling Language was much more 
comprehensive than its predecessors that could accurately incorporate up to 30% 
of the Life Cycle Objectives (MML Group for MOKA, 2002). 
4.2.3. Methodologies to incorporate Sustainability within Product Development 
Process 
The success of the product development endeavour is a result of a substantial 
degree of coherence between the diverse set of methodologies and tools.  
Throughout the success of all the interdisciplinary engineering industries 
exemplifies the decisive role of ‘lean approach’ towards Sustainable Product 
Development. The well-renowned and proven effectiveness of the lean approach 
enables the top management to institutionalize ‘lean’ throughout the company. 
The commitment of a medical device company to opt for Lean Product 
Development approach would accomplish the Total Quality Management 
objectives to minimize waste and optimize consumption of resources. Thus, 
promoting overall Sustainability by gaining significant savings in financial and 
non-financial resources (Aras Corp. <www.aras.com>). The lean approach is 
required to be all-pervasive throughout every stage, value chain activity and 
development process. Moreover, the development teams have to commit to 
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unlearning old practices for applying new ones in order to initiate a bottom-up 
incorporation of lean product development strategy. As a result, the Lean 
approach is known to be a simple, non-intrusive and straightforward process that 
aligns itself with the on-going product development activities (e.g.: Designing) 
and product development processes (e.g.: Product Quality Planning). 
The organization can combine other tools and approaches to complement the lean 
product development approach, namely, New Product Value Analysis, Team 
Dynamics, Value Engineering, Design for Six Sigma [DFSS], Design for 
Manufacturability/Design for Assembly [DFM/DFA] and Root Cause &Fault 
Analysis (source). The goal is to ensure smooth transition from one development 
stage to another by virtue of effective articulation of the business processes and 
their corresponding activities. 
With the goal of reconciling Lean Product Development and Sustainability, 
medical device companies can adopt the seven eco-principles enumerated by the 
World Business Council for Sustainable Development (WBCSD). These principles 
advocate reduced consumption of material and energy for commercializing 
products and services; minimize disposal and utilization of toxic waste; increase 
the incorporation of renewable resources (materials/energy) and opt for end-of-
life opportunities in product design (DeSimone & Popoff, 1997; Trotta, 2010). 
The feasibility evaluation during design related activities are able to unearth the 
relevant conflicts, synergies and contradictions. Consequently, as discussed in 
previous chapters, the renowned Theory of Inventive Problem Solving (TRIZ) 
elucidates 39 sources of contradictions. For example, when a company decides to 
increase the number of functions in a device results in multiple components. Thus, 
adding to the weight, while sustainable product development recommends lower 
weight of the product to save resources during production/transportation 
(Fitzgerald et al., 2010; Trotta, 2010). Such challenges are usually encountered 
during Product Development that is resolved by incorporating the pre-defined 40 
inventive principles identified and proposed by the inventors of the TRIZ 
methodology. Product development teams are advised to tailor the 40 inventive 
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principles subjectively for each project in order to resolve sustainability related 
conflicts for enhancing the sustainability quotient of their products and services. 
Moreover, Trotta (2010) identified a suitable combination of the pertinent WBCSD 
principles for each of the 39 contradictions that would be encountered during any 
Sustainable Product Development endeavour. Similarly, product development 
teams can scout for various patents and research publications to determine 
suitable solutions in the domain of product design, materials and engineering 
methodologies for substantially modifying the knowledge and implementing 
them in their design process, accordingly. This approach is commonly known as 
Design-by-Analogy as compared to Case Based Reasoning that utilizes previously 
acquired experience (Fitzgerald et al., 2010; Ghazalli & Atsuo, 2009). 
The product development teams require a robust infrastructure of software and 
hardware tools in combination with an information communication system for 
materializing the design strategies and objectives by virtue of concurrent 
engineering. Consequently, Manufacturing Process Management (MPM) is a 
methodology that enables effective communication between the stakeholders and 
value chain partners, namely product designers, engineers, contract 
manufacturers and suppliers. The MPM embodies the concept of concurrent 
engineering and allows an organization to document the product development 
(Computer Aided Design [CAD]; Computer Aided Engineering [CAE]; Product 
Data Management [PDM]) and manufacturing process (Computer Aided 
Manufacturing [CAM]; Manufacturing Resource Planning [MRP]), for regulatory 
requirements and the implementation of a lean product development approach. 
Furthermore, MPM allows the product development organization to automate the 
various design and process modifications changes in collaboration with Product 
Life Cycle Management and Knowledge Management approaches for adapting to 
a dynamically changing scenario which is characteristic of any modern product 
development endeavour (Fortin & Huet, 2007). 
The computational tools that are utilized to design the structure and geometry 
(CAD), evaluate from a virtual standpoint (CAE) and plan the production 
assemblies (CAM) are vital for product development, in order to proactively 
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address prospective challenges and inefficacies within the product design that 
may lead to any negative repercussions for the company and its stakeholders 
(Werner et al., 2004; Schweiger, 2006).  
The integrated utilization of CAE-CAD is known to deliver more savings in both 
time and financial resources by accomplishing a more robust product prototype. A 
thorough assessment of the integration reveals that 70% of the life cycle cost can 
be identified by only 20% of the product knowledge and reducing the time needed 
for capturing product knowledge with a significant magnitude of user friendliness 
(Schweiger, 2006). 
Once the preliminary concept of a product is subjected to product designing, 
which generates design files (a virtual product) with data/information and 
knowledge concerning the volumes and geometries, materials and manufacturing 
processes. The Life Cycle Analysis carries out the environmental impacts of the 
design. Furthermore, in order to initiate Life Cycle Engineering activities for 
improvising the sustainability quotient of the product, it is essential to develop a 
methodology that combines Life Cycle Assessment Tools with Computational 
Modelling Tools (3D CAD/CAM) with EcoDesign guidelines. EcoDesign 
guidelines are basically a collection of best design practices. In addition, 
EcoDesign contains a database of various ecological questions with its relative 
answers for improvising the impact of the product undergoing design and 
analyses. In this approach, the environmental compliance parameters can be 
merged with the computational design approach. Cappelli et al. (2006) proposed 
such a novel approach to integrate EcoDesign and Life Cycle Assessment into a 
Virtual CAD Framework. 
Filho et al. (2009) have recommended some EcoDesign methods and tools to aid 
the product development teams: 
a) Environmental Design Industrial Template (EDIT) is a software that addresses 
the economics and product design for analysing the effects of a product’s design 
for any one of the end-of-life option. 
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b) Environmental Design Support Tool (EDST) evaluates products design with 
respect to environmental sustainability, namely material selection, recyclability 
and disassembly analysis.  
c) Green Design Advisor evaluates products based on number of materials, mass, 
amount of recycled material, toxicity, energy use, disassembly time and end-of- 
life disassembly cost. 
d) Method to Assess the Adaptability of Products (MAAP) evaluates product’s 
conformity at assembly, maintenance, and repair, upgrade and remanufacture 
processes. 
4.2.4. Significance of Knowledge Systems and Management in Product 
Development 
When the designing and manufacturing activities are poised for integration, the 
product development teams could potentially encounter knowledge gaps 
pertaining to the diverse technical and engineering sectors, which are 
characteristic to a certain product design or production method. For example, 
designing a novel syringe and simultaneously opting for a newly developed 
plastic injection moulding methodology could pose an impediment to the 
company in terms of the design engineers lacking thorough knowledge of the 
injection moulding process capabilities. Furthermore, the modifications in the 
organizational structure which may have to be implemented for augmenting the 
competitiveness of the company, in addition to accommodating new technologies. 
Therefore, the presence of a robust knowledge management infrastructure 
comprising of a knowledge repository containing previously stored knowledge 
that has been captured, stored, subjected to continuous evolution and made 
accessible throughout the organization, irrespective of the software platforms. 
One of the contemporary approaches, namely Expert systems and Knowledge 
Based Systems, contain previously stored knowledge in the form of IF and THEN 
statements. Moreover, these Expert Systems have been utilized in numerous 
engineering applications ranging from identifying and planning inspection 
schedules for component production to train technical personnel in the domain of 
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design and evaluation. Similarly, conducting automatic re-meshing of a design 
mesh structure during finite elements analysis (Cakir, 2006). In simple words, 
Expert Systems are an artificial intelligence based tool to emulate human-like 
decision making using previously stored knowledge. Similarly, Dwivedia et al 
(2003) proposed the development of knowledge based engineering module for 
diagnosing defects in the casting approach of manufacturing and the evaluation of 
defects through a non-destructive testing method. In addition, Venkatachalam et 
al. (1993) proposed a Knowledge Based approach to Design for Manufacturability. 
Medical devices, as stated previously, are the culmination of a diverse engineering 
and scientific disciplines with their own pertinent design and production 
approaches. As a result, the design and production methods possess their own 
specific knowledge domains that are further subjected to continuous evolution. 
Thus, indirectly resulting in knowledge gaps between various disciplines as 
outlined in the example of a new injection moulding technique and syringe 
design. A design engineering team well versed with contemporary injection 
moulding techniques would encounter knowledge gaps, if a new generation 
injection moulding technique would be incorporated into the production process. 
In this scenario, the process engineering team would possess an upper hand in the 
recently updated knowledge domain of injection moulding.  
Moreover, these expert systems have been utilized to generate recommendations 
for both evaluation and improvisation of a given design proposed by the design 
engineering teams. The recommendations are generated by virtue of the 
production, design and operations rules stored in the expert system that actively 
participate in the verification and validation of the proposed design. 
Meanwhile, when concurrent design engineering and feasibility evaluation 
activities are carried out, substantial amount of knowledge is generated during the 
“hand-off” between the development teams pertaining to the CAD-CAM or CAD-
CAE interfaces. This is attributed to their specific files characteristics that are 
required to undergo a certain degree of transformation to be accessible for the 
subsequent computational activity. The transformation steps require specialized 
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knowledge (both tacit and explicit) from the engineers, which is quite challenging 
to store as well as standardize (Deng et al., 2002; Lee, 2005; Wheelwright & Clark, 
1992). Therefore, Knowledge based Engineering (KBE) is incorporated by devising 
automated/semi-automated software applications for standardizing and 
automating routine engineering design activities. The goal is ensure that the 
captured and stored knowledge is re-usable (Chapman & Pinfold, 1999; Kulon et 
al., 2006). The software applications for KBE tools are devised through the 
codification of tacit and explicit knowledge using JAVA and C++ (Chapman & 
Pinfold, 1999; ElMaraghy, 2009). Furthermore, the KBE can be coupled with a 
geometry engine to enable automatic generation of product concepts in terms of 
computational models of Computer Aided Design (CAD) for virtual and real 
prototyping (Kulon et al., 2006). Moreover, KBE is beneficial for larger product 
development organizations which engage in a multitude of product development 
activities which are further composed of millions of parts with close tolerances, 
designed and validated by product development teams distributed globally 
(Corallo et al., 2009; Lee, 2005; Lee et al., 2005). 
The product development teams must scout for other known barriers due to 
variations encountered in a globalized product development scenario, namely, 
Data Exchange Standards, Engineering Drawing Symbols, Measurements and 
Units, Design Software Differences and variations, Operating Systems and 
Programming Languages (Hu et al., 2006). 
4.2.5. Significance of Interoperability between Computational Methodologies 
The tools, systems and methodologies utilized during product development 
should demonstrate a high degree of interoperability (ability to work together) 
amongst each other. In order to promote enhanced interactivity among various 
systems and tools engaged in design, development, marketing, production and 
supply of a medical device. Interoperability provides a significant visibility in 
cases where seamless interaction between team members throughout the 
enterprise and the collaborative partners is desired. The utilization of Java as a 
universal Web programming language and Common Object Request Broker 
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Architecture (CORBA) as a platform-independent middleware are also essential 
key components of the collaborative production management (CPM) architecture 
(Vogel, 2001). 
CORBA is devised by Object Management Group’s (OMG) open vendor-
independent architecture and infrastructure for which computer applications 
function in synchronicity over a wide array of networks. Moreover, using the 
standard protocol IIOP, a CORBA-based program from any vendor would be 
applicable, irrespective of almost any computer, any operating system, any 
programming language, and any form of network. CORBA is able to integrate 
various computational and non-computational machines from a diversified range 
of vendors, which spans across mainframes, desktop computers, real-time 
systems, and hand held devices and embedded systems. Accordingly, it is the 
middleware of choice for large sized enterprises and especially for servers that 
require numerous clients with high hit rates and coupled with higher reliability; 
scalability and fault-tolerance capabilities of performance (Object Management 
Group < http://www.omg.org>). 
Poor interoperability between various computational design and software based 
management tools usually result in excessive financial losses (Szykman et al., 
2001). While these challenges are being resolved during various product 
development activities, the evolution of computational tools into its next 
generation versions are required to provide representations that permit 
information exchange through direct electronic interchange in a distributed 
product development environment. 
4.2.6. Advantages and Challenges in Customization of Computational 
Modelling Languages 
The computational tools also posses their own share of challenges and 
disadvantages in addition to the issue of interoperability. Alongside, due to the 
complexity and the expertise intensive nature of the computational tools, physics 
and engineering based analysis poses an impediment for the Product Engineers to 
analyse their product designs. Therefore, the tools have to be customized with 
 122 
features to permit integration into the product design activities for faster and more 
accurate analysis. Tikare et al.(2005) referred that although the Computational tool 
customization allowed product engineers to cost effectively analyse their designs 
from a engineering and physics standpoint, it was later uncovered that the 
generality of the models to simulate diverse set of problems was compromised. 
Moreover, the customization in itself consumed significant monetary and material 
resources, including man-hours. Thus, the engineering and management should 
jointly approve the customization approach after thorough assessment in order to 
justify the expenditure. 
The availability of the most compliant computational tools, experienced 
development teams, most effective materials and reliable technologies do not 
necessarily assure that the projected product development results would be 
materialized. The reason being that the limitations of each of these crucial facets 
could fall into lengthy development cycles. 
The limitations of the vital facets of a product and its development path are 
enumerated in detail as follows: 
I] Computational Tools 
i) Interoperability between various Computational Tools (Szykman et al., 2001) 
ii) Inability to accommodate every life cycle objective (Wyatt et al., 2009). 
iii) Complexity, that requires advanced expertise, may require capital-intensive 
customization for user-friendliness. (Tikare et al. 2005) 
iv) Significant manual intervention maybe required in the steps of “Meshing” and 
“Geometric Processing”, as their automation is identified to be extensively 
complicated. (Shimada, 2011). 
II] Characteristics of Materials (Long, 2008) 
• Usability in prototyping, production (Batch and Mass) and during Scale-
Up.  
• Functioning and Compatibility with Other Materials.  
• Easy retrieval for Recycling and Remanufacturing.  
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• Satisfy Multiple Criteria related Performance, Environmental, Safety and 
Reliability Requirements of Multiple Life Cycles.  
III] Production Machinery Considerations (Kumar & Suresh, 2007) 
 Tolerances 
 Complexity of the Machinery Layout 
 Reliability: Operational capability, maintenance, up gradation, up time and 
downtime, efficiency. 
 Flexibility levels for various capacities/volumes and product types. 
 Ability to accommodate reverse logistics for end-of-life options namely re-
use, recycling, reconditioning, remanufacturing. 
Only those Organizations who committed to innovate on the frontiers of the 
aforementioned challenges in concurrence with their stakeholder welfare would 
lead in comparison to their competition. The subsequent sections would discuss 
the role of the proposed MCHM of Chapter 3 in Design Optimization during the 
Product Development Process. 
 
4.3. Multifaceted Framework for Sustainable Medical Device 
Development 
4.3.1. Conceptual Underpinnings of the proposed Multifaceted Framework for 
incorporating Sustainability in Medical Devices  
Medical device companies need to look forward for incorporating modified 
versions of well-established product development tools to establish a decisive 
knowledge curve and stay ahead of competitors. These product development tools 
include but are not limited to Lean Manufacturing, Design for Six Sigma and 
Current Good Manufacturing Practices and Product-Process Flexibility (Kadamus, 
2008). Furthermore, the synchronicity of these conceptual tools with their technical 
and engineering counterparts, in terms of computational and machinery is of 
paramount importance for the success of product development endeavour. 
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The relevant information is compiled into the pre-existing knowledge systems and 
databases by way of Knowledge based Engineering (KBE) (Corallo et al., 2009). 
The KBE captures tacit as well as explicit knowledge and provides crucial 
assistance during the concurrent design and engineering. In this segment the 
principles of TRIZ, Taguchi, Design by Analogy and Case based reasoning would 
be implemented to identify the best suitable solution for addressing synergies and 
trade-offs during the design phase (Xiong & Sun, 2006). 
An iterative process of concurrent engineering design and optimization is 
conceptualized. This iterative process involves manufacturing process 
management, which co-relates product design with production feasibility. The 
product design segment within the multifaceted framework comprises of 
computer aided design and engineering tools. These design-engineering tools are 
operated using a high performance-computing infrastructure (or supercomputing) 
to conduct more design iterations within a short span of time. Meanwhile, the 
concurrent design and engineering segment chiefly entails the role of an Expert 
System conjugated with the MCHM for selecting suitable design candidates of the 
product during the design optimization process. The design candidates would be 
selected on the basis of the adherence of the design with reference to Tier 1 and 
the desired level of compliance with the chosen criteria in Tier 2 and Tier 3. 
The Expert System in conjugation with the MCHM plays a pivotal role in 
optimizing the product design with reference to a wide spectrum of constraints 
(e.g.: lower emissions) and objectives (e.g.: higher reliability for multiple life 
cycles) during the Multidisciplinary Optimization procedure. In each of iteration, 
the resultant design is evaluated on the basis of its ‘Value’ (SAVE International 
<www.value-eng.org>). The ‘Value” is defined by the design candidate’s 
profitability, emissions/waste generated, resources consumed, knowledge 
generated and customer satisfaction in accordance with regulatory compliance. 
Moreover, the value is also determined by the contribution towards the Tier 2 and 
Tier 3 criteria as well (Hede et al., 2011). The Optimization process is rooted within 
the conceptual approach of the Systems engineering based Design Structure 
Matrix (<http://www.dsmweb.org>), for identifying various degrees of 
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interdependencies between the various sub-systems of a medical device and their 
corresponding components, parts and sub-assemblies.  
The synchronicity of all the design iterations and life cycle management activities 
is carried out by a robust information and communication technology 
infrastructure (SIEMENS <http://www.plm.automation.siemens.com/en_us/>). 
The quintessential paradigm of overall Sustainability as explained in Chapter 2 
and Chapter 3 spans across both a macro-level (e.g.: social structures and 
ecosystems) and micro-scale (e.g.: mining of copper and its material properties) 
issues. The objective behind any sustainable product design activity is to 
encompass both ends of the spectrum to a desired limit at which the 
synergies/conflicts between the company’s resources can be effectively addressed. 
Therefore, the product is considered as the source of the critical tangible impacts 
onto the three domains of sustainability within and outside the organization 
(Sutcliffe et al., 2009). 
Furthermore, the pragmatic constraints surrounding the product development 
teams, range from convoluted legal procedures for attaining regulatory 
compliance to limited time availability for studying the market dynamics. The 
proposed conceptual multifaceted framework would only provide a guideline for 
the company to re-configure its product development strategy to address the 
constraints of its external business environment. The ultimate goal is include as 
much as overall sustainability as possible without compromising any of the 
necessary requirements to address stakeholder welfare outlined in Tier 1 of the 
MCHM. 
4.3.2. MCHM in Product Design and Optimization 
As discussed in Chapter 3, the conceptualization of the Multicriteria Hierarchical 
Model (MCHM) is based on the hierarchical nature of Analytical Hierarchical 
Process (AHP). Consequently, the aim of this sub-section is to propose the role of 
MCHM in product design optimization which is envisaged on similar lines of 
AHP participating in design optimization activities as investigated previously by 
other researchers (Wang et. al., 2010; Jia et al., 2010).  
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Ghazalli & Atsuo (2009) discussed the role of an AHP model in the selection and 
rejection of candidates for the remanufacturing of a certain automobile 
component. This is one of the few cases wherein AHP has actively participated at 
the structural level of the configuration of a product. These authors discussed the 
development of a computer aided evaluation system that utilizes case based 
reasoning coupled with an AHP model which is codified within the computer 
based system using object oriented C#. The goal of their research was to evaluate 
the prospects of remanufacturing for any given automobile components/parts by 
comparing the configuration of the part under consideration with reference to 
other automobile parts documented in a company’s product database.  
The remanufacturing process usually entails the disassembling of the product, 
followed by inspection, cleaning, replacing or repairing worn out parts and re-
assembling to be returned to the market (Sundin, 2004). The users of the computer 
aided evaluation system have to feed the information of the part/component to be 
remanufactured followed by the evaluation of the part/component with respect to 
various characteristics (or criteria) including wear-out-life and technology cycle. 
These criteria constitute the AHP Model. The values of the evaluation results are 
compared to reference weights of the same characteristics (or criteria) in the AHP 
model. In order to enable the comparison more effectively, the computer aided 
evaluation system also utilized an Artificial Intelligence Tool and Nearest 
Neighbour Algorithm to scan through the product database for determining the 
most relevant candidate for remanufacturing. 
Similarly, Singh (2006) investigated the application of group technology and 
pattern recognition using C and objected oriented technology to evaluate existing 
systems elements (parts, components, sub-assemblies) in a company’s product 
database and co-relate similarities to a new system which is undergoing 
development. Singh (2006) utilized a binary conversion and template matching 
method coupled with Analytical Hierarchy Process for enabling the searching of 
suitable system elements from the company’s database. Meanwhile, the sorting 
procedure was conducted by using a ranking based evaluation approach based on 
a comparative index. 
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As discussed in Chapter 3, in which AHP has been conjugated with fuzzy logic for 
a wide variety of applications, AHP has also been investigated in the domain of 
design optimization. Moreover, the incorporation of Fuzzy Logic has proved to be 
effective in both design optimization as well as decision-making. For example, 
Wang et al. (2010) investigated the structural parameters of the XK717 CNC 
milling machine for which the design variables were identified by the Taguchi 
Method (Fowlkes & Creveling, 1995), followed by finite element method to 
determine the X, Y, Z displacements and the first three natural frequencies. The 
Fuzzy AHP was incorporated with the relevant evaluation criteria to deduce the 
scores for conducting the design optimization of the structural parameters in 
accordance with the displacement and natural frequencies. Accordingly, the 
volume power of a diesel engine was evaluated and the pertinent structural 
parameters were optimized using an equivalent fuzzy logic AHP Model (Jia et al., 
2010). 
In contrast to the aforementioned research endeavours, which only focus on the 
design related specifications of the product under consideration, the approach of 
design optimization for a medical device proposed in this chapter actively 
involves project management facet of product development in close coordination 
with the exhaustive list of interconnected technical tools. The proposed 
multifaceted framework eliminates the additional barrier of designating 
scores/weights to each criterion and directly engages in the design optimization 
by using Multi Disciplinary Optimization. In Section 3.5 of Chapter 3 in which 
each criterion of the MCHM was envisaged to be co-related to a set of 
parameters/specifications with their “maximum achievable and minimum 
acceptable” values. Moreover, the multifaceted framework aims to resolve 
potential design related contradictions and impediments by subscribing to the 
conceptual approaches of TRIZ; Case based Reasoning and Design by Analogy 
(Fitzgerald et al., 2010; Ghazalli and Atsua, 2009; Khomenko & Ashtiany, 2007). 
The stated problems solving techniques would provide insights to the engineers to 
define the most suitable configuration and then execute an iteration of 
optimization followed by evaluation and further modification in a similar manner. 
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The proposed approach is more pragmatic in nature as it encompasses various 
social sustainability criteria and aligns with the Total Product Life Cycle 
development approach recommended by the FDA and other pertinent regulatory 
bodies (Parametric Technology Corporation (PTC), 2008 <http://www.single-
sourcing.com/products/value/3988_PLM_QMS_WP_EN.pdf>). 
4.3.3. Structuring the Multifaceted Framework  
In comparison to the previously stated research investigations, in which score 
based Analytical Hierarchy Process has been used for conducting Design 
Optimization, the proposed conceptual Multifaceted Framework causes two 
distinct advantages.  
Firstly, the MCHM discussed previously, is an active participant in the design 
optimization procedure by exemplifying the conflicts and synergies. In addition, 
the proposed framework would access the previously stored knowledge curve for 
the advancement of the development endeavour. Secondly, the proposed 
framework is pragmatic in nature suited for an industrial product development 
and commercialization environment by virtue of its ability to be easily 
customized. The proposed framework consolidates a wide spectrum of theoretical 
methodologies and well-known engineering systems used by both academia and 
industry (Figure 4.1.). 
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Figure 4.1 – Proposed Multifaceted Framework 
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Founded on the principles of Quality Function Deployment (<www.qfdi.org>), 
the stakeholder considerations have to be translated into product requirements to 
address the needs of the organization and the stakeholders. The product 
requirements are further translated into specifications that are designated by their 
“minimum acceptable and maximum achievable values”, as discussed in Chapter 
3. The range of values would aid the Product Development Team to perform the 
“Goal and Scope Definition” after every design iteration. 
The paradigm of “Goal and Scope Definition” would direct the Project Engineers 
and Managers to arrive at the most ‘optimal design’ of the Medical Device that 
would satisfactorily attain a desired level of environmental compliance, product 
performance, manufacturability, safety & regulatory compliance and economic 
gain. Nevertheless, during the iterations, the Engineers and Project Managers 
would be made aware of the prospective feasibility of the device which would 
further facilitate them in implementing informed decisions for either continuation 
or termination of the design candidate undergoing optimization. 
Simultaneously, during the identification of Stakeholders’ considerations up to 
Product Specifications, the Project Managers and Engineers should actively scout 
for pertinent prior art in the form of research papers and patents. The inundating 
task of identifying pertinent prior art searching can be alleviated by using suitable 
Neural Network Systems (Trappey et al., 2006). Neural Network Systems are 
capable of complex pattern recognition between inputs/outputs and adaptive 
learning. Thus, it is a suitable tool for searching pertinent prior art from a plethora 
of research literature and published intellectual property. 
The utilization of Theory of Inventive Problem Solving (TRIZ) and Design by 
Analogy coupled with Case based Reasoning is considerably supportive for 
identifying and addressing the underlying conflicts during product design 
(Fitzgerald et al., 2010; Ghazalli and Atsua, 2009). 
The identified knowledge in the form of literature should be transformed into 
3D/2D CAD Models using Optical Character Recognition Software under the 
close supervision of qualified and competent Design Engineers. The newly 
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identified, documented and codified knowledge should be added to the existing 
knowledge database that contains previously stored design and engineering 
knowledge of the Organization (and its collaborative partners). Moreover, during 
the Design and Engineering Phases, the knowledge from the database would be 
continuously accessed for standardizing and/or automating routine tasks. 
Knowledge Based Engineering approaches enables the synchronization of 
Computer Aided Design and Engineering (CAD/CAE) Activities in concurrence 
with the pre-existing knowledge (Corallo et al., 2009; Schut and van Tooren, 2007). 
The aforementioned set of planned activities would result in a robust preliminary 
design, which would be subjected to various constraints namely materials 
availability and their properties (Carlos et al., 2005), cost analysis (Hart, 2010) and 
environmental compliance of waste produced/emissions released using Life Cycle 
Assessment (Gaha et al., 2011). 
The engineering design approach of Multidisciplinary Optimization (MDO) 
utilizes “Optimizers” to resolve problems and conflicts pertaining to the various 
constraints, objectives and specifications that arise out of the interactions between 
diverse engineering and scientific disciplines (Robledo et al., 2011; Schut and van 
Tooren, 2007).  
The Multidisciplinary Optimization (MDO) approach in this multifaceted 
framework is recommended to subscribes to the concept of a Design Structure 
Matrix (<http://www.dsmweb.org>) to identify the ‘appropriate and optimal’ 
values of the pertinent specifications of each component in order to ensure the 
desired level of environmental compliance, product performance, 
manufacturability, safety and regulatory compliance and economic gain. The 
economic gain is a critical factor for the growth of the organization and its 
contribution towards the social capital (Tier 2 and Tier 3 of Figure 3.2 and Figure 
3.6).  
Incompatibilities between systems and tools are well expected. Accordingly, Gaha 
et al. (2011) recommend the utilization of an Application Programming Interface 
of a geometric modeller of a computer aided design tool. For example, when the 
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design engineer intends to conduct environmental impact analysis of the CAD 
model of the product under design. The role of the Application Programming 
Interface would be to extract the product data and automatically transfers to the 
desired application/tools for environmental impact analysis. This leads to saving 
the time required for carrying out environmental impact assessment and other 
subsequent iterations. Moreover, the formats incompatibility and absence of a 
common format is no longer an impediment for data and information transfer. 
Consequently, the product designer is less dependent on additional specialized 
environmental expertise for conducting his design optimization iterations and 
analysis. 
In order to obtain an “optimal” solution towards the Device Design, the MDO 
Approach, incorporates the technique of Topological (Surface) and Shape 
(structural) Optimization (Cascini et al., 2007). Topological Optimization 
determines the optimal material distribution within a given design space by 
modifying the apparent material density as defined by the design variable. 
Whereas Shape Optimization identifies a suitable shape that satisfies the stated list 
of constraints and minimizes a certain cost function. The cost function denotes 
parameters whose values have to be minimized as opposed to utility function that 
needs to be maximized. The design domain is further subdivided into finite 
elements and the optimization algorithm alters the material distribution within the 
design space at any iteration in accordance with the objective and constraints 
defined by the Project Managers and Engineers. The optimization algorithm 
determines the shape and the material density distribution within the given 
design domain in order to minimize, maximize or improvise the objective function 
(i.e. the Evaluation Parameters) while satisfying the Constraints. The Shape and 
Topology Optimization results in a new set of values for the specifications of the 
device to address the diverse set of objectives and constraints. The goal of the 
optimization approach is to determine the best suitable design or even the best 
possible compromise for satisfying a diverse set of constraints and objectives. 
In this Chapter the utilization of Multidisciplinary Optimization is depicted to be 
conducted concurrently with the TRIZ-Design by Analogy-Case based Reasoning 
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to determine the ‘best geometry’ as opposed to only a MDO based ‘Optimization’ 
(Cascini et al., 2007; Fitzgerald et al., 2010; Ghazalli and Atsua, 2009). 
The intensive design activity should be complemented with robust prototyping 
techniques and preliminary evaluations to conduct Verification (with respect to 
desired specifications) and Validation (with respect to stakeholders’ 
requirements). These two qualification activities would entail lab, as well as field-
testing, followed by recording the results in the knowledge database to be re-used 
in the subsequent design iterations. 
The on-going ‘MDO’ design iterations of the robust preliminary design would also 
be subjected to inputs from the Eco-Design Database to increase the 
environmental sustainability quotient of the design (Capelli et al., 2006; Filho et al., 
2009). During each of design iteration conducted for reducing the environmental 
impact, it is further recommended to consider the Environmental performance 
indicators (EPIs) as a measure of the current or past environmental performance of 
an organization (Jasch, 2000). One of the main strengths of the proposed 
framework is the potential use of benchmarking within the sector (Tyteca et al., 
2002). One of the main weaknesses of EPIs is that they are often only collected for 
aspects on which data is readily available (Olsthoorn et al., 2001). 
Meanwhile, the facet of manufacturability of the device would be governed in 
coordination with the Manufacturing Process Management (MPM) (Fortin and 
Huet, 2007; Qi et al., 2004). The Corrective and Preventive Actions (CAPA) and 
Engineering Change Notices (ECN) that are implemented after ‘validation’ of the 
Device Design (Design Master Record, Design History Record, Design History 
File) are routed through the MDO based ‘Optimization’ Step and the MPM 
sequence (Matlis, 2007a; 2009b). 
The FDA during the approval stages requires the following documentation which 
reside in their respective separate and standalone information systems:  
•Design History File (DHF) contains a compilation of records that describe the 
design history of a finished device. The DHF information resides in Computer 
Aided Design (CAD) and Product Development Systems (PDS). 
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•Device Master Record (DMR) contains a compilation of records containing the 
procedures and specifications for manufacturing a finished device. The DMR 
information resides in Document Management, Product Development and 
Manufacturing Specification Systems. 
•Device History Record (DHR) contains a compilation of records that hold the 
production history of a finished device, also known as a Batch or Lot Record. The 
DHR information resides in device records, lot or batch records, equipment 
maintenance and calibration records and operator certification in Manufacturing 
Execution Systems. 
These documentations are critical for knowledge capture/storage, production, 
validation and incorporation of corrective and preventive actions/ engineering 
change notices. 
From a technological perspective, a MPM solution provides an effective bridge 
between the Computer-Aided Design/Product Data Management (CAD/PDM) 
and Enterprise Resource Planning/Manufacturing Execution System (ERP/MES) 
software in accordance with the Complete Product Life cycle Management (PLM). 
Post Design Phase, the Enterprise Resource Planning/Manufacturing Execution 
System (<www.iqms.com>) play a key important role in communicating and 
managing the various activities associated with the Product Life Cycle namely, 
extraction, production, distribution, use, disposal and end-of-life (Hauschild et al., 
2005). The activities of the MPM are further promoted by the XML Interactivity 
between various systems for establishing a data-interchange mechanism that is 
compatible with Web-centric clients and servers. The XML software and network 
interactivity ensure a desired level of work package traceability (Design 
Modification Activities and CAPA/ECN) and Systems (Hardware and 
Computational Software) interoperability (Fortin & Huet, 2007; Qi et al., 2004). 
The networking and intercommunication of XML, in accordance with MPM for 
executing production and device integration activities, is known as Collaborative 
Production Management (Vogel, 2001). 
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The conventional practice of an MDO based ‘Optimization’ always implements 
the standard set of Optimizers. As investigated by Price et al. (2010), the Expert 
System can be considered as the chief optimizer in the MDO procedure. Moreover, 
Eldrandaly (2007) demonstrated the application of AHP based decision making in 
conjugation with an Expert System. Therefore, this research report recommends 
that the MCHM (which from Chapter 3 is inspired from the AHP methodology) 
could be programmed as a software application-using object oriented C language 
within an expert system (s) for orchestrating the Optimization procedure. As the 
Expert Systems decision-making is required to be based on certain fundamentals 
that could be provided by the hierarchical structure of the MCHM and the scored 
criteria of the second and third tier (Saaty, 2008). The hierarchical arrangement of 
these criteria and their scores would aid the “Goal and Scope Definition” at the 
end of each design iteration.  
The product development teams need to determine the most suitable pathway to 
incorporate Life Cycle Analysis during the Design Optimization Phase. One 
known method is to combine with the Computational Aided Design Tools 
(Cappelli et al., 2006; Gaha et al., 2011). The other approach, investigated by 
Pineda-Henson and Culaba (2004) had devised a Green Productivity Analysis 
Methodology. In their methodology they combined Expert Systems with Life 
Cycle Analysis and Analytical Hierarchy Process for evaluating the environmental 
impact and productivity of engineering processes in the semiconductor 
assembly/packaging. The Green Productivity Analysis Methodology comprises of 
three key components corresponding to the software modules of a front-end 
database system, an embedded expert system or knowledge base and a Windows 
Shell program/interface program. The CLIPS (C Language Integrated Production 
System) Version 6.1, public-domain software was used as the expert system 
development tool. The Windows shell was codified in C language and further 
compiled using Visual C/C++. The objective of the windows shells program was 
to establish a linkage between the database system and the CLIPS expert system.  
Additionally, the Artificial Intelligence tools suitable to the development teams’ 
specific requirements can be considered to minimize any occurrence of expensive 
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errors arising out of inefficient decision making which is normally characterized 
by human intervention (Welle & Haymaker, 2011). The overwhelming weight of 
multiple iterations and calculations for an enormous collection of specifications, 
objectives and constraints is mitigated by the application of High Performance 
Computing to reduce the run-time during the Computational Aided Engineering 
and MDO activities (Kodiyalam et al., 2002). Finite Element Analysis, 
Computational Fluid Dynamics and Progressive Failure Analysis are the 
recommended CAE tools for evaluating the influence of various loading 
conditions on a wide variety of materials & their structures. These advanced 
computational tools enable product development teams to determine the specific 
load limits for a certain structure comprising of certain materials (Abumeri et al., 
2010; Kodiyalam et al., 2004). 
Before each simulation is carried out, it is recommended to employ mathematical 
programming methodologies, such as Signal Flow Graphs, which are in a position 
to predict the impact of a certain simulation strategy on the project timeline. The 
computational simulation is a time consuming activity and, accordingly, demands 
that the design engineers define a strategy of simulation and the scope of design 
evaluation including boundary conditions, during their modelling tasks. In order 
to decrease the timeline, the processing power of the Computing Systems could be 
raised or lowered for complying with the project deadlines (Isaksson et al., 2000). 
4.3.4. Design Optimization Strategy and Evaluation of the deduced Design 
Candidates 
In this chapter two broad defined strategies for conducting design optimization 
are proposed for the development of an interdisciplinary medical device. For 
either of the two strategies the values of the Reliability of Device performance and 
integrity play a decisive role. According to the first design strategy, the 
development teams are recommended to observe the following steps: 
1) Identify the maximum achievable and minimum achievable values of the 
Reliability of the Device and its integrity against various loads (stresses and 
strains) throughout the life cycle. 
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2) From the literature and preliminary investigations determine the reliability 
values for the corresponding number of life cycles. For example, the reliability for 
5 life cycles would be higher than the reliability requirements for one to two life 
cycles. Product Development Team Products have to account for the possibility 
that products with higher reliability may require more durable materials that may 
not necessarily be eco-friendly and non-toxic in nature. If there is no opportunity 
to switch to more sustainable materials and products, then the medical device 
company has to conduct its due diligence for obtaining the mandatory 
certifications and clearances. Moreover, multiple life cycles and high reliability 
materials could significantly add to the cost and may bring about future cost 
savings under favourable market conditions. Therefore, the development team 
should include their objectives of financial gain that are closely related to the 
social sustainability goals and the future expansion plans. 
3) Identify opportunities for incorporating Modularity for a platform-derivative 
product development approach that can be reconciled with the requirements of 
disassembly/reassembly in the end-of-life opportunities (Chandrasekaran et al., 
2004; Wyatt et al., 2009). 
4) Subscribe to the aforementioned MCHM based Expert System Design 
Optimization Approach to investigate the optimum number of life cycles of a 
given medical device that sufficiently satisfies the Tier 1 criteria and is also 
modular in its configuration. If the Modularity is found to conflict with Tier 1 
criteria, the designers can reduce the level of modularity either gradually or 
directly minimize it (refer Figure 4.2), depending upon the design idiosyncrasies 
of the medical device. This step would demand simultaneous engagement of 
project management, senior management and product development teams for 
communicating the results and decisions. 
5) Preliminary investigation to confirm compliance with Verification (Product 
Specifications) and Validation (Value Chain Partners and Stakeholder) 
considerations. The regulatory bodies including FDA, ISO, REACH, ROHS and 
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WEEE are persistent about their compliance to safety and performance and not 
necessarily specify the compulsion to include the modular nature of a product. 
6) Iteratively repeat steps from 1 to 5 to determine a list of numerous design 
candidates to be filtered further for finalizing the best suitable design. 
The second strategy is to follow steps from 1 to 6 excluding the Modularity 
and/or End-Of-Life opportunities, as not all medical devices can be designed with 
high degree of modularity. 
The design optimization procedure is known to yield a multitude of “most 
suitable design candidates” that would satisfy each criterion of the Tier 1 to a 
significantly large extent within the expected range of the assigned specifications. 
The business sectors of Medical devices have experienced fierce competition 
mainly characterized by shorter product development cycles and price. These are 
the 2 desirable attributes from the viewpoint of a patient and his/her medical 
healthcare providers. Consequently, the medical device company needs to launch 
the most effective and competitive device in the target market. As a result, 
generating more than one effective design candidates is beneficial in the long run 
for competitiveness and knowledge growth. Nevertheless, the numerous design 
candidates (which have already cleared Tier 1 criteria) have to be subjected to a 
filtration process that selects only 10% of the total no. of candidates generated 
during the design optimization process which score highest in each of the 
following ranks enumerated below. 
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In terms of Tier 2 and Tier 3, the companies can choose their own ranking 
approach, as these criteria are more optional in nature. 
Rank 1: Safety; Human Factors/ Ergonomics; Regulatory Compliance; Acceptable 
level of availability and performance of the Total Product Life Cycle Management 
Systems. This level encompasses the key considerations of all the value chain 
partners and Stakeholders.  
Rank 2: Modularity for Platform-Derivative Approach and End-Of-Life Options. 
The Modularity is categorized as high when more than 70% of the product can be 
disassembled into distinct system elements; Medium-Approximately 50%-60% of 
the product can be disassembled into a few distinct system elements while the 
other components and sub-assemblies cannot be broken down further. The lower 
degree of modularity is around 20%-40% of the product that can be disassembled 
into a few distinct elements in comparison to the majority of the ‘un-
dismountable’ components/parts/sub-assemblies. 
The numerous design candidates which although satisfy each criterion of Tier 1 are subjected to 
an additional hierarchical arrangement of Tier 1 criteria to select the best few with the highest 
degree of compliance. The Magnitude of Degree is categorized as follows: High (>70%), 
Medium (50%-60%) and Low (20%-30%). 
Figure 4.2 –  Screening of Design Candidates during Multidisciplinary Optimization 
Rank 1 
Safety; Ergonomics; Regulatory Compliance; Total Product Life Cycle Management Systems.  
Rank 2 
Modularity for Platform-Derivative Approach and End-Of-Life Options 
(Hölttä-Otto &Weck, 2007) 
Rank 3 
Lowest Environmental Impact. 
Rank 4 
Rate (i.e. speed) of Reimbursement by virtue approved Payment Modalities  
from the Insurance companies and Medical Policies (Miller, 2007) 
Rank 5 
                                  Degree of compatibility with the Value Chain partners. 
Rank 6 
Competitiveness: Market Acceptance and shorter time to market. 
Rank 7 
Degree of Aesthetic Appeal. 
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Rank 3: Lowest Environmental Impact. A comprehensive life cycle evaluation of 
the end-of-life reverse logistics and supply chain would be conducted to 
determine the “accurate reduction” in emissions/waste and socio-economic 
consequences to stakeholders. This rank also includes the performance and 
efficiency of waste management methods and emission control techniques (e.g.: 
adsorption; plasma treatment) (Pubule et al., 2011). 
Rank 4: Faster Rate (i.e. speed) of Reimbursement by way of approved Payment 
Modalities from the Insurance companies and Medical Policies (Miller, 2007). 
Rank 5: Higher degree of compatibility with the Value Chain partners namely 
Production, Supply, Distribution and End-Of-Life. The degree of compatibility is 
also evaluated on the extent of modifications required in the Total Product Life 
Cycle Management System for the proposed design. 
Rank 6: Higher degree of Competitiveness and shorter time to market in 
comparison with other market competitors and product substitutes. 
Rank 7: Higher degree of Aesthetic Appeal: The development teams can consult 
an expert for evaluating the aesthetic appeal or incorporate an artificial 
intelligence tool that verifies the proposed design candidates with reference to the 
previously stored design principles specifically promoting aesthetics (Catalano et 
al., 2002; Kaljun and Dolsak, 2011). The contradictions pertaining to aesthetics and 
product functionality cannot be resolved using TRIZ or any other method thereof 
as aesthetics is subjective from emotional; regional; temporal and cultural 
standpoints.   
The criteria in Tier 1 are arranged in ranks only for the filtration of various design 
candidates and not for the decision modelling between medical device selections. 
Unless the decision-making is found to be more challenging than anticipated. 
Moreover, the financial gains and social sustainability criteria in Tier 2 and 3 can 
be considered for further screening of the 10% of the total number of candidates to 
finalize 2-3 best designs. This ranking methodology presumes the Collaborative 
Strength of the Team and their Expertise to be more than adequate for 
materializing the designs into a commercial product (Akgün et al., 2006). 
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4.4. Concluding Points 
The chapter begins with the discussion of various conceptual product 
development approaches which have illustrated an extensive focus on long term 
planning, product configuration and its underlying technologies, suitability of 
these tools to a certain organization and flexibility within the value chain to adjust 
for uncertainties. 
In this chapter the most important facet of non-linearity of product development 
and design is discussed. In addition, a brief outline of the various technical tools in 
design, engineering analyses and product development planning are discussed. 
Moreover, the critical role of identifying, storing and ensuring the accessibility of 
engineering and non-technical knowledge is ascertained to be crucial for adhering 
to the project timelines. Similarly, product development teams have to define an 
engineering analyses (or simulation) strategy to ensure that the evaluation of the 
virtual product is more comprehensive without expending excess of time and 
resources.  
Notwithstanding, the advantages of customizability of the proposed multifaceted 
framework for a wide array of medical devices, the Product Development Teams 
would have to manually assign the values to each specification for every criterion. 
The arduousness of the customizability is governed by the complexity of the 
device that may or may not relevant to the classes of the medical devices. 
Nevertheless, as discussed previously, Knowledge Based Engineering applications 
can be incorporated for automating unproductive repetitive tasks.  
The proposed multifaceted framework has been devised by considering the 
critical role of the MCHM for product design optimization by conducting an 
exhaustive literature research and validation by expert opinion. Furthermore, the 
literature review reveals that the coordination of a multitude of technical tools and 
computer-based systems could elucidate conflicts in terms of their data formats 
and programming structures. 
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The objective of this chapter is to demonstrate the active participation of the 
MCHM Design Optimization Procedure. This further justifies the revision of the 
conceptual structure of the AHP as proposed by Saaty in the 1990s (Saaty, 1990).  
 142 
  
 143 
 
Chapter 5 
Research Methodologies 
5.1. Introduction 
This chapter outlines the research methodologies utilized for evaluating the 
models and frameworks discussed in Chapter 2, 3 and 4. The models and 
frameworks as discussed previously are devised for incorporating social, 
economic and environmental sustainability within in product design.  
Different sources of data were used in order to enhance validity and reliability of 
the case studies and expert interviews (Yin, 2003). Data was crosschecked by using 
the results of the survey and of the interviews. Several on-site visits were 
undertaken during the research. Some of the visits took place before and others 
after the interviews. 
This chapter also discusses the research proposition that forms the fundamental 
basis of the proposed models and frameworks. This discussion of research 
methodologies with reference to the research propositions illustrates the goal of 
the thesis with a higher degree of clarity.  
Section 5.2 discusses the structuring the of various research methodologies 
adopted in this thesis, followed by Section 5.3 which outlines the case study 
approaches and the type of interview method chosen for addressing issues 
pertaining to overall Sustainability in medical device development. Meanwhile, 
Section 5.4 outlined the Analytical Hierarchical Process (AHP) decision modelling 
approach and pair-wise comparison technique in detail (Saaty, 1990a; 2006b; 
2008c; 2009d). The goal of the pair-wise comparison in this thesis is to only capture 
the insight and tacit knowledge in product development and decision making of 
experts from Academia and Industry with reference to various economic scenarios 
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(ranging from Keynesian to Free Market Capitalism) (Wapshott, 2011). The reason 
for using pair-wise comparison solely for capturing the insight and  tacit 
knowledge for product development is to incorporate them within the case 
studies. Moreover, as in any of the case studies discussed in this thesis does not 
have any specific alternative to be chosen in comparison to a set of alternatives. As 
a result, certain facets of AHP based decision modeling such as consistency 
ratio/index would not be given much importance. Moreover, the criteria chosen 
for pair-wise comparison would be solely from Tier 2 and Tier 3 which are entirely 
optional in nature and their inter-relations would be governed by the product 
configuration, the capabilities and resources accessible to the medical device 
company and the economy of the geographical location in general. For example: In 
certain business scenarios, end-of-life options may contribute to additional 
employment; nevertheless in certain countries the economic policies may or may 
not provide subsidies for such end-of-life options and in certain circumstances 
neither of the end-of-life options may bring about any savings in emissions/costs 
to the company.  
5.2. Defining the pathway of the Research Methodology 
The decision modelling approaches and product development methodologies 
discussed in Chapter 3 and Chapter 4 would constitute as an important facet of 
business management practices to enable the finalization of important decisions. 
Previously conducted research investigations for evaluating various approaches 
pertaining to business management practices, such as Malmi and Ikaheimo (2003) 
combined case studies and interviews. Meanwhile, Szychta (2002) included 
fieldwork research using up to around 290 questions in combination with 
interviews.  Similarly, Roslender and Hart (2003) conducted a series of semi-
structured interviews in two organizations prior to their field study.  
Moreover, unstructured and semi-structured interviews have been regarded as 
reliable sources of information and knowledge for delivering a profound insight 
on the theoretical propositions of a research endeavour in order to enable any 
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form of course correction. The same approach can be considered for validating the 
data collected by previously conducted field research (Patton, 1990). 
Frequently, quantitative and structured methods are popular amongst economists 
(Meredith et al., 1989) and production operations management researchers 
(Westbrook, 1994). Notwithstanding, the facet of criticism; wherein many experts 
sometimes argue that quantitative approaches are retrospective in nature, unless 
real-time analyses is conducted. Meanwhile, the approaches of case studies with 
questionnaires and interviews attempts to validate the theoretical underpinnings 
of the proposed framework and models discussed in this thesis. However, the 
evaluation methods are prone to suffer from short sightedness and a narrow-
minded viewpoint during the planning of case studies and 
interviews/questionnaires. Therefore, for each case study the scope has been 
adjusted accordingly, to determine the prospective actions an Enterprise can 
implement for increasing the degree of overall sustainability.  
5.3. Introduction to the Case Study Method 
The case study approach can comprise of single or multitude of cases. Even if one 
can generalize from a few cases or a single case, a multiple case approach would 
broaden the scope and strengthen the validity of propositions outlined in this 
thesis. The propositions that will be discussed in this chapter specifically have 
been ascertained by virtue of extensive literature review and preliminary 
interviews with experts from academia who had previous experience in a 
industrial environment. 
Yin (1994) attempts to differentiate between literal replication and theoretical 
replication in which cases are structured to corroborate with each other on the 
propositions. The literal replication is meant to produce similar results while 
theoretical replication is aimed at obtaining different results for anticipated 
reasons. 
As case study approach has an exploratory facet to it and accordingly, it is 
challenging to determine the most suitable theoretical foundations to guide the 
project, even before data collection commences. Therefore, the units of analysis in 
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a case study in this thesis are the models outlined in Chapter 3 and 4, which 
would be evaluated in more than one Enterprise that develop and/or manufacture 
medical devices ranging from Class I to Class III.  
The enterprises were selected on the basis of their size and include SME (Small 
and Medium Enterprises) and large sized enterprises. Similarly, the size of the 
enterprise is considered crucial in order to gain an insight into the constraints they 
encounter in terms of financial, knowledge, material and technical resources (and 
other resources in Section 3.3 of Chapter 3). These constraints govern the ability to 
incorporate sustainability within any medical device across various classes.    
Furthermore, the quality of the case study design is of utmost importance as the 
activity itself. The four tests are outlined as follows in Figure 5.1, which includes 
construct validity, internal validity, external validity and reliability. Yin (1994) 
proposes the users to address these four tests throughout the case study process, 
beginning from design, data collection, and data analysis and reporting. 
Tests Case study tactics 
Phase in research 
activity 
Construct validity 
- use multiple sources of evidence 
- establish chain of evidence 
- ensure that key informants evaluate the draft 
of the case study report 
data collection 
data collection 
composition 
Internal validity 
(only for causal 
inferences) 
- conduct pattern matching 
- conduct the construct of the explanations 
- conduct analysis with respect to time-series 
data analysis 
data analysis 
data analysis 
External validity - use replication logic in multiple-case studies research design 
Reliability 
- use case study protocol 
- develop case study data base 
data collection 
data collection 
Figure 5.1 – Facets to ensure Quality in the case study design (Ying, 1994) 
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In social research methodologies where case study method is utilized regularly, 
the construct validity is defined as the extent to which the case study user can 
legitimately draw inferences after implementation of his/her propositions and 
theoretical constructs.  
On the other hand, external validity is based on the degree to which the 
experimental results of a particular study (and its pertinent contexts) are 
applicable (or possible to be generalized) to other situations. Usually causal 
inferences (i.e. cause-effect based inferences) are applicable in terms of their 
external validity, as they can be considered across a wide spectrum of 
circumstances, which are quite unique compared to the conditions, which the 
study was previously conducted. The loss in external validity can occur, when the 
previously conducted study ‘may’ have been carried out in small samples with 
very specific contexts (such as geographical locations and specific cultures) that do 
not possess any relevant commonalities to other situations. For example: The 
market acceptability of a car design suited for customers in the Nordic region that 
resonates with their culture may not be easily extrapolated (or applicable) to 
customers in South America. As both these regions have different socio-economics 
and cultural differences.  
The internal validity is the extent to which the cause-effect inferences based on a 
certain scenario in a case study are valid. In simple words, this means the validity 
of studies (and also the inferences) that intends to establish a certain cause-effect 
relationship. The facet of reliability can simply be understood as the validity of the 
propositions and case study methods employed by the user. 
The thesis favours the use of expert interviews and opinions to ensure that the 
case study design entails a substantial degree of quality as per the aforementioned 
tests. 
According to Figure 5.2, the four types of the case study are outlined as follows: 
• Type 1 - The study of a single case for a single unit of analysis under review; 
• Type 2 - Study of a single case for multiple of analysis under review; 
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• Type 3 - Study of various cases for a single unit of analysis under review; 
•Type 4 - Study of various cases for multiple units under review; 
In this thesis more than one case is considered in terms of multiple enterprises and 
the units under review are also more than one (Type 4). The units under review 
are the models and frameworks ones mentioned in Chapter 3 and 4 namely, 
multicriteria hierarchical decision model (Figure 3.2 in Chapter 3), the project 
selection approach using the multicriteria hierarchical decision model (Figure 3.4 
in Chapter 3), multicriteria hierarchical decision model pertaining to the end-of-
life options (Figure 3.5 in Chapter 3) and the multifaceted model (Figure 4.1 and 
4.2 from Chapter 4). 
 single-case designs multiple-case designs 
 
Holistic 
(single unit of 
analysis) 
 
 
 
TYPE 1 
 
 
TYPE 3 
 
Embedded 
(multiple units of 
analysis) 
 
 
 
TYPE 2 
 
 
TYPE 4 
 
Figure 5.2 – Classification of case study types (Ying, 1994) 
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5.3.1. Data Analysis 
The qualitative aspect of the data analyses during case studies would occur in 
accordance with the cognitive skills and analytical abilities of the researchers who 
conduct the case studies and the respondents who have participated in the case 
studies, respectively. The reason is that the description of the units of analyses and 
the scope of the case study needs to be well addressed by both parties by virtue of 
reliable data collection approaches. These data collection approaches would be 
discussed in detail in subsequent sections. This would also enable in presenting 
relevant and valid conclusions. 
According to Yin (1994), the objectives and structure of the case studies are based 
on the following research propositions of this thesis which are in accordance with 
the analysis and review of the pre-existing literature: 
•The opportunities to include social, economic and environmental sustainability 
are dependent on the design of the medical device(s). 
•The ability to include social, economic and environmental sustainability is 
dependent upon the learning curve, accessibility to material resources and 
financial capital of the Enterprises. 
•The presence of essential regulatory, social and economic policies poses either a 
barrier or promoter for incorporating social, economic and environmental 
sustainability within medical device design.  
These aforementioned facets are responsible for shaping the data collection 
procedures and also directing the case study. The objective is to capture critical 
data and ignore irrelevant details that do not corroborate with the visible and 
tangible outcomes. For instance: minor factors such as strained employer and 
employee relations although can derail major projects, but enterprises are capable 
of solving such internal conflicts within themselves in order to adhere to the 
project deliverables/deadlines. The relation between the factors stated in these 
propositions and the causality with respect to incorporation of social, economic 
and environmental sustainability is conducted during the data collection 
procedures. 
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5.3.2 .The Research Process in the Case Study  
According to Saunders, Lewis and Thornhill (2007) the research process that 
precedes the case study activities starts with the definition of the subject of the 
case study. This is further followed by clarifying the structure of the topic (or 
subject) to define clear objectives. The motive of the case study approach in this 
thesis is to evaluate the prospects of effectively incorporating the social, 
environmental and economic sustainability within design of the medical device. In 
order to strengthen the fundamental concepts of sustainability within product 
development and product design, a thorough literature survey was conducted 
which comprised of corporate newsletters, peer reviewed published research 
papers, book chapters, technical articles written in renowned magazines, such as 
Medical Device and Diagnostics Industry <www.mddionline.com> (Saunders, 
Lewis & Thornhill, 2007). Moreover, a few preliminary unstructured interviews 
were conducted with academicians in the area of product development research, 
decision modelling and medical devices to gain further insight on the resource 
based constraints to incorporate overall sustainability. Similarly, the major 
technical/non-technical challenges were also ascertained during unstructured 
interviews to address and incorporate overall sustainability within the design 
phase and the product development process as a whole across the Organization 
and its stakeholders. The motive was to structure a consistent approach for 
conducting a series of case studies and evaluating multiple units of analyses. 
As mentioned by Yin (1994) the case study approach is most appropriate when the 
user has limited control over the on-going circumstances within the situation and 
cannot really influence the behaviour of the events/variables associated with the 
causalities. However, some critics point out the lack of rigorous approach within 
this method and the vulnerability to incorporate biases, despite the advantage of 
the flexibility to suit the context of the case under consideration.  
The approach of case study is always governed by the type of research 
questions/propositions, the ability of the investigator to influence/control the 
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events under investigation and the ability to co-relate to on-going events in 
comparison to historical events.  
Case studies are also categorized according to following manner:  
•Descriptive: These types of case studies are intended to characterize or portray 
certain situations/events. 
•Explanatory: These types of case studies are considered for creating causality 
relationships between variables under consideration.  
•Exploratory: The case studies with a motive to comprehend the 
events/circumstances-taking place. 
The case studies that were conducted include a combination of all three 
aforementioned categories. Consequently, on the basis of the propositions, 
exploratory facet is first actualized which is followed by the explanatory phase of 
determining the causality between various variables to corroborate with the 
propositions while simultaneously characterizing the enterprise under 
consideration to modify the interview structure, accordingly. 
5.3.3. The Application of Case Study 
As recommended by Yin (1994) a multitude of facets are to be accounted for 
structuring a case study. The motive is to articulate a logical framework between 
empirical data, research questions and conclusions by virtue of a sound 
methodology.   
The facets are as follows: 
•Propositions and assumptions on which the research questions are defined. 
•The objectives that are to be addressed within the case study. 
•The unit(s) of analysis. 
•The logical connection between the empirical data and the 
propositions/assumptions. 
•Criteria to interpret the findings.  
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Furthermore, a case study permits the users to opt for multiple sources of 
evidence and methods of analyses for corroborating the propositions (better 
known as data collection). These methods of analyses range from empirical 
documentation, records/files, questionnaires, interviews, observations, direct 
participatory observation and assessing physical artefacts of projects under 
development or completed (Yin, 1994).  
In this thesis, no one particular method of analysis is considered advantageous 
over the other. On the contrary, all of these approaches are complementary to each 
other. During the case studies it is observed that each medical device of every 
category has its own particular design architecture for a specific physiological 
function in accordance with the Enterprises’ engineering and business 
management capabilities. Therefore, more than one method of analysis was 
considered necessary within the case study approach (Yin, 1994). 
Moreover, the procedures for collecting evidence and empirical data were 
conducted independently under the guidance of authorized representatives of 
each Enterprise. They (the authorized representatives) include but are not limited 
to research and development directors, engineers, scientists and business 
managers. The experiences and opinions were noted with reference to their 
product development processes. This approach was adopted so as to benefit from 
the expert advice of the Enterprises’ learning curve without allowing any 
cognitive biases of the members of the Enterprise to interfere with the analyses 
(Hilbert, 2012) 
5.3.4. Interviews as a critical component of the Case Studies 
In this thesis interviews have been considered to play an important role in case 
studies (Yin, 1994). The three main categories of conducting interviews are as 
follows (Patton, 1990; Saunders, Lewis and Thornhill, 2007): 
a) Informal conversational Interview 
The interview questions are defined during the case study with specific reference 
to the Enterprise and its Medical Device. As a result, the interview becomes more 
relevant and is able to determine many more factors that lead to the development 
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of the medical device and opportunities for including sustainability from a 
viewpoint of solving technical/non-technical contradictions specific to the 
Enterprise's Device. The major drawback is that there are too many people to 
interview and ultimately data organization becomes increasing challenging. 
b) Interview guide approach 
The interviewer has a pre-defined script after thorough literature survey and 
probably other unstructured interviews.  The context of the enterprise and the 
medical device under consideration can be maintained and gaps can be easily 
determined in order to modify the script accordingly. Despite the advantage of 
systematic data collection, if the interviewer makes adjustments within the script 
then there are chances of substantially different responses. Therefore, it is essential 
for omission of unnecessary details and questions during interviews to maintain 
the context of the propositions to be addressed. 
c) Standardized open-ended interview 
The questions are open ended in nature and are pre-defined by the interviewer. 
The respondents perceive flexibility to answer the questions based on the context 
of their Enterprise and medical device under consideration. As a result, the 
responses can be more comparable. Nevertheless, additional flexibility to fit the 
context of the Enterprise and the specific device under consideration is 
substantially limited, especially in the case of medical devices when each Class has 
its own diversity and is in turn manufactured by a wide spectrum of market 
players with each having their own specific uniqueness to enhance overall 
sustainability. 
d) Closed quantitative interview 
The set of pre-defined questions are presented to the respondents who choose the 
appropriate responses from a list of options. Even if the data analysis and 
comparability is simplified, the flexibility and contextual understanding are 
dramatically limited. However, the interviewer can easily include specific 
experiences of the respondents and ask additional sub questions around the main 
 154 
question under discussion without making the interview too open ended and 
unstructured. 
In this thesis an ‘Informal conversational Interview’ was adopted for the case 
studies in the Enterprises that developed and/or manufactured medical devices. 
In addition, a ‘closed quantitative interview approach’ based on a questionnaire 
was also considered for the multifaceted framework, as described in Figure 4.1 
and 4.2 of Chapter 4.  
The reason is that the design optimization approaches and product development 
activities vary in diverse circumstances and hence additional feedback was 
obtained from the survey respondents. The questionnaire for the multifaceted 
framework (Figure 4.1 and Figure 4.2) is mentioned in Chapter 6 and was emailed 
to around 10 experts who have substantial experience in product development 
and design engineering. The questionnaire was followed by a 1 hour long distance 
interview and notes were made and re-confirmed by emailing the respondents to 
prevent any erroneous comprehension due to the disparity in area of expertise 
between the interviewer and respondent(s).  
The questionnaire had multiple-choice options of either YES/NO for questions 
that discuss the validity of combing a few engineering and management elements 
during design optimizations. Similarly, the options of Low/Medium/High were 
provided for gaining insight into the feasibility of the combination of engineering 
and product development elements. To explain in simpler terms, engineering 
element can include design engineering tool (computer aided design) and product 
management element could also be total product life cycle management system.  
Hartley (1994) also concurs that interviews are an effective method to gain a 
detailed insight from the most crucial resource of product development, which are 
better known as Human Resources for who justify the utilization of various 
product development tools and the customers for whom the products are 
primarily devised. The face-to-face or long distance interviews permit the 
interviewer to perceive the pragmatic realities pertaining to product development. 
For instance: The recent financial crises of 2008 resulted in many companies opting 
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for redundancy. This resulted in a few employees were made to accommodate the 
workload of the employees whose jobs were either outsourced or terminated. 
Consequently, the respondents who had an exhaustive list of responsibilities 
found it challenging to adhere to the hours decided for the long distance 
interviews. 
5. 4. Analytical Hierarchical Process 
5.4.1. Introduction 
The multi-criteria hierarchical model that is discussed in detail in Chapter 3 and 
Chapter 4 is based on the fundamentals of Analytical Hierarchical Process. This 
section of the research methodologies discusses the decision modelling approach 
of Analytical Hierarchical Process (AHP) which has been at the centre stage of this 
thesis for inclusion of Sustainability related criteria into product design.  
In this chapter, the pertinent criteria of the following paradigms are arranged in a 
hierarchical manner: Product performance (in addition to stakeholder safety) with 
environmental compliance and bare minimum profitability (in Tier 1), economics 
of the business sector that enables the implementation of the model (in Tier 2) and 
the social impact of the business with its commercialized medical device (in Tier 
3).  
The concept of sustainable medical device is sub-divided into constituent criteria. 
This simplifies the problem for examining each criterion with respect to other 
criteria. Although, accounting for sustainability related criteria one cannot 
presume a reductionist approach as sustainability is to be considered from a 
holistic standpoint (Hermele, 2009). On the other hand, a holistic approach would 
demand the decision modelling approach to be more exhaustive in nature and 
during the product development endeavour certain crucial criteria (from all three 
domains of sustainability) are capable of exerting a substantial impact 
(positive/negative) onto overall sustainability (Hede et al., 2011). These crucial 
criteria can enable the user to derive a single overall priority index for every 
option (or alternative) under evaluation (Hemphill et al., 2002). 
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Consequently, in this chapter a methodology for decision modelling using AHP 
based approach is discussed with the allocation of weights to enable prioritization 
of pertinent criteria in Tier 2 and Tier 3, after the most dominant and crucial 
criteria are finalized and incorporated within Tier 1. The assignment of weights 
and pair-wise comparison would not be done for Tier 1, as each criterion in Tier 1 
is non-negotiable. 
The Tier 2 and Tier 3 would encompass the conventional AHP decision modelling 
approach. Moreover, not a single criterion from Tier 2 to Tier 3 could be included 
in product design if it cannot be reconciled with any one criterion of Tier 1. A 
more detailed discussion has already been included in Chapters 3 and 4. 
For the pair-wise comparison method the following criteria were selected:  
End-of-life and Modularity (Tier 2) 
Employment (Tier 2) 
Income Distribution (Tier 2) 
Housing (Tier 3) 
Community welfare (Tier 3) 
Business Growth from Tier 3 to represent both Mergers & Acquisitions and 
Corporate Expansion.    
Market Share (Tier 3) 
The other criteria in Tier 2 and Tier 3 from Figure 3.2 of the MCHM which denote 
an increasing degree of cost effectiveness from Tier 1 to Tier 3 and an increasing 
degree of commitment towards renewable resources/reduction of emissions and 
waste was recommended by the Experts from Academia and Industry, who also 
participated in the pair-wise comparison procedure. 
For the criteria in Tier 2 and Tier 3 the pair-wise comparison procedure from the 
AHP process has the following steps: 
1. Identification of sustainability criteria that are dependent on the Tier 1 criteria. 
For instance: The modular approach towards product development and end-of-
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life are dependent upon the product design and its ability to adhere to regulatory 
compliance.  
2. The chosen sustainability related criteria are arranged into the hierarchy of Tier 
2 and Tier 3 in accordance to their ability to influence the near future continuation 
of the enterprise and long-term growth plans, respectively. For instance: End-of 
life is located in Tier 2 which would immediately impact the product performance 
and the company’s sales while the plans for corporate growth are placed in Tier 3 
as they are pertinent to long term growth strategies.  
The objective to arrange the pertinent criteria in the aforementioned form of 
hierarchy is to illustrate that the stakeholders should accept a medical device with 
bare minimum profitability for the developers/manufacturers on which 
additional degrees of overall sustainability can be established. Moreover, without 
these two critical criteria as outlined in Tier 1, the other criteria in Tier 2 and 3 
such as long term corporate growth would be counter intuitive and futile in 
nature. 
3. The assigning of numerical weights and pair-wise comparison of the criteria 
mentioned in Tier 2 and 3. The scores were assigned based on their relative 
importance between two criteria at a time based on the Saaty (1980) scale in Table 
5.1. The assigning of numerical weights involved interviews with a total of 7 
experts. During the interviews, the pair-wise comparisons between the outlined 
criteria in the two tiers (Tier 2 and 3) were discussed and simultaneously, the 
experts revealed their opinions as well as experiences pertaining to sustainability 
and product development. A pair-wise comparison of one criterion with respect to 
other criteria is determined to be more objective as opposed to subjective 
judgments on only a single criterion under consideration. As considering only one 
criterion for evaluation would entail an experts’ biases and even preclude a more 
holistic approach with reference to other criteria (Hilbert, 2012). Meanwhile, 
comparing one criterion with all other simultaneously would transform the expert 
interview sessions into a more exhaustive form, which may lead to confusion 
between the interviewer and the expert. Therefore, comparing one criterion with 
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the other at a time followed by trying to co-relate with other criteria as well was 
identified to be more convenient for both the interviewer and the experts.   
4. The scores are aggregated and the relative weights on each hierarchical level are 
analysed. 
5. Evaluation of the consistency of the collected data from the experts after 
aggregation. 
6. In contrast to conventional AHP related applications; there are no options or 
alternatives that would be evaluated in terms of the hierarchical structure of the 
proposed multicriteria hierarchical model (MCHM) in this thesis. The MCHM that 
comprises of Tier 1 as the critical tier and Tier 2/3 would select and reject suitable 
design candidates during product development and product design process for 
which consistency index/ratio may or may not be applicable. The goal of the pair-
wise comparison is to capture tacit knowledge and insight from the Experts 
pertaining to product development. Furthermore, the criteria in Tier 2 and Tier 3 
are also optional in nature.   
7. The ‘Informal conversational Interviews’ that were more semi-structured 
addressed the following two issues:  
a) The pair-wise comparison between various criteria in terms of their ability to 
influence each other. For instance, whether growth in market share could also 
bring about increase in the hiring practices of the company. Similarly, whether 
adopting end-of-life options may or may not increase the hiring in the company. 
The experts were not asked to assign any numerical value to the ability of one 
criterion to influence the other during the pair-wise comparison between two 
criteria at a time. The responses were collected in the form of short notes, which 
would be discussed in Chapter 6.  
b) The diverse economic circumstances in which the relations between criteria 
during pair-wise comparison can undergo substantial changes.  For example: If 
the medical device company is based in Sweden, where the social safety net in 
terms of healthcare and unemployment benefits is larger than the United States. 
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As a result, the disposable income tends to be higher and the medical device 
company can focus on increasing the market share and look forward for corporate 
expansion which would eventually bring about job growth and other forms of 
technology transfers for social benefit (Krugman, 2012).  
The responses were collected in the form of short notes, which would be discussed 
in Chapter 6. 
The goal is to determine the role played by diverse socio-economic circumstances 
based on the degree of Government presence in regulating the financial markets 
and providing social welfare. To illustrate further, the experts were requested to 
provide their feedback on the pair-wise comparison between two criteria with 
reference to the socio-economic scenario in Sweden, where the government has a 
dominant role in the economy, while United States government has a much lesser 
role in the economy and the government in Portugal holds a position which is 
between United States and Sweden. The countries namely, Sweden, United States 
and Portugal were given as examples to exemplify diverse socio-economic 
circumstances. 
Furthermore, as the interviews were ‘informal and conversational’ in nature is the 
reason for not defining a script for the interview which lasted for around 30-40 
minutes. Instead of the script, the questions were spontaneous in nature but were 
based on the guidelines from 1 to 7 outlined for the pair-wise comparison.  
The advantage of AHP based decision modelling technique is to evaluate various 
candidates in terms of a wide spectrum of coherent or conflicting criteria by virtue 
of pair wise comparison of each criterion with respect to the other. Similarly, 
candidates or alternatives could be evaluated on the basis of the numerical value 
for each criterion they address in the Tier 2 and Tier 3 of the MCHM.  This 
approach results in ranking of various candidates to enable the user of the MCHM 
to select the most suitable alternative (Rogers, 2001). For instance, Figure 3.4 in 
Chapter 3 illustrates the ability of the MCHM to select suitable projects for further 
development. Meanwhile, the ranking based elimination of various design 
candidates during the design optimization phase as discussed in Chapter 4 and 
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illustrated in Figure 4.2 is not related to the pair-wise comparison method. 
However, the MCHM can function similar to an AHP decision modelling 
approach solely on the choice of the user of the MCHM in terms of Tier 2 and Tier 
3. 
The AHP approach on which the MCHM is based utilizes the hierarchical 
arrangement of the criteria for exemplifying the overall objective of the decision 
making, while simultaneously accounting for a wide spectrum of criteria ranging 
from economic, social and emotional in nature. In conventional AHP, the objective 
is placed at the top, the criteria in the centre and the options at the lower level 
(Nigim et al., 2004). 
The users either by themselves or in interactions with experts assign weights via 
subjective judgment to each pair-wise comparison of two criteria at a time. This is 
followed by computing the overall weight of each criterion and evaluating the 
level of consistency of the assigned scores (Hobbs and Meier, 2003) 
Greening and Bernow (2004) have stated that the major impediment in the AHP 
decision modelling is to obtain a consensus based agreement between various 
decision makers and their biases/experiences, which is shown to substantially 
affect their judgment. However, studies such as Wu et al. (2007) and Liang et al. 
(2006) state that the AHP decision modelling process is a systematic and 
numerical approach that incorporates the subjective evaluation of all decision 
makers into account for selecting the final candidate. Moreover, Zhong-Wu et al. 
(2007) considered the AHP technique to be simple in comparison to their other 
multi criteria counterparts for quantitatively evaluating non-quantitative criteria. 
In this thesis, the impediment pertaining to ensuring a consensus between various 
Experts is less relevant because the pair-wise comparison approach has been used 
only for capturing tacit knowledge and insight. Moreover, the tacit knowledge 
and insight disseminated by the Experts is relevant to the specific contexts which 
could be pertinent to certain circumstances which occur during the development 
of medical devices  
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5.4.2. Description of the AHP process 
The hierarchical structure of chosen criteria to devise the AHP decision modelling 
approach was devised by Saaty(1980). An example of this hierarchical structure is 
denoted in Figure 5.3. 
 
Figure 5.3: Analytical Hierarchical Process 
Hon et al. (2005) have described the key steps for decision modelling by the AHP 
approach which are: building a matrix of pair-wise comparison, the eigen values 
followed by the eigenvector calculation and reviewing the consistency of the 
matrix and ultimately the normalizing the weights of the selected criteria. The 
process can be resumed as follows: 
1. As stated the previously the objective, criteria (and sub-criteria) and candidates 
are located in their respective hierarchical positions. The hierarchy is represented 
by the illustrated figure; wherein X1 and X2 are two criteria, X1.1, X1.2 and X1.3 
are the sub-criteria associated with X1 and X2.1, X2.2 are the sub-criteria 
associated with X2. The alternatives are designated by A1 and A2. 
 2. Pair-wise comparison is conducted as follows: Elements, X1.1, X1.2 and X1.3 are 
compared pair-wise with respect to their importance towards X1.1 (from the X1 
criterion) and using Saaty scale presented in table 5.1. The process is repeated at 
each level until the final top level of the hierarchy is attained. This step also 
includes the calculation of consistency ratios of the matrix judgment to confirm 
that the assigning of scores is consistent in nature. 
In Table 5.1 the numbers (9; 7; 5; 3; 1) represent values of pair-wise comparison 
situations when A is compared to B, the comparison of B with respect to A would 
A1 
Main Objective 
X1 
X1.1 X1.2 X1.3 
X2 
X2.1 X2.2 
A2 
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be the reciprocal value (1/9; 1/7; 1/5; 1/3). For example: When A is compared to 
B and if A is strongly more important than B then the score is 7. Accordingly, the 
score of B with respect to A would be 1/7. 
 
Table 5.1 – Saaty (1980) Scale of assigning weights on the basis of pair-wise 
comparison. 
Score Pair-wise evaluation 
9 A is absolutely more important than B 
7 A is strongly more important than B 
5 A is strongly important than B 
3 A is moderately more important than B 
1 A is equally important than B 
1/9, 1/7, 1/5, 1/3,1 Reciprocal values 
 
In the matrix representation, as illustrated in Figure 5.4, when a criterion is 
compared to itself the score is usually 1. This means that result the diagonal, 
which corresponds to each and every criterion being compared to its own self, is 
scored as 1. The scores below the diagonal of unity are reciprocals and hence 
judgments pertaining to the upper region of the triangle, which is right hand side 
above the diagonal, are to be considered for evaluating the alternatives (Kablan, 
2004). 
The AHP decision modelling approach is based on the eigenvector analysis 
technique mentioned in Kablan(2004) and is denoted in the matrix for criteria C1, 
C2,…..,Cn. The numerical values assigned to aij are as per Saaty scale illustrated in 
the previous Table 5.1 ‘A’ is the consistency matrix of the judgments and Saaty’s 
(1980) method would enable the users to calculate K (the vector of weights) which 
is the principal right eigenvector of the matrix A.λ max is the highest value of the 
eigen value of matrix A and Z is the identity matrix and K is the eigenvector. 
When the pair-wise matrix is perfectly consistent then λ will correspond to the 
equal number of alternatives under consideration (n). The consistency index (CI) 
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and the random consistency ratio (CR) are computed according to Kablan (2004) 
and as indicated in Figure 5.4. 
The Random Index is the average value of the Consistency Index for random 
matrices using the Saaty (1980) scale, which is further based on Forman’s (1990) 
random indices. Moreover, Saaty (1980) only accepts a matrix as consistent if and 
only if Consistency Ratio < 0.1 (Alonso & Lamata, 2006). 
 
Figure 5.4 – Matrix approach towards Analytical Hierarchical Process (Forman, 
1990; Saaty, 1980; Alonso & Lamata, 2006) 
The consistency ratio provides an insight on the consistency of the matrix with 
reference to a purely random matrix. The values of the random index are obtained 
from published tables for every size of the matrix, n (n is also the no. of criteria). 
When the consistency ratio ≤0.10 the decision makers pair-wise comparisons are 
considered consistent (Kablan, 2004; Lee et al., 2007; Zhong-Wu et al., 2006; Hon et 
al., 2005). 
5.4.3. A simple explanation of the AHP process and computation of the 
consistency index  
Figure 5.5 represents the computation process of AHP after collecting the data 
from the pair wise comparison, for an example with 3 criteria (N=3). 
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Criteria  A B C Nth root Priority Vector (PV) 
A     Nth root of A/ Total  
Nth Root 
B     Nth root of A/ Total  
Nth Root 
C     Nth root of A/ Total  
Nth Root 
SUM SUM A SUM B  SUM C Total Nth 
Root 
Total adds to 1. 
SUM*PV (SUM A)* PV 
of A 
(SUM A)* PV 
of B 
(SUM A)* PV 
of B 
  
Figure 5.5 – Simplified explanation of Analytical Hierarchical Process 
The required steps can be described as follows:  
Step 1. The pair-wise comparison starts from each row from left hand side 
towards every criterion on the right hand side mentioned in the columns. 
(Direction denoted by the bold arrow               pointing towards the right). 
Step 2. The values in each row are multiplied (A v/s A, A v/s B and A v/s C) and 
the cube root is computed. This is because n=3 (as in no. of criteria) so nth root is 
cube root. 
Similarly, the pair wise comparison is conducted for B and C from their respective 
rows. 
Step 3. The numerical values of the nth root are added together (denoted by the 
block arrow pointing downwards       ). 
Step 4. The values of each nth root for each row is normalized i.e. the value of 
each nth root of each row is divided by the total sum of all the nth roots. As a 
result the normalized value of all the nth roots would total to 1. This is similar to 
the concept of a % percentage, but only without the changes in decimal place by 
multiplication of 100. The normalized values are also known as priority vector 
(PV). 
Step 5. The numerical scores in each column (starting from A) from top to down 
are added to compute SUM-A. This SUM-A is multiplied by the priority vector (or 
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normalized value) to obtain a SUM*PV value for A. The direction is denoted by 
the square dotted arrow pointing downwards     ) 
The SUM*PV of A and B and C are added up to obtain λmax. 
Step 6. The consistency index is calculated by the following formula: (λmax-
N)/(N-1). 
Step 7. The consistency index divided by the random index presented in Table 5.2 
(based on the number of criteria) gives the consistency ratio. 
Table 5.2. – Random Index with respect to the number of criteria (Forman, 1990; 
Saaty, 1980; Alonso & Lamata, 2006) 
 
 
 
 
 
 
 
 
 
 
If the Consistency Ratio (CR) <0.10, the experts’ pair-wise comparisons are 
considered to be relatively consistent. Meanwhile, if the Consistency Ratio (CR) > 
0.10, the experts have to be consulted again for their pair-wise comparisons and 
the source of inconsistencies have to be identified.  
The AHP technique is suitable in situations where multiple diverse criteria are to 
be considered for decision-making (Liang et al., 2006). The diversity can range 
from economical, social, emotional and technological in nature to name a few. The 
simplicity coupled with the concept of prioritization. Moreover, the quantitative 
N (number of criteria) Random Index (RI) 
1 0.00 
2 0.00 
3 0.58 
4 0.90 
5 1.12 
6 1.24 
7 1.32 
8 1.41 
9 1.45 
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scale permits mathematical calculations of the prioritization for obtaining a single 
overall index to denote the justifiability of an alternative under consideration. In 
previous research endeavours, AHP has been considered for group decision-
making in combination with the Delphi approach (Lai et al., 2002). The AHP 
method does deliver insight into the conflicts between various experts who 
participate in pair-wise comparison, which would eventually govern the 
consistency ratio, and the judgments. 
5.4.4. Advantages and limitations of the AHP and incorporation of enhanced 
flexibility in MCHM. 
The AHP technique is suitable in situations where multiple diverse criteria are to 
be considered for decision-making (Liang et al., 2006). The diversity can range 
from economical, social, emotional and technological in nature to name a few. The 
simplicity coupled with the concept of prioritization. Moreover, the quantitative 
scale permits mathematical calculations of the prioritization for obtaining a single 
overall index to denote the justifiability of an alternative under consideration over 
other alternatives that are being evaluated similarly. In previous research 
endeavours, AHP has been considered for group decision-making in combination 
with the Delphi approach (Lai et al., 2002). The AHP method does deliver insight 
into the conflicts between various experts who participate in pair-wise 
comparison, which would eventually govern the consistency ratio, and the 
judgments. 
The MCHM as discussed is based on the conventional simplified AHP approach, 
as defined by Saaty (1980). The MCHM as discussed in Chapter 3 is to act as an 
effective mediator between the Engineering and Project management activities of 
medical devices. For instance, while the senior manager can define corporate 
growth strategy for the company, the project manager can use the MCHM for 
selecting the most suitable medical device for development. 
The arrangement of criteria of the MCHM, as shown in Figure 3.2 and Figure 3.6 
of Chapter 3 denotes a network which resonates with Saaty’s (1990a; 2006b) 
Analytical network Process (ANP). The ANP also uses a pair-wise comparison to 
 167 
illustrate the inter-dependency between various criteria in order to choose the 
most suitable alternative. This structure is unique in comparison to AHP; wherein 
the criteria are considered independent of each other. As discussed in the previous 
section of this chapter that the criteria are usually interrelated and the context of 
the co-relation between the criteria change dramatically for various types of 
economic structures and geographical locations. Therefore, the senior 
management can implement suitable business strategies based on this decision 
model in order to reduce the overall ecological and negative social impacts. The 
core purpose is to avoid a situation wherein the company reduces the negative 
externalities at one end and eventually increase the degree of social/ecological 
externalities elsewhere.  
The inter-connected framework of the MCHM resonates with the phenomena of 
complex adaptive system, in which systems continuously interact with each other 
by virtue of multiple feedback loops. In the case of a product development 
enterprise, such as an innovative medical device company, the continuous 
exchange and dissemination of information and knowledge leads to the 
commercialization of robust products/services at a much faster rate (Chiva-
Gomez, 2004). The MCHM does not explicitly endorse any specific restriction on 
the inter-relations between the criteria. Furthermore, the MCHM prefers to 
preserve the aforementioned hierarchical structure in scenarios where 
irreconcilable conflicts arise out of the dynamic interactions between the resources 
as stated in Section 3.3 of Chapter 3. 
The AHP approach considered in this thesis aims to coherently combine the 
experience and knowledge from the chosen experts (from academia and Industry) 
by utilizing the quantitative scoring scale devised by Saaty(1980). In contrast to the 
conventional approach of determining points of conflicts between various experts, 
the pair-wise comparison has been considered with respect to specific pertinent 
contexts, so as to alleviate the impediment of ‘forcibly’ reconciling conflicts via 
mathematical calculations which would eventually denote a single overall score 
without portraying the holistic picture of the situation on which the decisions are 
being made. For instance, in the experience of one expert, the introduction of end-
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of-life options is more important than increasing employment in the company. 
The reason being that recycling, remanufacturing and reusing can increase 
employment in the company or with other collaborators who conduct end-of-life 
options. However, end-of-life is not necessarily a profitable or even an 
environmentally sustainable approach if excessive resources have to be expended 
in transportation and re-transforming them in a market that changes rapidly and 
dynamically (Nasr and Thurston, 2006). This is also the reason for the Tier 1 to 
contain the minimum degree of profitability and reduction of emissions/waste so 
as to ensure that when such aforementioned conflicts occur in certain specific 
situations for a medical device company, then more rational decisions can be 
implemented.  
This implies that the scoring by a certain expert is relevant in one particular 
situation and becomes less relevant in another situation. Therefore, the goal is to 
articulate the inputs from the experts during the semi-structured interviews (or 
informal conversational interviews) based on the research propositions in Section 
5.3.1 while conducting pair-wise comparison. This justifies the reason for not 
defining an interview script for the pair-wise comparisons. 
The inputs provided by experts with respect to the specific contexts can act as a 
more suitable approach to address conflicts that arise while considering either two 
of more criteria between each other. Furthermore, these inputs would be 
incorporated during the case study activities, which have been discussed in detail 
in Chapter 6. 
Furthermore, as discussed in the subsequent chapter that when the pair-wise 
comparison of the experts are discussed, a specific short note is mentioned on the 
relevant context with respect to more than one business and economic scenarios. 
For example: A medical device company in Portugal should focus more on 
employment than market share. An Academician from a Portuguese University 
mentioned this comparison, which was in reference to the on-going European 
Union financial crises. Because, in his opinion growth in market share eventually 
takes place when there is increase in disposable income of the population to 
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purchase goods/services, as this income is generated by virtue of employment or 
entrepreneurship (small-medium/large scale) (D’Alessandro et. al, 2009). 
Therefore, the essential ingredient of flexibility is introduced in this proposed 
MCHM wherein the relevant contexts are mentioned so that the pair-wise 
comparisons made by the chosen experts can be considered across all types of 
medical devices companies (small/large) across various geographical and 
economic circumstances. 
5.5. Concluding Points 
In this chapter, the importance of case study method is discussed in detail with 
primary focus on expert interviews using ‘Informal conversational Interview’ 
process for conducting the case study and ensuring the quality of the design of the 
case study. Moreover, the case study method provides the freedom to the user to 
test and validate the propositions/frameworks in a ‘real life setting’ and 
determine the prospects of external validity of other case studies as well. The most 
critical point to be noted in this chapter and throughout the whole thesis is that 
the MCHM, which is based on conventional AHP, is applicable at the 
design/development phase of the Medical Devices, as opposed to choosing an off-
the-shelf medical device available in the market. The selection of a suitable off-the-
shelf medical device can be conducted if certain less relevant criteria are excluded; 
nevertheless the choice in this case is given to the user of the MCHM provided the 
regulatory compliance and bare minimum profitability are maintained.  
Moreover, during the design/development phase the medical devices companies 
are bound to encounter a multitude of uncertainties at the socio-economic and 
business frontiers. As a result the proposed forms of flexibility provided by the 
pair-wise comparisons from the Experts coupled with short-notes from the 
interviews (in the subsequent chapter) are mentioned to mitigate the impact of 
such uncertainties. This is also one of the reasons for the pair-wise comparison 
method of the AHP decision modelling approach to be used for capturing insight 
and tacit knowledge pertaining to product development and not for selecting any 
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specific alternative over other alternatives for which aspects of AHP method such 
as consistency index/ratio become less relevant or even irrelevant. 
The objective is to enable the users of the model to adapt within less time to their 
specific business and economic scenario within the design/development phase so 
as to prevent or minimize expensive corrections.  
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Chapter 6 
Results and Discussion 
6.1. Introduction 
With reference to the decision modelling approaches and product development 
frameworks described from Chapter 2 up to Chapter 4 with their research 
methodologies as outlined in Chapter 5. This chapter reveals in detail, the 
outcomes of the discussed methodologies for evaluating the effectiveness of the 
proposed decision modelling approaches and product development frameworks.  
This chapter commences with Section 6.2 that describes the pair-wise comparison 
of the criteria mentioned in Tier 2 and Tier 3 of the MCHM. The pair-wise 
comparison which was conducted by interviewing a total of seven Experts from 
Academia and Industry who not only assigned suitable numerical scores while 
comparing one criterion with the other criteria but also disseminated their own 
expertise as well as experience (including insights) towards incorporating overall 
Sustainability during product development.  
On the other hand, Section 6.3 describes the results obtained from the another set 
of experts from Industry and Academia who provided their feedback by virtue of 
a ‘informal conversational interview’ and a structured questionnaire for 
evaluating the multifaceted model which illustrates the role of the MCHM in 
design optimization in coordination with a wide range of technical and non-
technical tools. This was in contrast to an active application of the multifaceted 
model within the design engineering activities of a company engaged in product 
development. The reason for adopting the stated methods of evaluation is 
attributed to the availability of the time (at least 1 year) and the substantial 
reconfiguration of a company’s design engineering process, which leads to 
undesired opportunity cost. Moreover, as many of the technical tools in 
 172 
computational design engineering in conjugation with other technical tools such 
as production machinery and conceptual tools such as QFD <www.qfdi.org> have 
been well studied in both academic and industrial circles. Consequently, obviating 
the requirement of a detailed industry based evaluation. Furthermore, the 
objective of the thesis entails the evaluation of the MCHM (inspired from AHP) 
for conducting product development and even product design which beyond the 
conventional role of decision modelling. 
Meanwhile, Section 6.3 describes the results from the case studies conducted 
within the 6 entities as mentioned in Chapter 5. The research propositions as 
outlined in Section 5.3.1 of Chapter 5 have been evaluated within the case study 
approach through interviews, questionnaires and in certain scenarios even by 
active participation. Furthermore, at the end of this chapter a 2 page note is 
mentioned which establishes the co-relation between the three sections of this 
chapter and the significance of the various techniques considered to evaluate the 
proposed decision modelling approaches and product development frameworks. 
6.2. Pair-wise comparison of Tier 2 and Tier 3 of the Multicriteria 
Hierarchical Model (MCHM) 
As discussed previously in Chapter 2 and 3, the three aforementioned domains of 
sustainability are inter-connected within each other. Therefore, assigning either a 
financial value or a numerical value for decision making has proven not only to be 
reductionist in nature, but even suffering from poor accuracy (Hermele, 2009; 
Jansen, 1992). 
This impediment is the core justification for the thesis to adopt a more qualitative 
approach towards the pair-wise comparison procedure pertaining to the criteria 
outlined in Tier 2 and Tier 3 of the Multi-criteria hierarchical model (MCHM) 
which as mentioned in Chapter 3 and 4 is remotely similar to the Analytical 
Hierarchical Process (AHP).  
The categorization of the pertinent criteria into three tiers with the primary tier 
being non-negotiable to which any or all criteria selected from Tier 2 and Tier 3 
have to compulsorily satisfy. The product engineers and managers would 
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collaborate to ensure that the Enterprises’ goals and stakeholders’ requirements 
are incorporated within the design phase of the product. Moreover, the design 
optimization process that would generate suitable designs candidates as 
alternatives to which the MCHM would be used for further screening.  
In this thesis, no particular case study (discussed in the subsequent sections) 
contains any design candidates for which the MCHM has been utilized for 
selecting a suitable design candidate. On the contrary, the feedback from the pair-
wise comparison interviews conducted with 7 experts was utilized to guide the 
case study participants for incorporating overall sustainability within their 
product development process. The experts were consulted for assigning suitable 
scores for each pair-wise comparison, as mentioned in Section 5.4 of Chapter 5. 
The objective was to gain insight into their tacit and explicit knowledge of 
addressing circumstances pertaining to diverse business, technical and economic 
situations. For instance, developing advanced medical devices in geographical 
regions with diverse economic frameworks that range from a stronger presence of 
Government (e.g.: Sweden), medium presence of Government (e.g.: Portugal) and 
low presence of Government (e.g.: United States). 
Therefore, the approach in this thesis is aimed at articulating the responses from 
the experts with reference to their pertinent contexts, especially when in certain 
economic and political circumstances; more than one criterion can be addressed 
simultaneously. For instance, as stated previously in Section 5.4 in Chapter 5, the 
end-of-life options can contribute to increased employment in a certain business 
and economic situation and in another situation can prove to be expensive and 
even ecologically detrimental in nature (Nasr and Thurston, 2006). The MCHM, 
which is based on a modified version of a conventional AHP, is envisioned to 
address more dynamic circumstances between the aforementioned domains of 
Sustainability. As a result, the focus (or the importance) on the consistency ratio 
has been kept at the bare minimum in this thesis is solely because the pair-wise 
comparison method is to gain insight into the product development expertise of 
the experts with respect to diverse business scenarios and economic 
circumstances. The other reason for the consistency ratio to be less significant is 
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because the product development teams can opt for either one or more of the 
criteria mentioned in Tier 2 and Tier 3 of the MCHM. While in conventional AHP 
the consistency ratio requires all the mentioned criteria and sub-criteria to be 
considered. The calculations of the consistency ratios have been mentioned in the 
subsequent sub-sections but their importance is kept at a bare minimum. 
Furthermore, the conventional AHP does not explicitly account for the inter-
dependencies between various criteria, unlike its Analytical Network Process 
counterpart. However, the principle of prioritization which is essential for the 
medical device development with simultaneous consideration of bare minimum 
overall sustainability (as in Tier 1 of the MCHM) is the key principle attribute for 
which a modified version of a conventional AHP has been proposed in the form of 
the multicriteria hierarchical model (MCHM) (Saaty, 1990a, 2006b). Moreover, as 
every criterion in the MCHM is interrelated with other criteria; nevertheless 
certain criteria exert a stronger influence on the fate of the medical device 
company and the other criteria. As a result, the most crucial criteria outlined in 
Tier 1 are imperative for any of the other criterion in Tier 2 and/or Tier 3 to be 
successfully materialized. This justifies the MCHM to be organized into three tiers. 
For instance, a medical device that is modular in nature (Tier 2) and profitable 
(Tier 1), but does not attain regulatory compliance (Tier 1) would never be allowed 
to enter the market. Thus, incurring substantial financial losses for the company 
who develops/manufactures it, as product design can incorporate both regulatory 
compliance as well as being modular in nature. 
The stated approach of articulating the responses via interviews from the experts 
is envisioned to provide flexibility into the MCHM to be applicable to a diverse 
range of socio-economic circumstances (e.g.: Sweden and United States). 
Moreover, such an approach also delivers an additional benefit of minimizing 
conflicts between the socio-economic circumstances by expounding the 
underpinnings of the three domains of sustainability and enabling the senior 
management in collaboration with the product development teams to chart out 
suitable business and product development strategies. 
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6.2.1. Evaluating the validity of the MCHM: Informal Conversational Interview 
approach 
The chosen experts represent both academia and industry for the Tier 2 and Tier 3 
pair-wise comparison interviews. The experts approved the three-tier structure 
and in addition recommended an increasing degree of Cost Effectiveness and 
lowering of the overall Environmental Impact from Tier 1 onwards up to Tier 3.  
During the interviews, all the Experts unanimously agreed that the product design 
configuration, accessibility and attributes of the listed resources (Section 3.3 in 
Chapter 3), product commercialization strategies and current economic scenario 
(such as Keynesian Economics v/s Free Market Economics) as discussed by 
Wapshott (2011) would define the success or failure of the Enterprise to 
accomplish its desired objectives.  
Further literature review on the AHP revealed that utilizing a fuzzy logic 
approach towards decision modelling in AHP has proven to be substantially 
successful, especially in cases that involved selecting suitable business processes 
for reverse logistics and supply chain distribution for Remanufacturing (Hummel 
et al., 2002; Nukala and Gupta, 2005). However, when compared to the current 
economic and business environment that entails dynamic exchange of information 
with relatively high uncertainty would eventually render the applicability of 
Fuzzy logic in decision modelling to become less effective (Siler and Buckley, 
2005). Therefore, the justification of adopting regular human intervention for 
finalizing appropriate decisions is well founded, notwithstanding the utilization 
of improvised decision modelling tools. 
6.2.2. Results from the interviews and pair-wise comparisons 
As illustrated in Figure 6.1, the academicians (Experts 1 to 4 and 7) prioritized 
End-of-life (EOL)/Modularity; Employee Welfare and Contribution to Income 
Distribution of the Stakeholders in contrast to investments in Community Welfare 
Programs, as they envisioned their chosen criteria to eventually contribute 
towards overall social welfare and environmental stability. The justification stated 
by these experts was that employment and income distribution would increase the 
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purchasing power of the employees to further contribute to overall socio-
economic growth, including housing (D’Alessandro et. al, 2009). Thus, further 
propagating the growth of commerce and business (Handler & Grossman, 2009). 
Almost all the experts from both academia and industry stated that end-of-life 
(EOL) options/modularity would eventually lead to increase in employment 
provided the cost model is optimized to not be more expensive and the resources 
expended for transportation and re-processing of materials should not have a 
detrimental ecological impact.  
On the other hand, Experts from Industry (Expert 5 and 6) denoted a higher 
priority towards Corporate Expansion and Market Share, as in their opinion these 
two criteria would eventually contribute to the overall socio-economic 
development of the stakeholders, in terms of increase in employment and income 
distribution. Moreover, in the opinion of the Industry Experts the two 
aforementioned criteria namely, Corporate Expansion and Market Share would 
eventually entail Product Modularity and EOL options as one of the key business 
strategies (Wapshott, 2011). As a result, as EOL options and modularity eventually 
lead to employment and better ecological sustainability, while concurrently 
resulting as an outcome of a company’s growth objectives is one of the major 
reasons for this criterion to receive a lower ranking by some of the experts from 
Industry.  
Meanwhile, Community Welfare Programs received higher ranking than Business 
Growth/Market Share as the Experts from Academia argued in favour for the 
presence of social capital which is crucial for building up the economy as a whole 
on which corporate growth can occur (Wapshott, 2011). 
Both, Academicians and Experts from Industry possess their own specific 
perspectives on the role of Business in socio-economics, product design and 
environmental impact. However, substantial insight can be gained from their 
diversified viewpoints, as the Experts from academia were providing their 
feedback with respect to the on-going EU economic crises. As a result, the focus 
was more on employment, housing, income distribution and end-of-life options.  
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Figure 6.1 – Scores assigned by experts from academia and Industry during pair-
wise comparisons. 
 
During the interviews, one of the academic experts stated that Small and Medium 
sized Enterprises who develop medical devices usually focus more on growth in 
sales for a time of 5 years and later look forward for expansion. Meanwhile, large 
sized Enterprises opt for increasing market share and business growth (as well as 
diversification). 
One of the academics expert stated that in countries such as Sweden and Denmark 
that have a stronger presence of Government in regulation of financial markets, 
healthcare, social programs and unemployment benefits. This is one of the reasons 
the companies operating in these geographical region are requested to report their 
corporate social responsibility activities (such as employee housing, income 
distribution and social activities). However, the respective governments do not 
define magnitude of socially responsible activities and the enterprises are 
provided with freedom to opt for any degree (even minimal) of socially 
responsible commitments. This is also one of the reasons, companies in these 
geographical regions prefer not to dedicate more priority towards socially 
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responsible activities owing to the substantial presence of the Government and the 
high quality of social welfare services they provide via the tax revenue (Krugman, 
2012). 
This situation is quite contrary to what is found in countries such as the United 
States, where the role of Government in the Economy, Financial markets and 
social programs is very small. This is also, one of the reasons large corporations in 
these nations are provided with tax benefits and other incentives in terms of access 
to easier credit for their corporate social responsibility endeavours. 
For companies operating in geographical regions where the government has a 
stronger presence in economics and also encourages environmental sustainability, 
companies tend to lobby with the respective governments to implement 
legislation that favours more environmentally sustainable products. The reason 
being that fierce competition is originating from distant countries such as India 
and China is mitigated because the companies operating in these distant countries 
are known to externalize their social and environmental costs to increase their 
profits (Stiglitz, 2007). Furthermore, substantial quantity of non-renewable fuels is 
expended eventually releasing waste/emissions when material goods are 
imported from distant geographical locations. 
The feedback obtained from these experts would be considered during the case 
studies, which are discussed in the subsequent sections of this Chapter. 
 
6.2.3. Calculation of Consistency Ratio 
This section illustrates the calculation of the consistency index as outlined in 
Section 5.4 of Chapter 5 and provides additional details on the numerical scores 
assigned by the experts from academia and industry. 
 
 
 
 179 
Table 6.1. – Pair-wise comparison by Expert 1 from Academia 
Criteria EOL-Mod Employ Income Housing Community Business Market Share Nth root Weight 
EOL-Mod 1 1/9(0.11) 1/3 (0.33) 1/7 (0.142) 1/3 (0.33) 1/8 (0.125) 1/8(0.125) 0.22 0.02 
Employ 9 1 7 1/3 (0.33) 7 3 3 2.78 0.31 
Income 3 1/7 (0.142) 1 7 7 4 4 2.3 0.25 
Housing 7 3 1/7(0.142) 1 4 1/7(0.142) 1/8(0.125) 0.8 0.09 
Community 3 1/7(0.142) 1/7(0.142) ¼(0.25) 1 5 5 0.87 0.09 
Business 8 1/3 (0.33) ¼ (0.125) 7 1/5 (0.2) 1 1 0.89 0.10 
Market Share 8 1/3 (0.33) ¼ (0.25) 8 1/5 (0.20) 1 1 1 0.11 
SUM 39 9.778 8.989 23.722 19.73 14.267 14.25 8.86 1 
SUMXWeight 0.78 3.03 2.24 2.13 1.77 1.4267 1.5675 12.94 (λ max)  
Consistency Index 12.94-7/6=0.99 
Consistency Ratio 0.99/1.32=0.75 
This expert from academia assigned lower ranking for end-of-life options and 
community welfare projects, while Employment; Income Distribution, Housing 
and Business Growth/Market Share have received higher ranking. Only when 
Business Growth/Market Share is compared with Community Welfare Programs 
is assigned with a lower ranking. Moreover, in the expert’s viewpoint end-of-life 
can be accommodated as a part of Business Growth/Market Share and hence less 
importance was assigned to this criterion. 
Table 6.2. – Pair-wise comparison by Expert 2 from Academia 
Criteria EOL-Mod Employ Income Housing Community Business Market Share Nth root Weight 
EOL-Mod 1 7 4 2 6 7 8 4.07 0.372 
Employ 1/7 (0.142) 1 8 9 6 4 5 2.76 0.252 
Income ¼(0.25) 1/8(0.125) 1 4 4 7 9 1.63 0.148 
Housing ½ (0.5) 1/9(0.11) ¼(0.25) 1 8 9 9 1.36 0.124 
Community 1/6(0.166) 1/6(0.166) ¼(0.25) 1/8(0.125) 1 6 8 0.63 0.057 
Business 1/7(0.142) ¼ (0.25) 1/7 (0.142) 1/9(0.11) 1/6(0.166) 1 1 0.26 0.023 
Market Share 1/8(0.125) 1/5(0.2) 1/9(0.11) 1/9(0.11) 1/8(0.125) 1 1 0.23 0.021 
SUM 2.325 8.851 13.752 16.345 25.291 35 41   
SUMXWeight 0.8649 2.230 2.035 2.026 1.441 0.805 0.861 10.262 (λ max)  
Consistency Index 10.262-7/6=0.543 
Consistency Ratio 0.543/1.32=0.41 
In contrast to Expert 1, this Expert has assigned a very high score for 
Modularity/End-of-life options, which is even higher than Employment owing to 
the perspective of the stated criterion would eventually contribute towards job 
growth. Similarly, EOL options/Modularity was higher ranked than Housing and 
Income Distribution. Meanwhile, similar to Expert 1 the Business Growth/Market 
Share was assigned a lower ranking compared to Community Welfare Programs 
even when this criterion received a lower ranking compared to other criteria. The 
reason is that these two experts argue in favour of the presence of social capital as 
a critical factor in economic growth. 
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Table 6.3. – Pair-wise comparison by Expert 3 from Academia 
Criteria EOL-Mod Employ Income Housing Community Business Market Share Nth root Weight 
EOL-Mod 1 1/7(0.142) 1/7(0.142) 8 8 1/7(0.142) 1/7(0.142) 0.59 0.062 
Employ 7 1 9 7 7 1 1 3.15 0.335 
Income 7 1/9(0.11) 1 8 6 1 1 1.67 0.178 
Housing 1/8(0.125) 1/7(0.142) 1/8(0.125) 1 1/7(0.142) 1 1 0.31 0.0330 
Community 1/8(0.125) 1/7(0.142) 1/6(0.166) 7 1 1/6(0.166) 1/6(0.166) 0.26 0.0277 
Business 7 1 1 1 6 1 1 1.7 0.1812 
Market Share 7 1 1 1 6 1 1 1.7 0.1812 
SUM 29.25 3.536 12.433 33 34.142 5.308 5.308   
SUMXWeight 1.81 1.18 2.21 1.089 0.945 0.9618 0.9618 9.1576  (λmax)  
Consistency Index 9.1576-7/6=0.3596 
Consistency Ratio 0.3596/1.32=0.272 
In this Expert’s viewpoint, end-of-life options are not as important as EOL is a 
component of Business Growth/Market Share which in itself is considered 
equivalent to Community Welfare Programs. Meanwhile, Employment and 
Income Distribution is given a higher ranking. In contrast, housing is given much 
lower ranking as the Expert argued that social capital, income distribution and 
economic growth would eventually lead to growth in housing. 
Table 6.4 – Pair-wise comparison by Expert 4 from Academia 
Criteria EOL-Mod Employ Income Housing Community Business Market Share Nth root Weight 
EOL-Mod 1 9 1/9 (0.11) 8 1 7 7 2.31 0.22 
Employ 1/9 (0.11) 1 1/6 (0.166) 6 1 6 6 1.2 0.117 
Income 9 6 1 7 1 7 6 3.98 0.388 
Housing 1/8 (0.125) 1/6 1/7 1 1 1 1 0.42 0.041 
Community 1 1 1 1 1 6 6 1.66 0.162 
Business 1/7(0.142) 1/6 (0.166) 1/7 (0.142) 1 1/6 (0.166) 1 1 0.33 0.0322 
Market Share 1/7 (0.142) 1/6 (0.166) 1/6 (0.166) 1 1/6 (0.166) 1 1 0.34 0.033 
SUM 11.519 17.498 2.726 25 5.332 29 28   
SUMXWeight 2.53 2.047 1.057 1.025 0.863 0.9338 0.924 16.901(λ max)  
Consistency Index 16.901-7/6=1.6503 
Consistency Ratio 1.6503/1.32=1.25 
This Expert from Academia also argues in favour of the role of social capital for a 
prosperous economy and hence has ranked Community Welfare Programs equal 
to other criteria and higher than Business Growth/Market Share. Similarly, 
Income Distribution has been given a higher degree of importance compared to 
End-of-life, as the former criterion generates the purchasing power of the 
consumers for sales of goods/services and the Expert considered EOL as a part of 
Business Growth/Market Share. Meanwhile, Business Growth/Market Share have 
consistently been given lower rankings.  
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Table 6.5. – Pair-wise comparison by Expert 5 from Industry 
Criteria EOL-Mod Employ Income Housing Community Business Market Share Nth root Weight 
EOL-Mod 1 1/5 1 1/5 1 1/5 1/5 0.398 0.042 
Employ 5 1 5 1 5 1 1 1.99 0.212 
Income 1 1/5 1 1/5 1 1/5 1/5 0.398 0.042 
Housing 5 1 5 1 5 1/5 1/5 1.2 0.127 
Community 1 1/5 1 1/5 1 1/5 1/5 0.398 0.042 
Business 5 1 5 5 5 1 1 2.5 0.266 
Market Share 5 1 5 5 5 1 1 2.5 0.266 
SUM 23 4.6 23 12.6 23 3.8 3.8   
SUMXWeight 0.966 0.9752 0.966 1.6 0.966 1.01 1.01 7.4932(λ max)  
Consistency Index 7.4932-7/6=0.0822 
Consistency Ratio 0.822/1.32=0.06 
Compared to Experts 1 to 4, the responses from this Expert from Industry were 
found to be consistent with the Consistency Ratio being lower than 0.10 
From an Industry related Expert’s standpoint End-of-life, Income Distribution and 
Community Welfare Programs are ranked lower compared to other criteria such 
as Business Growth/Market Share. The reason is that the aforementioned three 
criteria in the Expert’s opinion are strongly related to the growth objectives of the 
Enterprise. 
 
Table 6.6. – Pair-wise comparison by Expert 6 from Industry 
Criteria EOL-Mod Employ Income Housing Community Business Market Share Nth root Weight 
EOL-Mod 1 1/6(0.166) 6 1/7(0.142) 6 1/8(0.125) 1/8 (0.125) 0.5 0.05 
Employ 6 1 7 1 7 1 1 2.2 0.22 
Income 1/6(0.166) 1/7(0.142) 1 1/7(0.142) 7 1/6(0.166) 1/6(0.166) 0.34 0.034 
Housing 7 1 7 1 7 1 1 2.3 0.23 
Community 1/6(0.166) 1/7(0.142) 1/7(0.142) 1/7(0.142) 1 1/7(0.142) 1/7(0.142) 0.18 0.018 
Business 8 1 6 1 7 1 1 2.2 0.22 
Market Share 8 1 6 1 7 1 1 2.2 0.22 
SUM 30.332 4.45 33.142 4.426 42 4.433 4.433   
SUMXWeight 1.5166 0.979 1.12 1.01798 0.756 0.9752 0.9752 7.338(λ max)  
Consistency Index 7.338-7/6=0.056 
Consistency Ratio 0.056/1.32=0.042 
In the viewpoint of this Industry related Expert who has ranked Employment and 
Business Growth/Market Share higher compared to End-of-life, Income 
Distribution and Community Welfare. As in this Expert’s opinion, End-of-life can 
be categorized as a part of growth strategy and not necessarily result in high 
employment and increase in employment generates more tax revenue and better 
purchasing power of the consumer for a prosperous economy.  
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Table 6.7 – Pair-wise comparison by Expert 7 from Academia 
Criteria EOL-Mod Employ Income Housing Community Business Market Share Nth root Weight 
EOL-Mod 1 5 1/3(0.33) 3 3 7 7 2.5 0.247 
Employ 1/5(0.2) 1 1 7 5 7 7 2.3 0.227 
Income 3 1 1 7 5 7 7 3.38 0.333 
Housing 1/3(0.33) 1/7(0.142) 1/7(0.142) 1 1 3 5 0.71 0.07 
Community 1/3(0.33) 1/5(0.2) 1/5(0.2) 1 1 1 1/5(0.2) 0.42 0.04 
Business 1/7(0.142) 1/7(0.142) 1/7(0.142) 1/3(0.33) 1 1 1/3(0.33) 0.31 0.03 
Market Share 1/7(0.142) 1/7(0.142) 1/7(0.142) 1/5(0.2) 5 3 1 0.5 0.05 
SUM 5.144 7.626 2.956 19.53 21 29 27.53   
SUMXWeight 1.2705 1.731 0.9843 1.3671 0.84 0.87 1.3765 8.4394(λmax)  
Consistency Index 8.4394-7/6=0.2399 
Consistency Ratio 0.2399/1.32=0.18 
Similar to this Expert’s other Academic Experts has assigned End-of-life, 
Employment and Income Distribution with a higher priority in contrast to 
Business Growth/Market Share and Community Welfare Programs. The 
justification is also rooted in the role of social capital and safer environment, 
which would lead to a better community and prosperous commerce. 
 
6.2.4 Concluding Points for Pair-wise Comparison 
For a Medical Device Enterprise, the role of regulatory agencies, the economic 
policies of the geographical region, the business growth objectives of the 
Enterprise and the configuration of the device are crucial for the success/failure of 
the development endeavour. The device configuration on the basis of the 
resources would govern the inclusion of end-of-life options/modularity, 
profitability and opportunities to increase employment. As outlined during the 
pair-wise comparisons, Experts from Academia have reinforced their viewpoint 
on the crucial role of social capital in the propagation of a prosperous economy 
(Wapshott, 2011). For instance, better income distribution via improved wages for 
employees of an Enterprise and more opportunities of employment to be created 
by the Enterprise leads to sales of goods/services (Fishman, 2012). Meanwhile, the 
Experts from Industry stated that Business Growth/Market Share would 
eventually bring about better income distribution and employment opportunities 
for the benefit of the overall social welfare of the stakeholders; nevertheless they 
did not deny the role of a social capital necessary for the propagation of commerce 
but rather were in support of corporate related growth to materialize the socially 
relevant objectives. 
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6.3. Evaluating the role of Multicriteria Hierarchical Model (MCHM) 
in Design Optimization 
6.3.1. Introduction and Recapitulation 
The results discussed in this section are pertaining to the evaluation of the 
proposed Multifaceted Framework as discussed in Chapter 4, which involves the 
active role of the Multicriteria Hierarchical Model in design optimization with 
reference to a multitude of technical and non-technical tools. 
The methodology defined in Chapter 5 utilizes the approach of ‘informal 
conversational interview’ and a structured questionnaire, in contrast to an active 
application of the multifaceted model in an industrial setting. The justification lies 
in the limitation of time for the implementation in order to validate the 
Multifaceted Framework at an industrial scale. On the other hand, the availability 
of academia and industry experts, who due to their in-depth experience can 
provide substantial insight on the conceptual validity of the multifaceted 
framework. Furthermore, as discussed in detail in this section, the effectiveness is 
subjective to specific design engineering scenarios and the product configuration, 
which is further based on the enterprises’ obligations and ambitions.  
The experts selected and contacted for the evaluation of the Multifaceted 
Framework were not the same as the experts for the pair-wise comparison. 
Accordingly to Chapter 3, each criterion within the three tiers is comprised of one 
or more specifications with their “minimum acceptable and maximum achievable 
values”. For example, the regulatory requirements for a pacemaker have to be 
functional for a minimum period of 2 years (minimum acceptable). Moreover, the 
medical device company’s knowledge in engineering and materials sciences 
reveals that for a given set of materials and engineering design architectures, the 
pacemaker design can survive from 2 years to up to 5 years. However, the 
reliability engineering required for a 5-year operation life span would be more 
expensive and only a small segment of the market may opt for such a robust 
design (maximum achievable). 
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As a result, the product engineers and managers aim for obtaining the most 
optimal values of these specifications to at least attain a bare minimum magnitude 
of sustainability, in terms of environmental safety, obligatory stakeholder 
considerations and desired level of profits. 
Inspired from previous research endeavours; wherein AHP has been utilized for 
design optimization of a product design and even programmed via object oriented 
C# language to select suitable candidates for product development or 
remanufacturing (Ghazalli & Atsuo, 2009; Singh, 2006; Wang et al., 2010). This 
thesis also studies the opportunity to incorporate the decision modelling approach 
of the Multi-criteria Hierarchical Model (MCHM) within design optimization 
activity that not only encompasses product specifications but also addresses 
stakeholders’ considerations such as increase in employment (Tier 2) and 
Community Welfare (Tier 3) in terms of the profitability. The Figure 3.6 elucidates 
the role of product design with the utilization of resources (as mentioned din 
section 3.3 of Chapter 3) to gain profitability that can be further invested in 
building the company and the social capital for the stakeholders. The details are 
discussed in Chapter 3 with substantial focus on prior research endeavours and 
the novelty explored in this thesis. 
The design optimization would actively involve a previously stored (and 
continuously updated) knowledge curve, close coordination of interconnected 
technical (e.g. Finite Element)/non-technical (e.g.: QFD <http://www.qfdi.org>) 
tools with the aforementioned problem solving techniques for resolving conflicts 
(TRIZ/Design by Analogy). The knowledge curve in this thesis is focused mainly 
towards knowledge based engineering tools and expert systems (Corallo et al., 
2009; Price et al., 2010). Consequently, the proposed approach is substantially 
pragmatic in nature as it encompasses social criteria and aligns with the Total 
Product Life Cycle Development strategy recommended by the FDA. 
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6.3.2. Informal conversational Interviews with a structured Questionnaire 
i) The role of experts and the structure of the Questionnaire 
The experts were interviewed by the ‘informal conversational interview’ approach 
during the filling up of the questionnaire. The responses were collected by email 
and re-confirmed by a phone interview. Moreover, the responses from these 
experts have been coherently articulated with their specific contexts to determine 
the circumstances in which the proposed multifaceted model for design 
optimization using the MCHM approach would function effectively or encounter 
additional undesired impediments. 
The objective of this research methodology is to validate the ability of the MCHM 
to actively participate in product design that is a key phase of product 
development (Trotta, 2010). 
Some of the experts did express the inability of the questionnaire approach to 
precisely define the diverse circumstances and contexts in which a decision model 
can play the role of an effective design optimizer in complex engineering design 
solutions. Therefore, the coupling of interviews and questionnaires was 
considered to be a suitable approach to alleviate the disadvantages of the two 
techniques; wherein the questionnaire counters the less structured nature of the 
informal interviews and the interviews are able to capture the insight and tacit 
knowledge of the experts pertaining to design optimization activities at a 
industrial scale with reference to its technical as well as economic feasibility. 
Furthermore, only 6 experts chose to answer the questionnaire and provide their 
feedback via interviews. In this case study, Expert 1 and 2 are from the same 
University (just like 5 and 6) and their responses were jointly approved for the 
questionnaire. Meanwhile other experts chose to discuss the multifaceted 
framework by reviewing the questions and accordingly, preferred to disseminate 
their insights throughout the interview process instead of filling up the 
questionnaire. 
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The questionnaire is outlined as follows: 
QUESTION 1: In your experience can an Expert System incorporate a decision 
making model such an analytical hierarchy process that is a category of 
multicriteria decision-making? 
YES or NO 
If YES then how effective (increase in performance) would it be? 
LOW [or] MEDIUM [or] HIGH 
 
QUESTION 2: As each domain of expertise namely Design, Training, Operations 
Management and Logistics, Supply Chain and others would have their own 
corresponding Expert Systems. Therefore, is it possible to connect all these Expert 
Systems and by using a codified decision making model such as AHP effectively 
and moreover efficiently execute the Multidisciplinary Design Optimization 
Process? 
LOW [or] MEDIUM [or] HIGH 
 
QUESTION 3: How effective is an Expert System in Product Design in 
coordination with CAD/CAM/CAE tools? 
LOW [or] MEDIUM [or] HIGH 
 
QUESTION 4: How effective is an Expert System as an Optimizer for 
Multidisciplinary Design Optimization (MDO)? 
LOW [or] MEDIUM [or] HIGH 
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QUESTION 5: Let us imagine that for the MDO of a cell phone that involves the 
corresponding learning curves or knowledge systems for Product Design for 
structural integrity of plastics, plastics processing, product design for structural 
integrity of metals and metals processing and so on so forth. 
So is it possible for multiple Expert Systems and Knowledge Systems to act as an 
Optimizer for the Multidisciplinary Design optimization task? 
YES [or] NO 
If YES then how effective it would be? 
LOW [or] MEDIUM [or] HIGH 
 
QUESTION 6: How feasible it is to have an infrastructure with Expert Systems for 
acting as an Optimizer for the MDO process, coupled with other 
CAD/CAM/CAE tools and conducting environmental life cycle analysis using the 
SimaPro software (Pre Consultants BV <www.pre-sustainability.com>) and 
simultaneously conducting Manufacturing Process Management in order to 
confirm whether the product design is compatible with the manufacturer’s 
production process? 
LOW [or] MEDIUM [or] HIGH 
 
QUESTION 7: Based on Question 6 would the inclusion of a High Performance 
Computing Systems (or better known as a Supercomputer) reduce the processing 
load of one or multiple Expert Systems? 
YES [or] NO 
If YES then how effective it would be? 
LOW [or] MEDIUM [or] HIGH 
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QUESTION 8: Scale of funding that is needed for Question 6 and 7? 
LOW a few hundred thousands USD$ [or] Medium 1-2 million USD$ [or] 
High 3 million USD$ and above  
 
QUESTION 9: Can Expert Systems be effectively combined with TRIZ (use neural 
networks for obtaining the right set of patents and research cases), Case based 
reasoning and Design by Analogy to govern Product Design? 
LOW [or] MEDIUM [or] HIGH 
 
QUESTION 10: In the above 2 situations how well does XML fare to satisfy needs 
of interconnectivity and interoperability? 
LOW [or] MEDIUM [or] HIGH 
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The results of the questionnaire are summarized in Table 6.8. 
Table 6.8. – Expert feedback for Multicriteria Hierarchical Model (MCHM) in 
Design Optimization 
Question no. Summary of the Question Expert 1 and 2 Expert 3 Expert 4 Expert 5 and 6 
1 
Expert System and Decision 
Modelling 
Yes, High Yes, Medium Yes, Medium Yes, Low 
2 
Expert Systems with 
MCHM and Design 
Optimization 
Medium Medium High Medium 
3 
Expert Systems and 
Computational Tools 
High Medium High Low 
4 
Expert System in Design 
Optimization 
High Medium High Low 
5 
Multiple expert systems 
and knowledge systems in 
design optimization 
Yes, High Yes, Medium Yes, High Yes, Medium 
6 
Expert systems and a wide 
range of technical tools 
High Medium High Medium 
7 
Expert systems with 
supercomputers for design 
optimization 
Yes, Medium Yes, Medium Yes, Medium Low 
8 
Scale of funding for Q6 and 
Q7 
High High Low High 
9 
Expert systems and 
10problem solving 
techniques 
High Medium Medium Medium 
10 
XML for interconnectivity 
and interoperability 
Medium Medium Medium Low 
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ii) Detailed responses by Experts 5 and 6 for each of the questions defined in the 
Questionnaire 
Two of the respondents (who are Expert 5 and 6) as they belong to the same 
institution, which were interviewed chose to provide additional feedback for each 
of the 10 aforementioned questions, instead of only responding to the 
questionnaire. 
For Question 1 they stated that Expert Systems are computer-based systems to 
emulate the decision-making ability of a human expert, while MCHM (a modified 
version of AHP) is a decision-modelling tool. Although, both possess some 
commonality on the frontier of decision-making, but are not necessarily the same. 
This implies that decision-making tools such as AHP always require inputs 
provided by experts. Therefore, they suggested utilizing the expert system to 
match the inputs provided by the experts during pair-wise comparisons. This 
approach can enable the MCHM to select the most suitable projects for further 
development (as mentioned in Figure 3.4 of Chapter 3). 
Moreover, the effectiveness of a MCHM programmed within an Expert System 
does not necessarily prove to be the most accurate in nature. The Expert systems 
that match human decision-making are based on diverse preferences and personal 
differences of experts. Moreover, it is extremely difficult to predict human 
behaviour in various different circumstances under different contexts. Similarly, 
tools such as AHP and MCHM are subjective in nature and possess their own 
degree of effectiveness for certain situations. 
For Question 2 and 3, they stated that the method in which these diverse tools and 
connected to each other by acknowledging their incompatibilities in terms of data 
formats and programming structures would define the effectiveness with respect 
to the volume of design activity and the available human/financial resources 
(Gaha et al., 2011). 
In Question 4, for the use of an Expert System as an optimizer in multidisciplinary 
design optimization (MDO), they mentioned that in principle an expert system 
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was never designed to be an optimizer in the first place and it is used in the 
decision making process that governs the actual MDO process. Although, Expert 
Systems can be combined with Genetic Algorithms (GA) and Particle Swarm 
Optimization (PSO) for interactive optimization, but this would occur without the 
benefits of an interactive algorithm, as it would not be interactive anymore 
(Yahya, 2003). 
With reference to Question 5, they approved the use of knowledge systems that 
are quite different from the fundamental framework of the Expert System. The 
knowledge systems have to be integrated for being considered as an optimizer 
and one cannot consider only parametric optimization, as these systems are 
required to modify the design that undergoes optimization.  
Meanwhile, for Question 6, they stated that as the softwares for CAD, CAM and 
CAE are usually proprietary in nature and hence unless there are features to 
effectively connect or integrate these tools, it would pose a substantial challenge 
that could be mitigated by a Total Product Life Cycle Management System (Lee, 
2005). Moreover, even for Question 7, they stated that maximum time loss occurs 
at the interface of these tools and unless they are resolved the inclusion of a 
supercomputer (or high performance computing) would not bring about any 
efficiency. Similarly, for Question 8 the costs would mainly depend on the number 
of proprietary softwares being used and the ‘developers licenses’ issued by the 
vendors of these software’s and the extent of programming done by a project team 
who decides to implement the multifaceted framework would provide a more 
deeper insight on the cost structure. 
For Question 9 they stated that case based reasoning and expert systems can be 
effectively combined for gaining an insight to make suitable decisions for the 
product design and architecture. A few researchers in the domain of TRIZ have 
devised a software application provide suitable combination of inventive 
solutions by virtue of the law of technical systems evolution and conflict 
resolution approaches (Russo et al., 2011). 
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For Question 10 in terms of interconnectivity and interoperability of XML, both 
the sender and receiver of information during design activity should probably use 
the same language and similarly, a file made in XML format would have to be 
transformed into a type of XML format which can be used in CAD tools (which is 
known as model exchange or co-simulation). They also recommended the use of 
Functional Mockup Interface for the stated recommendation <https://www.fmi-
standard.org/>. 
If a parametric optimization approach is desired then the optimization strategy 
should be incorporated within the AHP or MCHM Model in itself, provided the 
product design model remains the same throughout any iteration of the 
optimization process (Wang et al., 2010). As a result, for any iteration the designer 
would encounter a new Pareto optimal frontier with respect the resources stated 
in Section 3.3 of Chapter 3. On the other hand, Engineers can opt for a discrete 
optimization approach or machine learning or even artificial evolution (in terms of 
genetic programming and artificial neural networks). 
iii) Feedback from other experts who chose to provide their feedback through the 
‘informal conversational interview’ approach instead of responding to the 
Questionnaire 
The proposed Multifaceted Framework and the included Multi Criteria 
Hierarchical Model have been subjected to both expert review and opinion from 
experts in both academia as well as Industry. The experts from Industry concurred 
with the authors for a ranking based elimination of the design candidates 
pertaining to the criteria in Tier 1 as outlined in Figure 4.2 in Chapter 4 (Hambali 
et al., 2009). 
The Multifaceted Framework was evaluated by a total of ten Experts from both 
academia and industry combined who responded to the questionnaire and those 
who only chose to provide their feedback instead of responding to the 
questionnaire. To relieve the exhaustive level of complexity of the Multifaceted 
Framework, the experts from industry preferred the Engineering and Technology 
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Development Teams to direct the Product Design and Optimization under the 
supervision of the Project Management Team and Senior Management. The 
experts from the industry also highlighted that notwithstanding the anticipated 
budget of more than USD$ 3 million for implementing the Multifaceted 
Framework. The success is solely dependent upon the ease of integration with the 
Global Harmonization Task Force (GHTF) Requirements, Quality Management 
System (QMS) ISO 13485 and the Environmental Management System (ISO 14000) 
of the Medical Device Company <http://www.imdrf.org/>. 
An interview with industry representatives in the domain of Product Life Cycle 
Management stated that the Total Product Life Cycle Management System is 
known to effectively communicate with the Quality Management System and 
similarly, interoperate with the Knowledge based Engineering Tools after 
integration (Bermell-Garcia & Fan, 2008). Therefore, any potential discrepancies 
would probably stem from the incompatibilities between the engineering tools. 
The experts who discussed the questionnaire have also confirmed this facet.  
The experts from academia deemed the MCHM conjugated with Expert System to 
be an effective Optimizer. Nonetheless, the XML interconnectivity may not 
necessarily be able to support an exceedingly exhaustive design optimization 
endeavour, especially when more than one Expert System would be involved. 
This implies that the magnitude of design optimization required pertaining to the 
product configuration has to be appropriately finalized. Furthermore, the 
inclusion of Neural Networks for mining of prior art is considered to be capital 
intensive in nature and requires expert involvement for training for at least up to 6 
months. Therefore, the proposed Multifaceted Framework is suitable for medical 
device companies with a substantially large R&D budgets substantiated by robust 
learning curves and advanced expertise in engineering and project management. 
Moreover, the same academic experts stated that in scenarios of contemporary 
advanced engineering environments demand the inclusion of diversified domains 
of knowledge in technical and non-technical fields (including socio-economics, 
politics, and psychology. Thus, the nature of knowledge (especially non-technical) 
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and the intellectual process or activity undergoing codification in a Expert System 
would pose a major impediment for the Expert System to act as a successful 
Optimizer or even conduct decision modelling (Cowan, 2001). 
The recommendation of the academic experts, who evaluated the Multifaceted 
Framework, stated that Expert Systems are beneficial to the design and decision 
modelling process. Nevertheless not without limitations, as the in cases of an 
exhaustive design engineering environment encountered in aerospace 
engineering, which may not be a commonly occurring situation in medical device 
development. 
6.3.3. The Pragmatic and Creative facets of the proposed Multifaceted Model 
The technical tools (such as CAD/CAE/TPLCM) mentioned in the Multifaceted 
Framework are well established in the Engineering Industry and its effectiveness 
is subjected to the volume of design optimization tasks and the complexity of the 
design. This is one of the reasons, why an Expert Opinion Approach using 
interviews and questionnaires was considered in this thesis to evaluate the 
proposed Conceptual Multifaceted Framework. The Experts owing to their in-
depth experience pertaining to the feasibility and effectiveness of similar 
multifaceted frameworks are capable of providing valuable insight on the 
probability of success or failure, if an Industrial entity intends to implement a part 
or the whole of the proposed multifaceted frameworks. 
Accordingly, for design optimization of more simplified medical device designs, 
the product development teams can incorporate existing computational design 
engineering tools, such as CATIA and ANSYS (Nandwana et al., 2010). Similarly, 
these design-engineering tools can be combined with decision modelling 
frameworks (such as AHP) for analysing and modifying product designs 
(Hambali et al., 2009). For example, Akarte et al. (1999) proposed a AHP and 
Fuzzy Logic approach for selecting a casting process which was also connected to 
a Computational Design and Engineering System for aiding the Engineers in 
evaluating product process compatibility and conducting design improvements, 
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simultaneously. Likewise, product development teams with smaller R&D budgets 
can consider the decision rules of the MCHM Model and incorporate them in their 
existing Decision Modelling Software with some customized modification, as 
discussed in Ghazalli & Atsuo (2009). 
The most important facet stated by an expert in the area of new product 
development revealed that usually companies, who are either into development of 
Class 1 or Class 3 medical devices, usually do not engage in developing medical 
devices outside their specialty, especially if they are small medium sized 
enterprises. The justification lies in the pragmatic viewpoint that the technologies 
are entirely unique and specialized for devices that range from stents, syringes 
and pacemakers. On the hand other, large sized medical device companies possess 
substantial financial and non-financial resources, in terms of access of knowledge 
and material resources to reduce the time for attaining the learning curves 
necessary for economies of scale. The same expert revealed that owing to the 
financial crises, more medical device companies are focusing towards their 
economic growth and much less on environmental sustainability. 
The goal of the multifaceted framework is to evaluate the effectiveness of the 
MCHM and its ability to go beyond conventional decision modelling into design 
optimization at a comprehensive scale. Ultimately, it is concluded that the MCHM 
is most effective as a conventional decision-modelling tool for selecting suitable 
projects and even solving conflicts within product design as opposed to playing a 
critical role in design optimization. 
6.4. Analysis and Discussion of the Case Studies 
In this section containing case studies a wide range of technologies ranging from 
polymers, biodegradable and long term implants and Systems that comes in 
contact with body fluids/tissues. As the sector of medical devices are undergoing 
a continuous evolutionary pathway owing to the rapid growth in other sectors of 
science and technology. Concurrently, in this section each case study would assign 
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the term “Entity” for either an Enterprise(s) or a Person(s) with whom the case 
study was conducted. 
6.4.1. Case Study 1 
a) Brief Description of the activities 
Entity 1 provides consulting services in the area of novel innovations for enabling 
companies to identify grant opportunities and obtain funding for their projects. 
The services provided by them mainly include the preparation of grant 
applications, forming consortia with a project management framework and 
writing reports to public institutions in the areas of research and innovation 
policy.  
In addition, Entity 1 is based in Western Europe at a public funded University 
specializes in product development services ranging from concept development to 
engineering design analyses to clinical trials and regulatory documentation/ 
approvals. Concurrently, Entity 1 provides services in strategy consulting for its 
clients to attract more investment for their new medical device ideas by virtue of 
their strong network of suppliers and associates which are positioned as the key 
decisive factors for their continuing success. Some of their products are surgery 
via low frequency electromagnetism and intraocular implants. 
b) Reasons for selecting Entity 1 
Entity 1 was defining a concept of a Class 1 Medical Device that enables easier 
storage and dispensing of medication for elderly patients.  
c) Activities conducted during the case study 
An informal conversational interview by telephone and email was carried out 
with the proprietor of Entity 1. The conceptual validity of the multi criteria 
hierarchical model (Figure 3.2 of Chapter 3) formed the core subject of the 
discussion with respect to Class I to Class III medical devices as outlined in 
Chapter 2. 
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On the other hand, active participation during the conceptual development of the 
Class I Medical Device had occurred at the premises of Entity 1 for a period of 
around 30 days. Concurrently, the consortium of project partners was undergoing 
finalization. The delay was due to the less responsive approach by one of the key 
project partners. As this particular project partner comprised of only 4 individuals 
and was addressing a multitude of other project commitments simultaneously, 
leading to a lower degree of efficiency. 
The 1st month period was utilized for identifying suitable components for the 
Class 1 Device and validating the incorporation of certain product characteristics, 
such as additional cost benefits and modularity that would enable easy assembly 
and remanufacturing. 
d) Outcomes of the case study 
Entity 1 concurred with the fundamental structure of the MCHM (Figure 3.2 from 
Chapter 3) to be categorized into primarily two major criteria of Regulatory 
Compliance and Business Performance with the inclusion of the most crucial 
criteria into Tier 1. Likewise, incorporating the Modularity and End-Of-Life 
criteria in 2nd Tier for resolving any irreconcilable conflicts between multiple 
criteria. 
During the product conceptualization of the Medical Device activity at Entity 1 an 
attempt was made to eliminate barriers that could substantially delay the project 
and pose impediments for production as well as prototyping/testing. 
Following are the challenges encountered in terms of fabricating the components 
for the Class I Medical Device for easier storage and dispensing of medication for 
elderly patients:  
•The project partners intended to develop a medical device that was smaller than 
the existing large sized tabletop products available in the market. Moreover, for a 
smaller sized device to occupy lesser space on the table of the patients’ room or 
ward, the mechanical components are required to be smaller in dimension. 
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However, there were only a few manufacturers in the neighbouring geographical 
location that could produce the desired components. This posed a significant 
impediment in terms of supply chain activities and its pertinent uncertainties to 
transport the final product to the desired destination. 
•In terms of the design and fabrication of sub-millimetre (10-3 meters) and micron 
(10-6 meters) sized devices that act as sub-systems and components for larger 
systems in a relatively modular device architecture. The core challenge was to 
attain substantial reliability with economies of scale for cost effectiveness in a 
complex manufacturing set-up. 
•The magnitude of high-speed precision control and degrees of freedom for 
movement are usually governed by tolerances and close contact by virtue of 
surface-to-surface interaction (and abrasion of parts). Thus, potentially leading to 
thermal instability that would further result in diminished reliability or even 
failure before the anticipated time period. The other impeding forces are namely 
electrostatic forces, surface tension, bonding and adhesive forces that are 
augmented by humidity and intermolecular Van der Waals forces that apparently 
become dominant at the micro scale (Hsu, 2005). 
•Inclusion of multiple systems and sub-systems in a confined space, within the 
device architecture, to promote ease in manufacturing, assembly, 
repair/maintenance and fuel savings in transportation. 
•The tools considered for process modelling and simulation for design, fabrication 
and assembly of miniaturized sub-systems have to address the scaling laws and in 
certain cases acknowledge the dimensions, methodology and robustness of the 
fastening materials. Likewise, would be the considerations of the material 
properties that would exhibit different behaviour (mechanical, 
metallurgical/chemical) from its macro-scale counterpart and hence would 
require revised versions of the design and simulation tools. 
•A validated testing Protocol needs to be more comprehensive while designing 
and developing the sub-systems and their components. The axioms for validation 
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would include but are not limited to thermal shock, vibration, humidity and 
electromagnetic susceptibility. 
The two figures below illustrate the striking similarities between Figure 3.2 and 
3.6 of Chapter 3, which was modified to create Figure 6.2, as it specifically 
addresses the needs of the medical device under development. 
Figure 6.2 is the proposed layout of the medical device under development to 
Entity 1 towards the end of the case study. The mentioned components were 
identified by literature survey. 
 
Figure 6.2. – The Strategy of Product Development 
Meanwhile, Figure 6.3 is the proposed layout of the internal configuration of the 
medical device under development for Entity 1. 
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Figure 6.3. – The Internal Conceptual Layout of the Class 1 Medical Device for 
storage and dispensing of medication for elderly patients. 
 
e) Concluding Points 
The hierarchical arrangement of the aforementioned criteria in the MCHM (Figure 
3.2 of Chapter 3) is validated during the case study by virtue of feedback from 
Entity 1 and the project partners for the medical device under development. This 
implies that the hierarchical arrangement is applicable to medical device 
development activities across more than one Entity. 
The Western European Nations from where the Entity 1 and its project partners 
originate provides substantial support in terms of healthcare, which eventually 
acts as an incentive to drive down costs and look towards innovative technologies 
for providing a higher degree of cost effectiveness. In terms of addressing the first 
two research propositions mentioned in Section 5.3 of Chapter 5 within this case 
study, one of the project partners was a start-up firm comprised of members with 
not more than 5 years of experience after their respective undergraduate degrees. 
This is one of the reasons for this particular partner to require more time in 
finalizing the most suitable components with the lowest ecological impact and 
incorporating not more than a 30% opportunity for remanufacturing.  
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Furthermore, for the third research proposition, the Entity 1 was located at a 
publicly funded University. Consequently, the element of state sponsored research 
and development provides substantial alleviation of the cost intensive nature of 
developing engineering knowledge which can be further leveraged into new 
innovations and businesses that contribute towards society at large (Brodwin, 
2012). It is essential to remind that a considerable degree of autonomy is also a 
critical factor to promote innovation without stifling creativity. Hence, the 
University has implemented suitable project control mechanisms to enable a 
reasonable government oversight for promoting research and development with a 
required level of accountability. 
6.4.2. Case study 2 
a) Brief Description of the activities 
Entity 2 is a company that provides water purification solutions and is located at 
Western Europe. The founder and his members have around 20 years of 
experience in the Industrial sector of haemodialysis equipment.  
The entity 2 develops, designs, manufactures and installs customer specific 
haemodialysis equipment at the clients’ premises. Moreover, since the past 10 
years Entity 2 has also been developing technical panels, which are required for is 
connected to the haemodialysis machines. Since then almost every year the 
company launches new products. 
Entity 2 markets its products in the Western European region and in certain 
countries in Africa, including Angola, Morocco and Mozambique. Entity 2 
participates in the annual conference of European Congress of Nephrology to 
interact with potential and existing competitors and end-users namely doctors, 
technicians and nurses. 
b) Reasons for selecting Entity 2 
Entity 2 develops and manufactures haemodialysis equipment and filters which 
are categorized under Class III Medical Devices because the instruments come in 
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direct contact with internal body fluids. Class III medical devices are critical for 
the sustenance of the life of the person to whom it is prescribed.  
c) Activities conducted during the case study 
Close observation of the product development process and the effectiveness of the 
three tiers of the multi-criteria hierarchical model were ascertained. 
Firstly, the product development process at Entity 2 begins when a prospective 
customer initiates a request after which the management creates a cross functional 
team of employees from engineering, finance, marketing and competition 
analyses, regulatory and legislation compliance, testing/quality assurance and 
supply chain to define the product conceptualization and its components. 
Secondly, entity 2 considered the involvement of suppliers at early stages to 
determine the deliverables and the delivery time to their client(s). For example, 
one particular client desired a technical panel made from Reinforced Plastic 
Fiberglass (RPFG) that was fireproof and ecologically safe. Unfortunately, few 
suppliers could provide this at a lower at the price acceptable to Entity 2 and their 
clients, as there was no substantial market demand for such materials. As a result, 
a different material with an acceptable cost and relatively higher ecological impact 
compared to RFPG was chosen. This situation proves the validity of the criteria 
mentioned in Tier 1, wherein the ability of the supply chain to provide the 
Enterprise with the materials desired by the market (or client specifically) is 
equally necessary for addressing the client’s needs. The business collaboration was 
able to continue because the Entity 2 was able to reconcile this conflict by 
identifying a suitable material by a supplier for a desired price of the customer. 
Thirdly, once the raw materials were finalized, a conceptual design with the cost 
structure (and selling price) was calculated in consultation with the marketing and 
sales department.  Once the customer approved the preliminary plan, the 
prototyping activity was conducted in consultation with the client while 
simultaneously preparing operation manuals and technical drawings. 
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Fourthly, after development and fabrication (including testing and quality 
assurance) of the equipment’s, Entity 2 sent the technical equipment’s as ordered 
by the clients to their premises with the technical team of Entity 2. The goal was to 
reduce distribution costs and address the clients’ requirements “on the spot” 
without involving any delays which would have occurred in the case of a third 
party distributor or maintenance team. This unique approach of personalized 
product development and installation has been the core factor in the high 
customer satisfaction and growth in business of Entity 2.  
As mentioned in Tier 1 of MCHM in Figure 3.2 in Chapter 3, Entity 2 has adopted 
a much higher percentage of cost effectiveness and simultaneously adhering to 
regulatory, legislation and customer requirements (in addition to other criteria in 
Tier 1). Accordingly, Entity 2 was able to grow their business as mentioned in Tier 
3 only by simultaneously adhering to Tier 1, which also includes making 
substantial profits without overcharging their clients. 
Furthermore, the percentage of cost effectiveness as mentioned in Tier 3 was 
incorporated by Entity 2 in most of their products as they are able to address the 
markets’ needs pertaining to low energy and water consumption. However, not 
much importance is given to recycling, reusing and remanufacturing.  Entity 2 
focused mainly on four factors namely, materials, energy, maintenance/repair and 
toxicity for conceptualizing their products and evaluating their life cycles, while 
concurrently adhering to legislation and regulatory compliance. 
Meanwhile, the eco-friendly nature of the products developed by Entity 2 were 
not necessarily desired by their customers (as the costs could be higher), unless 
legislation demands it. Nevertheless, the trend towards more eco-friendly 
materials and products is slowly taking shape in the markets of their interest. 
Also, during the discussion, the representatives of Entity 2 provided a list of 
factors that pose as an impediment towards incorporation of environmental 
sustainability: 
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i) The technical tools for evaluating environmental impact with in-depth analyses 
and incorporating environmental considerations by way of eco-design tools 
within the product design requires specialized expertise which is not easily 
accessible and can prove expensive if sought from external 3rd party consultancies.  
ii) The training and implementation consumes time and in some cases disrupts the 
structure of the cross functional teams which are defined for each different 
projects. As a result, there can be multiple errors during implementation, selection 
and use of the tools. Moreover, the design tools were identified to be quite specific 
in nature and there was not any substantial clarity on the circumstances in which 
the tools could be more effective. Accordingly, the cost-to-benefit ratio towards 
the utilization of these tools was completely unclear. 
This implies that the incorporation of any new tools for attaining a higher degree 
of sustainability is required to comply with the Tier 1 criteria of collaborative 
strength of the teams, the knowledge curve and the competitive time to market in 
terms of delays caused by any known/unknown factors that gives competitors a 
better head start. 
These impediments are critical in nature because they tend to violate some of the 
most crucial criteria in Tier 1 of the MCHM, namely Collaborative Strength of the 
Team, bare minimum profitability and competitive shorter time to market.  
Moreover, the product development experiences of Entity 2 have the following 
direct and inverse relations pertaining to various factors, which can be co-related 
to the hierarchical structure stated in the MCHM in Figure 3.2 in Chapter 3: 
i) The clients determine the products’ quality by the functioning role of the 
components of the products developed by Entity 2 and specifically focus on the 
ease of use as an important selection criterion. 
ii) Clients prefer longer life spans with lower maintenance cycles coupled with 
minimal reduction in optimum performance. This includes lower consumption of 
energy and water. Moreover, the clients’ negatively view the possibilities of 
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incorporating too many changes in the future that can occur in the name of 
innovation. However, they prefer to select dialysis products that are indeed 
innovative during their selection process. One major dilemma that Entity 2 
observed is that due to the rapid growth in engineering and technology. This 
would enable stronger companies to innovate faster to address the markets’ 
desires and occupy the market share of Entity 2 by leveraging the eco-design and 
life cycle analysis tools more effectively. 
iii) Unfortunately, due to dialyses products are Class III medical devices that come 
in contact with the patients’ body fluids, the clients negatively perceive any 
opportunity for recycling, reusing or remanufacturing in their application areas. 
Consequently, the inclusion of end-of-life options in Tier 2 (negotiable criteria) in 
MCHM is clearly justified. 
This upholds the hierarchical categorization of the criteria in the MCHM, wherein 
stakeholder consideration in terms of safety and regulatory compliance gains 
priority, especially with respect to performance to longer life span and cross-
contamination.  
d) Outcomes of the case study 
After analysing the product development process and the management strategies 
of Entity 2 it is possible to present some suggestions, namely: 
1. Entity 2 should study the evolving trends of the market and start to identify 
suitable suppliers of new materials with lower ecological impacts and scout for 
some custom development opportunities to actualize economies of scale, in 
circumstances when the costs are substantially higher and undesired by the 
market.  
2. The, Entity 2 could leverage their knowledge curve to devise products that are 
innovative and operate for longer life spans, due to the analyses of changing 
trends in the market coupled with their previous experience in customer 
requirements. 
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3. The information pertaining to the knowledge curve could be stored in easily 
accessible documents and computational design files. The company could also 
procure design engineering services from external parties for computational 
modelling of the dialysis filters and water purifiers in terms of its flow rate, water 
and energy consumption (Corallo et al., 2009; Yamamoto et al., 2009). However, 
Entity 2 needs to clearly define a trade-off between the investment required by 
these third party service providers and the return-on-investment (Vogel, 2005). 
4. It was recommended to Entity 2 that the prototyping should be initiated while 
the product conceptualization and customer approval of specifications is under 
progress. As the previous learning curve of Entity 2 and moreover, the rate of 
technological innovation within the dialysis machines sector is not as rapid as 
nanotechnology and electronics. As a result, the Entity 2 can reduce the time taken 
to fabricate more effective prototypes within a short span of time and demonstrate 
to the client. 
At the premises of Entity 2, the interviews and active discussions were conducted 
within a one-to-one interaction with the Lead Technical Representative. The goals 
of the interviews were to determine the effectiveness of the proposed MCHM. 
During the interview, the stated representative mentioned the utilization of a 
rather similar but less structured Decision Modelling approach as outlined in 
MCHM within Figure 3.2 to 3.6 in Chapter 3. However, the Design Engineers of 
Entity 2 could successfully incorporate Remanufacturing and Recycling within 
their product components, except the components such as dialysis filters, which 
come into direct contact with human blood. Moreover, owing to their growing 
business in developing nations, Entity 2 was able to gain a competitive advantage 
in terms of economies and scale in order to locally source the materials and 
components. This certainly contributed to a substantial level of social and 
economic sustainability. It is essential that sourcing locally and adopting end-of-
life options reduces fuel consumption for transportation and saves additional 
resources that would have been expended in manufacturing from the extraction 
phase of the life cycle (Boustani et al., 2010; Nasr and Thurston, 2006).  
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Towards the end of the case study, the Engineers of Entity 2 have acknowledged 
the effectiveness of the MCHM as illustrated in Figure 3.2 to 3.6 and have chosen 
to incorporate the frameworks in its subsequent product lines. 
e) Concluding Points 
The recommendations enumerated in the previous section focus on the 
importance of the design phase and the learning curve for incorporating overall 
sustainability. Thus, addressing the first two research propositions of the thesis. 
Moreover, it is essential that regulatory agencies implement and enforce policies 
and provide incentives for the production low ecological impact materials. It is 
also important to note that advancements in dialysis technologies initially 
commenced in publically funded universities such as University of Glasgow and 
University of Giessen followed by commercialization by private entities, further 
fuelling more joint ventures between industry, academia and non-profits 
(<http://www.advancedrenaleducation.com>). Thus, proving the appropriate 
role of government and non-profit entities for stimulating innovation and 
economic growth (Brodwin, 2012). 
6.4.3. Case study 3 
a) Brief Description of the activities 
Entity 3 was initiated in 2007 and develops innovative medical devices (mainly 
Class I and II) for patients undergoing physiotherapy and who require continuous 
health monitoring. The products are wearable sensors coupled with wireless 
communication that conduct many different functions such as electromyography 
(EMG), electrocardiography and monitoring respiration. 
b) Reasons for selecting Entity 3 
Entity 3 develops customized Class I and II Medical Devices. These devices 
incorporate a wide range of components made of plastic, electronics, metals and 
other non-metals, which are quite characteristic of most medical devices.   
c) Activities conducted during the case study 
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After a detailed study of the product design and development process, 
recommendations were provided in terms of switching to materials with lower 
ecological impacts and reducing the quantity of material without compromising 
the structural integrity. Moreover, many inventive principles from TRIZ were 
recommended to reconcile conflicts that would arise from new materials with 
lower quantities so as to address more challenging circumstances in which the 
device has to operate (Fitzgerald et al., 2010). 
d) Outcomes of the case study 
Entity 3 had already finalized partners for distribution of products and 
personalized services for remotely and distantly located clients. Entity 3 attained 
roughly around 30% of cost savings and reduction in ecological impact when the 
Eco-Indicator 99 tool   was adopted. 
 
e) Concluding Points 
The members of Entity 3 possessed qualifications and work experience pertaining 
to design engineering and wireless electronics. As a result, they could easily adopt 
the recommendations for the material, design and problems solving technique. 
These recommendations address the first two research propositions.  
The environmental sustainability could be incorporated by virtue of reducing the 
material required and switching to more eco-friendly materials. However, this 
approach could conflict with the regulatory compliance requirements. For 
example, certain components were required by the regulatory agencies and hence 
could not be switched to different materials or even eliminated from design, even 
if they did not possess any operational functions. 
During the case study it was discovered that the electronics components did 
posses their own ecological and social impact, despite the RoHS and REACH 
compliance (Eichstaedt, 2011). 
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Moreover, small and medium sized enterprises (and even some large enterprises) 
are not able to compel the suppliers of the electrical components, such as cables to 
incorporate a higher degree of overall sustainability, unless there are regulatory 
policies compel them to do so.  
At the moment there are engineering processes to recover these minerals and 
metals from electronic waste, but unfortunately are quite cost intensive and are 
known to suffer from inefficiencies in terms of performance and consumption of 
resources (Cui & Zhang, 2008). Thus in certain circumstances acting 
counterproductive towards environmental sustainability. 
Nevertheless, there have been two major initiatives known as GeSI(Global e-
Sustainability Initiative)and StEP(Solving the E-waste Problem), in collaboration 
with United Nations and representatives from policy making and industries to 
promote responsible utilization of resources (United Nations University, 2009). 
This implies the critical role of policy makers and industry players collaborating 
with each other to actualize environmental sustainability. These initiatives aim to 
enable enterprises across different sizes and industrial sectors to recover precious 
metals and minerals from electronic waste and accordingly, become less 
dependent on unsustainable mining activity. 
As discussed in previous case studies, the members of Entity 3 also had conducted 
the preliminary research work of their innovative ideas with close collaboration 
with Universities. A certain % of the funding was funded by grants from 
Government sponsorships.  
6.4.4. Case study 4 
a) Brief Description of the activities 
Entity 4 is a physicist and a professor at a Western European University who 
specializes in the area of nanomaterials and smart polymers for developing 
sensing and therapeutic approaches for biomedical applications. 
b) Reasons for selecting Entity 4 
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Advancements in regenerative medicine, medical devices and bioengineering 
require a more interdisciplinary approach by virtue of innovation in engineering 
and physics (Hassler et al., 2011). The expertise of Entity 4 is in physics, 
specifically in the domain of phase transitions of ferromaterials and similar 
materials thereof which enables Entity 4 to collaborate with scientists in polymers, 
regenerative medicine and medical devices. The potential in the expertise of Entity 
4 has resulted in the development of biocompatible sensors/actuators for 
biomedical implants, which enables the user and his/her medical practitioner to 
monitor the performance of the patient and his/her implant. The ability of the 
MCHM approach to address product development and sustainability within 
polymers containing embedded sensors has been discussed in case study 3. 
However, case study 3 does not discuss implantable and biocompatible polymers 
for monitoring performance of patient and the implants. The reason being that the 
role of these embedded sensors are more critical for the patient’s life and comes 
under Class III Medical Devices. In addition, within the domain of regenerative 
medicine itself, there are substantial advancements of embedded polymers with 
electronic sensors to stimulate tissue growth. Consequently, the inclusion of this 
case study in the thesis is of utmost importance. 
c) Activities conducted during the case study 
During the interview it was revealed that the most critical criterion of social 
sustainability in terms of patient and end-user safety are biocompatibility and 
very low costs. Thus, leading to a safer implantable device with minimal increase 
in the final selling price of the product/service. 
Entity 4 discussed his research endeavours in the area of polymers with 
embedded sensors and actuators for biomedical implants in human bones. It was 
revealed that the electronic circuits which were printed onto the implantable 
biocompatible polymer and the electronic data acquisition systems were RoHS 
compliant (Source: INKtelligent printing® from Fraunhofer Institute for 
Manufacturing Technology and Advanced Materials 
<http://www.ifam.fraunhofer.de/content/dam/ifam/de/documents/IFAM-
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Bremen/2801/fachinfo/spektrum/en/Produktblatt-2801-EN-
Funktionsstrukturen-INKtelligent-printing.pdf>). This implies that the bare 
minimum sustainability has already been attained by default and without any 
conscious attempt towards incorporation. The same dilemma of case study 3 and 4 
is encountered here as well in terms of increasing the environmental sustainability 
of these electronics components in terms of extracting the metals/minerals and 
reducing the ecological impact of the insulation materials (United Nations 
University 2009). 
Furthermore, during the interview it was revealed that in many circumstances the 
sensing capabilities of printed electronics on biocompatible polymers is not as 
effective as silicon sensors. However, silicon sensors are not necessarily 
biocompatible and hence the research team of Entity 4 encapsulates the silicon 
sensors in a biocompatible polymer for incorporation inside an implant (Hijikata, 
2012; Schmidt et al., 1993). 
A project in tissue engineering and regenerative medicine by the research team of 
Entity 4 involved utilizing a biocompatible and biodegradable polymer with bone-
like minerals and bone-differentiating stem cells to be incorporated as a bone 
implant for treating bone defects. The polymer was electro active in nature that 
responds to electrical impulses when mechanical pressure is experienced by the 
bone. Moreover, as the bone is a piezoelectric material and by the application of 
suitable pressure a electrical impulses are released which initiate mechanical 
changes in the electro active polymer which further continuously provides 
additional mechanical stimuli to the bone in order to increase the rate of 
regeneration (Shastri et al., 1998). Furthermore, the continuous periodic action of 
mechanical pressure and electrical impulses enhanced the proliferation and 
differentiation of bone-based stem cells that further reduced the time taken for 
healing. This tissue-engineering composite was successfully tested in animals. 
d) Outcomes of the case study 
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The whole interview revealed that the social and environmental sustainability was 
automatically included by default by virtue of sound policies and the economies 
of scale of polymers/electronics technology brought about the cost effectiveness 
that resulted in a higher degree of overall sustainability. 
The presence of a few inventive principles of TRIZ was observed in the tissue 
engineering composite. They were the periodic action of mechanical and electrical 
impulses (Principle 19) and the role of electrical fields (Principle 28) (Russo et al., 
2011). 
The principle of Preliminary Anti-action (Principle 9) was observed in terms of 
shielding undesired effects of silicon sensors by encapsulation in a biocompatible 
polymer. In addition, the printed embedded sensors/actuators provide a more 
convenient approach to measuring the performance of the implant and avoiding 
the use of inserting any probes into the region of the body that contains the 
implant. As such a rudimentary approach is ineffective and even hazardous to the 
patient’s health. This advantage resembles the Principle 26 of Copying, wherein 
the function of the invasive probe was enabled onto the implant by virtue of the 
printed electronics.  
In addition, Entity 4 evaluated the role of MCHM with reference to Figure 3.6 and 
revealed the degree of criticality in percentage of the pertinent criteria illustrated 
in the figure. Entity 4 also recommended to view the product development 
process of polymer composites in the following stages which is similar to 
conventional product development process (Ulrich & Eppinger, 2004): 
Phase 0: Idea generation 
Phase 1: Ideas and Opportunities screening 
Phase 2:  Exploration and Investigation 
Phase 3: Concept Validation 
Phase 4: Design and Process Validation 
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Phase 5: Industrialization 
Entity 4 highlighted that the business structure and the engineering activities are 
substantially different from companies, which builds and integrates systems. This 
implies that the MCHM model is not completely suited for Enterprises that 
intends to develop a polymer composite with integrated systems. In addition, 
Entity 4 recommended that the MCHM approach of this thesis is more suitable for 
their clients who are Original Equipment Manufacturers (i.e. automobile 
manufacturers) or in simple words an automobile analogue to medical device 
manufacturers. As a result, this case study provides a unique perspective on the 
developmental challenges encountered by suppliers of sub-systems, components 
and materials for medical device development. 
It was observed that as technology intensive markets to address ever changing 
consumer needs rapidly evolves. This resulted that the project timeline becomes 
critical. This creates a need for simpler and more comprehensive evaluation of 
project prospects and risks. Therefore, a tier 1 approach of a handful of criteria to 
immediately eliminate less promising ideas leads to cost savings in terms of man 
hours for evaluation. Moreover, Entity 4 concurred with the approach of 
conducting a preliminary investigation, as outlined in Chapter 3, in order to gain 
more in-depth insight into the success potential of the project and eliminates any 
biases based on personal experience and existing learning curves (Hilbert, 2012). 
Furthermore, the inclusion of low cost and advanced polymer technologies with 
embedded sensors and actuators, which were a result of actualizing law of 
accelerating returns and globalization, has made it possible for regulatory policies 
to integrate bare minimum overall sustainability (up to tolerable levels) (Modelski 
et al., 2008). Entity 4 stated that the price is considered to be quite cost effective for 
a modern technologically advanced instrument that can enable development of a 
wide range of novel applications with very low costs. Thus, boosting the speed of 
research and development by creating more low cost prototypes for reducing the 
time for each developmental iteration and further contributing to costs savings. 
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It is also observed that the research team of Entity 4 adopted TRIZ inventive 
principles without any actual conscious attempt of incorporation. This could be 
attributed to the inventors and manufacturers of the electro active and 
biocompatible polymers. The biocompatible polymer, which provides the 
advantages of polymers without any health hazards, can be considered as an 
Inventive Principle Number 40 that is composite material. 
e) Concluding Points 
The case study revealed that the technologies and product development/design 
circumstances surrounding polymer composites with integrated systems is 
certainly unique from product development and design processes, which was 
encountered in other case studies in this thesis. As the role of physical chemistry 
and molecular chemistry plays a much stronger role, because chemical 
engineering processes are critical for the success and failure for integrating 
systems within these polymer composite matrices. Meanwhile, other cases usually 
procure materials and sub-systems from their suppliers and perform integration 
into a complete system or possibly engage in a joint development activity. 
Consequently, this case study delivers a unique insight towards the product 
development process of the suppliers. 
After reviewing the history of electrical engineering and the innovations within 
this sector that pioneered technologies in electromagnetism and 
electronics/semiconductors which has eventually lead to materialize into the 
domain of printable electronics and fibber optics.  
Some of the earliest advancements in electronics occurred in the 19th century from 
the endeavours of Prof. Ferdinand Braun of University of Würzburg and Mr. 
Jagadish Chandra Bose at University of Cambridge under Lord Rayleigh. Later for 
almost around 100 years of innovative efforts between public funded Universities 
and commercialization of novel technologies by private entities has resulted in 
substantial advancements with both economies of scale as well as scope (Fjelstad, 
2010). For instance, low cost printing of electronics on a wide variety of substrates 
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including glass ad paper for a wide variety of application ranging from sensing to 
display.  
As stated in the law of accelerating returns coupled with globalization of 
commerce and research endeavours has enabled the rapid growth of technology in 
the field of electronics to address growing needs in commercial, civilian and 
military sectors (Modelski et al., 2008).   
In comparison, the advancement of fibber optics although started sometime in late 
1960s within the private sector, namely MTI Instruments and has followed a 
similar curve as the printed electronics (Culshaw & Kersey, 2008). However, the 
scientific background of fibber optics dates from early 18th and 19th century by a 
plethora of independent inventors and physicists from public funded Universities. 
Consequently, supporting the hypotheses that the initial conceptual validation 
and proof of principle occurs usually within public funded institutions or non-
profits, owing to enormous investments required in research and cost intensive 
instrumentation followed by transferring to the private sector for further 
development (Hayes, 2010).    
These examples illustrate the role of appropriate government funding and 
involvement with reasonable oversight to avoid stifling of creativity and 
knowledge growth (Brodwin, 2012). 
The history of Electroactive Polymers dates from the 19th century starting from 
Wilhelm Röntgen and until Electret discovered and commercialized the initial 
rudimentary version. In the 20th century various collaborations between public 
and private universities and corporations lead to additional advancements. 
Furthermore, since two decades substantial government carried out growth in 
technological improvements for electro active polymers sponsored institutions 
and non-profits until the spin-off company, which was launched, to commercialize 
the technology was acquired by Bayer in 2010.  This further proves that leaps in 
technological advancements do require an appropriate support of publicly funded 
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institutions with considerable freedom to explore opportunities for 
commercialization. 
6.4.5. Case study 5 
a) Brief Description of the activities 
Entity 5 is an orthopaedic clinic. The clinic provides advanced testing and training 
facilities for its orthopaedic patients by employing a professional team of doctors 
and nurses. The areas of therapy are Orthopaedics and Traumatology, Sports 
Traumatology, Physical Medicine, Rheumatology, Podiatry, Physiotherapy, Sports 
Physician Assessment, Testing Effort Cardio-Pulmonary, nursing and many more. 
Moreover, they provide their support to the professional and amateur athletes of 
their city’s football club. 
b) Reasons for selecting Entity 5 
Entity 5 is an orthopaedic clinic that has developed in-house medical device and 
procured only fabrication services from an external engineering company. The 
clinic has been able to translate their impediments into a simple low cost solution 
by close cooperation with members of their clinic (Chatterji et al., 2008). 
c) Activities conducted during the case study 
The clinic has developed an indigenous Class I medical device after encountering 
challenges during the diagnosis of antero-posterior translation and rotatory laxity 
of the knee during magnetic resonance imaging. The device without inducing any 
injury to the patient’s affected knee is able to position the joint to maintain the 
stressed condition for improvised diagnosis, which is provides accuracy than x-
ray or MRI when the joint is more relaxed. A more effective diagnosis is desired 
because the pre-operative planning and post-operative care are critical for the 
patient’s health (Espregueira-Mendes et al., 2012). Through the efforts of over 3-4 
years, which involved 1 year of collaboration with a publically funded University, 
they have obtained a CE (Conformité Européenne 
<http://ec.europa.eu/enterprise/policies/single-market-
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goods/cemarking/index_en.htm>) certification for their device. The device has 
been designed to be simple, accurate and reproducible in order to assist in analysis 
of the anatomy and the function of the knee that suffers from an injury.  
During the research, it was revealed that the device was being developed in-house 
under the guidance of the orthopaedic specialists in collaboration with a few 
engineers from an engineering enterprise (while one biomedical engineer is an 
employee of the clinic). This means that the engineers could precisely gain an 
insight on the pragmatic requirements of the orthopaedic professionals in their 
environment of operation within the clinic. The device was under development in 
the clinic that leads to more frequent clinical trials and the safety of the patient 
was assured under strict supervision of the orthopaedic specialists by virtue of 
their extensive experience in healthcare. The close proximity of the biomedical 
engineer, the engineering company that conducts the prototype fabrication and 
the orthopaedic specialists played a critical role in reducing the development time. 
The proximity is not only with respect to location but also the awareness of 
diverse engineering, medical and scientific fields between the product 
development team members. Furthermore, the owner of the clinic has gained 
significant knowledge in mechanical engineering related fundamentals for 
orthopaedic applications and as a result can guide the development activity with 
more clarity and better focus. 
The list of materials and their quantities were evaluated and, by using Eco-
Indicator 99 tool (Pre Consultants BV <www.pre-sustainability.com>), was 
adopted to determine the most suitable materials from switching with the existing 
one. 
d) Outcomes of the case study 
After the analysis of the information and data obtained, and considered the 
literature review, some recommendations were provided. Firstly, to devise a 
project portfolio approach for future medical device development projects, which 
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illustrate the ability to share various technical and human resources and new 
knowledge (clinical and technical) that would be generated (Pacelli, 2004). 
Secondly, the developmental costs for medical devices are usually high, even for a 
simple contemporary medical device. Consequently, 1-2 year collaborative 
projects with public funded universities to access young and enthusiastic talent in 
orthopaedic sciences and biomedical engineering. Even in cases where there are 
no public grants for such projects, the costs to hire students for preliminary 
investigation is much lower than hiring engineering design companies who may 
charge higher fee. However, the logistics of such activities need to be planned and 
executed efficiently. 
After the Eco-indicator 99 analysis and discussion with the engineering partners of 
Entity 5 revealed that there are a few materials available, which possess lower 
ecological impact and provide similar mechanical properties with similar 
production costs. Meanwhile, materials with lower ecological impact and better 
mechanical properties were identified to have at least 80% higher production costs 
that were only justifiable in cases of economies of scale. Moreover, the existing 
material does provide the desired mechanical strength and flexibility to position 
the patient’s leg during diagnosis. Thus, Entity 5 did not opt for switching to a 
material with lower ecological impact, and accordingly concurring with the three-
tier structure of MCHM (Figure 3.2 in Chapter 3) 
e) Concluding Points 
This case study provides an insight on product development strategy where the 
factor of proximity of the project members, such as engineers, doctors and 
technicians dramatically reduces the time required for incorporating a wide range 
of human factor/ergonomics (Miller, 2007). The environmental sustainability 
aspect could not be considered in detail as the regulatory compliance 
requirements did not stress of a more ecological plastic as opposed to a material 
which creates a more functional device. This means that the Tier 1 of the 
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Multicriteria Hierarchical Model is maintained but without the bare minimum 
environmental sustainability.  
Meanwhile, the social sustainability aspect can be acknowledged in terms of 
collaboration with Universities which results in exchange of knowledge and ideas, 
which results not only in better devices but even publications and patents (namely 
intellectual property). The close collaboration with University would also result in 
imparting pragmatic skills to young engineering and medical students to train 
them to work in real life environments. 
The development of a simple low cost solution and the plans to sell the device to 
other hospitals would enable the purchasing clinics to provide more cost-effective 
treatment to their patients. It is important to note that not necessarily an external 
private medical device company could have provided the same advantage. As the 
developmental costs would have been dependent on the size of the company and 
the extra-cost in terms of lost opportunity to these medical devices companies.  
However, smaller medical device companies could have provided a similar 
solution but the geographical distance and the lack of close relations with the 
members of the clinic would have caused some delays. Furthermore, if future 
medical devices are far more sophisticated that incorporates specialized 
components, Entity 5 may have to initiate a long-term university collaboration 
(with a certain % of government grants) and a external medical device company. 
As encountered in case study 3, in terms of the role of policy for incentivizing 
more sustainable components for the medical device industry, is also applicable in 
this case study (United Nations University 2009). 
6.4.6. Case study 6 
a) Brief Description of the activities 
A University professor from a public University in Western Europe established 
entity 6 in 2010 at the Entrepreneurship Incubation Centre of the same University. 
Entity 6 researched and developed novel prosthetics and orthopaedic devices. 
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Entity 6 was a result of research endeavours between researchers from Life and 
Health Sciences Research Institute located near the public University of the stated 
geographical location, School of Health Sciences and the Departments of 
Mechanical and Industrial Electronics of the stated University in collaboration 
with clinicians at the Hospital located near the public University. 
Entity 6 uses a electro-mechanical platform using 3D design and modelling for 
designing and fabricating customized implants for correcting PectusExcavatum (a 
type of thoracic deformity in young children) by the Nuss procedure. This 
procedure entails using a video-assisted thoracoscopic surgery (VATS) technique 
to surgically insert a curved steel or titanium bar under the sternum to correct the 
deformities. The curved steel or titanium bar is structured by the patented 
technology developed by Entity 6 after a pre-operative Computerized 
Tomography scan of the patient’s thoracic region.  
The technology is in the form of a medical device comprising of pressure and 
strain sensors in a plastic enclosure with a brace to encircle the patient’s thoracic 
region to obtain measurements for structuring the steel/titanium plate. Entity 6 
has already filed for a few patents and is continuing their research for devising 
solutions in the areas of Pectus Carinatum, scoliosis and dental moulding. 
b) Reasons for selecting Entity 6 
Entity 6 develops both Class III and Class I medical devices and utilizes advanced 
computational modelling tools to address the specific needs of the patients in the 
most cost effective manner. 
c) Activities conducted during the case study 
During the interview, it was revealed that the plastic enclosure of the medical 
device comprises of a material that is extremely in low cost and is sourced from a 
distant supplier. Moreover, the material is the most ecological friendly in nature 
compared to other materials with similar mechanical properties. However, there 
are no opportunities for remanufacturing or reusing as the device comes in contact 
with the patients’ skin and by regulatory compliance requirements cannot be used 
 221 
for another patient. Moreover, the device is only composed of a few electronic 
sensors that are RoHS compliant. 
d) Outcomes of the case study 
After detailed analysis of the interview and feedback via email, it can concluded 
that the medical device has very limited components which prevents any 
opportunity for remanufacturing or reusing, even if the plastic enclosure cannot 
be reused. Moreover, the volume of sales is substantially low to justify a cost 
effective enclosure from a local supplier. 
e) Concluding Points 
The collaborative endeavours between publicly funded institutions and private 
entities has the potential to initiate many entrepreneurship ventures which 
address specific needs of the stakeholders of our society in the most cost effective 
manner. Although has RoHS complaint parts, the discussed medical device of 
Entity 6, does suffer from the same dilemma of social and environmental 
externalities as discussed in case study 3. (United Nations University, 2009) 
Likewise, when compared to other case studies, the product design does govern 
the magnitude of sustainability and also the presence of a robust knowledge 
curve. However, no substantial knowledge was required for assembling the 
medical device. Meanwhile, a few years were invested in the design/modelling 
procedures for analysing the thoracic region of patients suffering from Pectus 
Excavatum and assembling the machinery for structuring the metal implants in 
accordance with the patient’s specific condition. 
6.5. Co-relating the three sections of Chapter 6 
This chapter discusses the research questions with reference to the proposed 
Multifaceted Framework and the MCHM by virtue of detailed interviews for pair-
wise comparison of the criteria and case studies.  
The second section of this Chapter pertaining to the prospective role of the 
proposed MCHM (Figure 3.2 in Chapter 3) to actively participate in design 
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optimization is assessed by virtue of interviews and questionnaires. It is 
concluded that the combination of design engineering tools and optimization 
approaches have to appropriately selected for conducting the desired degree of 
design optimization of a product. Moreover, using the MCHM for design 
optimization is envisioned to be suitable for only a limited extent; nevertheless, for 
more complex design scenarios which requires additional software/hardware 
tools would render the MCHM less effective and hence be more suitable for 
decision modelling in the conventional manner.   
Meanwhile, the first and last sections are closely related. As discussed in the pair-
wise comparison section in which 5 experts from academia prioritized End-of-
life/Modularity; Employee Welfare and Contribution to Income Distribution in 
contrast to Community Welfare Programs. They justified their choice by 
envisioning that end-of-life options would contribute to sourcing 
materials/components from local suppliers and accordingly, this perspective 
concurred with the Entity No. 2 which end-of-life options were incorporated 
within the product design. Similarly, as per experts from Industry, Entity No. 2 
expanded their market share in Africa by developing competitive products and 
incorporated economies of scale for which materials/components were again 
sourced locally. This implies that growth in market share and/or corporate 
expansion does eventually contribute to income distribution of stakeholders. 
Moreover, in the concluding points of Case Study No. 3 of Entity No. 3, the United 
Nations initiatives for recycling electronic waste by encouraging collaborations in 
the domains of policy and technology was envisioned not only for environmental 
sustainability but even for growth in employment (United Nations University, 
2009). This further fortifies the viewpoint from the case studies ranging from 1 to 3 
with reference to the critical role of Government Institutions and sponsorship of 
advanced research at its initial stages to ensure a more cost effective transition into 
the market economy by the private sector.  
As discussed in Chapter 3 that the criteria in Tier 2 and 3 are optional in nature in 
addition to their interconnectivity. The consistency ratio of the pair-wise 
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comparisons was considered less important in comparison to the tacit knowledge 
disseminated by the Experts. 
With reference to the research propositions in Chapter 5, the disparity in 
knowledge curve is clearly observable between Entity No. 3 and Entity No. 5 
wherein Entity No. 3 was able to adopt newer material and modified design 
within a shorter time span compared to Entity No. 5. The reason for the disparity 
is attributed to the engineering related knowledge curve of Entity No. 3 in contrast 
to the orthopaedic science knowledge curve of Entity No. 5, in addition to the 
extensive dependency of the latter on an external engineering company. This 
impediment is present notwithstanding the advantage of Entity No. 5 that is an 
orthopaedic clinic wherein access to expertise in orthopaedic sciences, patients 
and instrumentation for treatment/diagnosis is readily available. 
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Chapter 7 
Conclusions and Future Research 
7.1. Introduction 
This chapter outlines the conclusions of the proposed multifaceted framework, the 
Multicriteria Hierarchical Model and its associated frameworks in this thesis. The 
previous chapter of results and discussions disseminated a detailed 
comprehension on the effectiveness of the proposed frameworks and models 
within an Industrial environment, in addition to the applicability of expert’s 
opinion within the initial phases of product development of medical devices. 
Moreover, it is essential to articulate and coherently compile the outcomes of the 
research in this thesis so as to ensure that users of the proposed frameworks and 
models gain substantial benefits after implementation. 
Furthermore, this chapter would also provide an insight to locate any potential 
shortcomings of the proposed frameworks and models during implementation in 
diverse product development scenarios. 
Section 7.1 would outline the results and discussions with reference to the 
literature review and illustrate the contribution to existing literature of overall 
sustainability, decision modelling and medical device development. Meanwhile, 
Section 7.2 would mention the direction of future research for the discussed 
frameworks and models.  Finally, this thesis does discuss the cultural paradigms 
and philosophical underpinnings that not only govern the perception to evaluate 
overall sustainability but even shape any prospective mitigation strategies against 
undesirable externalities. In order to attain a sustainable future, it is crucial to 
comprehend the flaws in our contemporary cultural and philosophical basis in 
order to devise better initiatives by both public and private institutions. 
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7.1.1. Co-relating the Results and Discussions with the Literature Review 
Moore (2011) and Parenti (2011) have co-related the negative externalities that 
occur as a result of unfettered industrial activities onto social structures and 
natural systems for which the defined demarcation appears to be illusionary in 
nature. However, a market economy approach towards novel innovations 
concerning renewable energy aims for lowering the socio-economic and ecological 
externalities (Fresner et al., 2010). Likewise, technologies pertaining to counter the 
hazardous impacts of emissions, such as carbon capture and utilization which 
transforms toxic carbon based emissions into economically useful products 
namely renewable fuels and plastics (Nasr & Thurston, 2006; Styring, 2011). 
Concurrently, as discussed during the case studies, the appropriate collaboration 
and intervention of Government is indeed desirable for materializing endeavours 
and initiatives, which are catered to attaining a higher degree of overall 
Sustainability.  
The pair-wise comparisons between the various optional and negotiable criteria in 
the MCHM in terms of product design and economic frameworks based on the 
degree of Government intervention, is rarely discussed in existing product 
development literature. As contemporary literature on decision modelling and 
product development towards overall Sustainability focuses more on the 
performance of the Enterprise that undertakes product development. 
Meanwhile, extensive research in economics and management has pointed out the 
role of economic policy and Government intervention in enabling the 
competitiveness of certain Industries/Companies (Denning, 2012). However, the 
focus on the product development and design, which is the key contributing factor 
to competitiveness, has mostly been kept at a minimum. 
In fact, Hede et al. (2011) discussed the role of incorporating social sustainability 
paradigms such as employment growth and corporate responsibility within 
product design. Concurrently, Fishman (2012) illustrated the example of General 
Electric in which the company was able to retain the skilled labour and even hire 
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additional skilled personnel by increasing its product value via innovation in 
product design.   
The role of MCHM in design optimization as discussed in Chapter 6 and the 
importance of computational design and engineering tools as outlined in Chapter 
4 exemplify the role of technical infrastructure to capture new knowledge, utilize 
existing knowledge curve and reduce the project timeline without undermining 
the desired outcomes. 
7.1.2. Co-relating Case Studies with Product Development Methods and 
Approaches to resolving Conflicts  
From the case studies in co-relation with the literature review of decision 
modelling in Chapter 3 and Product Development Processes in Chapter 4, a few 
pragmatic real life lessons are enumerated as follows: 
i. Enterprises engaged in product development should always keep of track of 
market dynamics and evolutionary patterns of technologies for staying ahead of 
their competition. This recommendation is attributed to the Law of Accelerating 
Returns in which diverse sciences and technologies interact with each other and 
result in disruptive outcomes (Modelski et al., 2008), even though the task appears 
to be intimidating. Nevertheless, Enterprises can always make suitable trade-offs 
between their desired market sectors and sizes to define their region of 
competitiveness and accordingly renew their product lines.  Moreover, Alexandre 
et al. (2003) have pointed out that the degree of maturity of the underlying 
technology/science of the physical/chemical entities of a product are essential to 
determine the functionality and the future market oriented success. Meanwhile, 
the thesis does concur with the previously published literature and existing 
product development practices to launch successful products. However, as stated 
previously the thesis lays a strong emphasis on sustainability, resolving 
contradictions out of a multitude of synergistic/conflicting specifications and 
economic structures of geographical nations where the products are under 
development or being marketed.  
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ii. The product development processes for Systems comprising of sub-systems and 
components cannot be equated with approaches used for polymer composites, 
biological products or even drug molecules in which molecular level forces and 
phenomena play a critical role or even are the actively performing entities towards 
accomplishing the desired degree of medical care envisioned by the product 
development teams. 
In simple words, the engineering required for fabricating a pacemaker is entirely 
different from building a biodegradable polymer composite with minerals/cells as 
discussed in Case 4, even though a few similarities can be accounted between each 
other.  
iii. Each project undergoing development should be accompanied with relevant 
documentation that mainly outlines project planning, development iterations and 
milestones. 
iv. The project partners must regularly communicate with each other for adhering 
towards the project deadlines for which meetings between key personnel is crucial 
for defining the suitability of the outcomes with respect to the desired results. 
v. The project partners should invest resources (Section 3.3 in Chapter 3) for 
establishing a preliminary knowledge curve for reducing the time required to 
speedup the learning process during the execution of the project. For example, 
project partners must train their project engineers/managers in technical/non-
technical areas which although are essential for the project but for which the 
participants do not have substantial prior knowledge. Similarly, the various 
crucial variables of the resources (Section 3.3 in Chapter 3) that are capable of 
derailing the project should be carefully scrutinized. 
Furthermore, it is imperative to establish a process to transfer the training and 
knowledge between various project participants (managers/engineers) for the 
smooth flow of the activities. It is essential to note that knowledge transfer need 
not require advanced computational or IT based systems. On the contrary, 
defining a suitable product development framework, which delivers insight into 
potential impediments and enables the project teams to build suitable strategies to 
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attain their desired goals, can also transfer knowledge. For example, the TRIZ 
Laws of Technical Evolution, which illustrates the pathway of evolution for new 
technologies, can enable the project teams to define new options for redefining 
their technologies or even improving existing ones (Fresner et al., 2010; Russo et 
al., 2011). 
vi. Both Case 3 and 6 reveal that solely the presence of domain knowledge 
pertinent to the medical device or logistical advantage in terms of access to 
patients and medical doctors does not guarantee success in a certain product 
development within a short span of time. However, the Enterprise could increase 
the probability of success by building suitable collaborations with efficient 
logistical planning in accordance with the prototyping and preliminary evaluation 
for human factors/ergonomics activities.  
As discussed in Chapter 3 and 4, about the potential emergence of a wide range of 
conflicts and synergies, when specifications co-relating with criteria pertaining to 
overall sustainability are considered simultaneously during product development. 
TRIZ, Design by Analogy and Case based Reasoning are mentioned as suitable 
approaches (Fitzgerald et al, 2010; Zhao et al., 2010). However, translating the 
conflicts precisely into the technical and non-technical specifications with 
reference to the product design can itself result in an overwhelming endeavor. For 
example, if a product design has a component whose structure needs to be 
modified to attain a higher degree of reliability in order to consider the component 
for multiple life cycles (in terms of Remanufacturing). Meanwhile, the change in 
design should require a few extra employees with decent wages either in design, 
production or maintenance to increase social sustainability, nevertheless without 
outweighing any potential profits (Fishman, 2012). 
In certain scenarios, a few small changes in product design can create more market 
value for the product in the market and outweigh the costs of adding a few extra 
employees without underutilizing them. On the other hand, in certain scenarios 
substantial product changes may be required to employ more personnel and may 
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also demand advanced machinery/material that may prove to be less cost 
effective if economies of scale are not materialized.  
This implies that because there are multiple conflicts and solutions interwoven 
into each other. Consequently, the most critical conflicts need to be prioritized, in 
order to be solved by a more advanced version of TRIZ, such as OTSM. 
Meanwhile, Enterprises should concurrently devise a risk mitigation plan based 
on technical and business strategies/processes to address conflicts/synergies that 
cannot be reconciled with the most critical ones. For the stated circumstances, the 
utilization of MCHM would be considered most appropriate (Khomenko & 
Ashtiany, 2007). 
With reference to the previously stated example, if more employees cannot be 
appointed in the design engineering phase. Then the Enterprise can choose to 
appoint employees in the lean production/product development processes to 
reduce costs and increase productivity that is anticipated to reduce 
emissions/wastage of resources.  
The ultimate objective is to balance the sustainability related goals by an 
Enterprise, as stated in Chapter 2 (Sutcliffe et al., 2009).  
7.1.3. Articulating the whole perspective of the Thesis 
i. One repetitive pattern has been observed in the conclusion of every case study 
in Chapter 6. Wherein any disruptive or significantly advanced innovation has 
always occurred as a result of a certain degree of support from publicly funded 
institutions. Usually, some of the most impactful innovations of our modern 
society do seem to have their roots in public funded universities followed by 
transfer to either private sector or launching start-ups (Gregorio & Scott, 2003). 
In certain interesting cases, it is observed that scholars from academia or private 
sector owing to their experience in healthcare and research initiate either in-house 
development of medical devices or form a suitable consortium between various 
stakeholders to provide specific solutions at very low costs to patients across all 
economic classes (Chatterjee et al., 2008). Thus, contributing more towards social 
sustainability. 
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ii. Moreover, the rapid rate of technology development coupled with globalization 
has resulted in substantial advancements of these innovations to provide diversity 
in terms of application areas at very low costs (Modelski et al., 2008). Some of the 
well-known examples are printed electronics in consumer products to implantable 
prosthesis and tissue engineering scaffolds. If observed carefully, medical devices 
are a culmination of engineering and sciences from all disciplines towards 
healthcare applications. 
iii. The electronics and electrical engineering innovations, which form a critical 
part of medical device, are usually procured by medical device companies (large 
to small-medium enterprises) from their respective Original Equipment 
Manufacturers (OEMs). Hence they do not have any control over the suppliers to 
provide more ecologically sustainable components.  
Therefore, the role of policy makers to implement policies for incentivizing 
development and commercialization of more socially responsible and eco-friendly 
materials would play a critical role. Concurrently, industry players and public 
institutions in collaboration with non-profits can materialize initiatives to devise 
and implement new methodologies for transforming materials waste. The material 
waste can be categorized mainly into electrical, electronic, plastic/other non-
metals, semiconductors and metals so as to be less dependent on socially 
detrimental mining activity (Eichstaedt, 2011). Some of the most impressive 
initiatives are GeSI (Global e-Sustainability Initiative) and StEP(Solving the E-
waste Problem), respectively (United Nations, 2009). 
This implies that a company all by itself can only attain sustainability to the extent 
of its ability to demand materials from suppliers provided they procure in 
quantities that provide the suppliers with economies of scale. In addition, the 
company should be able to leverage a robust learning curve to launch more 
sustainable products/services and invest in large-scale social responsibility 
programs. However, not all corporations possess such prowess in technology and 
political economy and hence the formation of a initiative does mitigate the risks of 
undesired competition stemming from perverse incentives and the cost intensive 
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nature of engaging in sustainability at comprehensive scale. Moreover, a company 
can engage in mutually beneficial and healthy public private partnerships for 
enhancing is contribution to social sustainability (Jamali, 2012).  
iv. The contemporary medical devices range from metal and non-metal prosthesis 
(external and sometimes internal), instruments, advanced implantable devices and 
scaffolds in regenerative medicine. The lines between pharmaceuticals, biological 
and medical devices are slowly blurring due to the rapid growth rate of 
innovation across diverse disciplines and science and technology. This is the core 
reason for the thesis to discuss a wide variety of cases from these aforementioned 
areas in Chapter 6. 
v. Moreover, during the case studies it is learnt that solely based on the desired 
function of the device would govern the nature of the materials and components 
in accordance with regulatory compliance requirements. As a result, one cannot 
forcibly incorporate a higher degree of sustainability as the Pareto Optimal 
Frontier based on the resources outlined in Section 3.3 of Chapter 3 and a 
company’s capabilities to deliver a product within the window of opportunity 
would pose a major impediment (Zhao et al., 2010). This is also one of the reasons 
for a few companies to desire a decision model that is comprehensive, objective 
and faster in terms of its application for gauging a project before pursuing it. 
Therefore, the three research propositions mentioned in Section 5.3.1 of Chapter 5 
in terms of ability to incorporate sustainability in design phase, the importance of 
a company’s learning curve to attain sustainability and role of socio-economic 
policies to actualize sustainability has been studied across companies of diverse 
areas and sizes.  
vi. As pointed out by Huesemann and Huesemann (2011), the advancements in 
technologies should not be considered as an “absolute ideal solution” for solving 
the challenges pertaining to socio-economic disparities, climate change and 
ecological degradation. They have explained in simple words that for developing 
an advanced technology to counter the threat of climate change would entail 
processes and materials whose development in it itself may exert undesired 
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ecological and socio-economic externalities. For example, carbon credits and clean 
development mechanisms have been criticized by social activists and intellectuals 
for the very same reason, as they support the view purported by these authors 
(Buen, 2013). 
vii. As pointed out by Huesemann and Huesemann (2011), the advancements in 
technologies should not be considered as an “absolute ideal solution” for solving 
the challenges pertaining to socio-economic disparities, climate change and 
ecological degradation. They have explained in simple words that for developing 
a advanced technology for countering the threat of climate change would entail 
processes and materials whose development in itself may exert undesired 
ecological and socio-economic externalities. For instance, carbon credits and clean 
development mechanisms have been criticized by social activists and intellectuals 
for the very same reason, as they support the view purported by Huesemann & 
Huesemann (2011) (Buen, 2013; <http://www.carbontradewatch.org>).  
vii. The pair wise comparison approach discussed in Chapter 5 of the criteria in 
Tier 2 and Tier 3 was identified to be a suitable method to capture the insightful 
thinking approach of the experts in terms of decision making for complicated 
situations with respect to socio-economics and business growth objectives. The 
inclusion of short notes provided with the scoring tables provides flexibility to the 
users of the MCHM approach to incorporate the recommendations disseminated 
by the experts within their product development processes. Similarly, the case 
study approach entailing interviews and active participation with the companies 
coupled with in-depth analyses of their problems and circumstances provides a 
pragmatic viewpoint on the scenarios (favouring and impeding factors) that occur 
in an interdisciplinary industry. 
viii. The proposed Multi Criteria Hierarchical Model (MCHM) which is an 
extensive revision of the Analytical Hierarchical Process decision modelling 
approach, demands substantial due diligence throughout the product 
development process. As exemplified in the preceding sections with reference to 
Design Optimization, certain criteria are a combination of technical as well as non-
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technical (or managerial) parameters, such as ‘market competitiveness’ that cannot 
be easily characterized by computational methodologies and artificial intelligence. 
Consequently, this requires regular intervention by the Team(s). This is 
anticipated to further slow down the design optimization process and depending 
on the magnitude of optimization required by the project could even render the 
whole endeavour ineffective. 
Meanwhile, the MCHM outlined in Figure 3.2 and its other associated models 
namely 3.3 to 3.6 bears certain similarities with the Analytical Network Process 
(ANP), especially for elucidating interrelations between various criteria (Saaty, 
2006). In addition to the similarities, the MCHM does not stress on additional rules 
and restrictions of the outlined interrelations, as described in the Analytical 
Network Process (Saaty, 2006). Recent research investigations have observed 
strong co-relations between the Product Development Processes and Complex 
Adaptive Systems, which are usually encountered in natural systems. These 
complex adaptive systems, similar to an ANP are a network of interconnected 
systems that influence each other and continuously interact with each other by a 
series of multiple feedback loops (McCarthy et al., 2006).  
ix. In the case of product development coordination of activities and continuous 
exchange of information are the critical paradigms for accomplishing an 
Enterprise’s desired goals (Chiva-Gomez, 2004). It is important to note that all the 
aforementioned domains of sustainability are closely interconnected with the 
dynamics of our natural ecosystems, which are holistic and emergent in nature, 
such as the Complex Adaptive System, as opposed to the reductionism, which is 
encountered within the conventional Analytical Hierarchical Process approach of 
Decision Modeling (Hermele, 2009; Parenti, 2011). 
Furthermore, unlike the ANP, the concept of Hierarchy is included within the 
MCHM in order to execute prioritization between the criteria in circumstances of 
irreconcilable conflicts so as to accomplish overall sustainability. The hierarchy of 
prioritization is based on varying degrees of overall sustainability, ranging from 
minimum tolerable (Tier 1) to advanced levels as described in Tier 2 and 3. The 
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thesis intends to point out that a product that is composed of multiple systems 
and sub-systems is a network as well as a hierarchy of its constituents. This facet 
has been one of the core reasons for the proposed MCHM to be outlined as a 
Hierarchical Model in Figure 3.2 and as a interconnected network in Figure 3.6.   
x. Similarly, the Strengths, Opportunities, Weaknesses and Threats are 
simultaneously addressed in Figure 4 (b) and Figure 6 to optimize the overall 
product development process (Pun et al., 2010; Saaty, 2006). 
The elucidated interrelations between the criteria described in Figure 3.6 enables 
the Teams to chart out a progress evaluation plan, conduct readiness assessment 
and provide guidelines for establishing a pro-active risk management framework 
for addressing overall stakeholder welfare (Dey, 2002; Pun et al., 2010). 
Similarly, Figure 3.4, 3.5 and 3.6 could aid the teams to plan out an effective 
Sustainability Roadmap, which resonates with the renowned Balance Score Card 
framework. Notwithstanding, the advantage of customization of the MCHM 
(illustrated in Figure 3.2) for each medical device, the development teams would 
have to manually perform the arduous task of feeding the scores and values in 
accordance with the complexity of the device. Unless, the teams could devise 
Knowledge based Engineering applications for automating routine Design 
Engineering tasks (Corallo et al., 2009). 
xi. Detailed studies have demonstrated that exhaustive Design Optimization 
iterations coupled with the systems thinking analysis for evaluating ecological and 
stakeholder impacts requires high end computational systems with substantial 
resources (especially non-renewable) to be expended throughout their life cycle. 
As a result, ironically exerting an enormous environmental impact that is 
undesirable (Fiksel, 2006; Parliamentary Office of Science and Technology, 2008). 
Although, the experts who were asked to provide their feedback for the 
multifaceted framework outlined in Chapter 4 via the questionnaire were not 
satisfied due to the rigidity of the questionnaire structure. However, they were 
impressed by the inclusion of interviews, which add flexibility to the case study 
by obtaining more insight on the subjectivity of the multifaceted model. As stated 
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before, the expertise provided by the experts was sufficient enough to avoid any 
actual implementation. 
The goal of the multifaceted framework is to evaluate the effectiveness of the 
MCHM and its ability to go beyond conventional decision modelling into design 
optimization at a comprehensive scale. Ultimately, it was concluded that the 
MCHM is most effective as a conventional decision-modelling tool for selecting 
suitable projects and even solving conflicts within product design. However, the 
framework can inspire suitable counterparts in design optimization tools for 
selecting and rejecting design candidates or directing the design of the 
computational models.  
Furthermore, the specifications that define the Pareto Optimal Frontier for any 
given device can be considered as an initiation point for Process improvements 
(e.g.: reducing time and cost savings) and Innovation (e.g.: new material research). 
For an advanced medical device, the characterization of Pareto Optimal Frontier 
could prove exhaustive in nature, and accordingly, an efficient collaborative team 
supported by an equally effective Organizational framework in conjunction with a 
robust knowledge transfer mechanism could alleviate the impediment(s). 
The aim of the thesis is to holistically comprehend the role of decision modelling 
to attain sustainability with minimal socio-economic and environmental 
externalities and concurrently providing a simplistic approach to choosing the 
best alternative in terms of project or product design by virtue of the hierarchical 
structure. 
7.2. Future Research 
The ‘pragmatic’ multifaceted approach towards product development with 
reference towards Decision modelling and Design Optimization was proposed 
and discussed to evaluate the effectiveness of the MCHM in decision modelling as 
well as design optimization. Additionally, the Multifaceted Framework is, in fact, 
only a few steps away from implementation provided the magnitude of design 
modelling and optimization, resources (Section 3.3 of Chapter 3) and their 
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idiosyncrasies pertaining towards the integration of various tools have been 
appropriately addressed. 
The subsequent step in this investigation would entail a research-based case study 
in an enterprise engaged in a design intensive R&D activity that is either remotely 
or closely related to Medical Devices. At the moment, the proposed Multifaceted 
Framework and the MCHM needs to be recalibrated for medical devices in the 
domain of Biological and Regenerative Medicine containing a solid architecture 
(e.g.: scaffolding structures) in conjugation with cells and bimolecular systems. 
In addition, as discussed in section 7.1.2 about the emergence of multiple 
interconnected conflicts/synergies that have to be effectively addressed without 
jeopardizing bare minimum overall sustainability (Khomenko & Ashtiany, 2007). 
It is recommended that further research be conducted to address these intertwined 
conflicts/synergies via the proposed MCHM and Multifaceted Framework (with 
minimal or substantial modifications). The justification is based on the conclusions 
from the case studies that materialising tangible/visible change in product design 
in accordance with welfare of stakeholders results in a more genuine form of 
Sustainability. 
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Special Note 
The Cultural and Philosophical Paradigms of Industrial Growth and 
Overall Sustainability 
The objective of a nation or an enterprise to either attain a minimal degree of a 
higher degree of overall Sustainability would require substantial commitment in 
both feasibility assessments of opportunities to incorporate sustainability and 
defining initiatives and measures to mitigate undesired outcomes. However, the 
paradigms and even philosophical underpinnings, which would define the 
structure of feasibility assessments and the mitigation strategies cannot be entirely 
excluded by either a nation or an enterprise, committed to overall sustainability.  
As mentioned in Fritjof Capra's (2010) book titled "The Tao of Physics: An 
Exploration of the Parallels between Modern Physics and Eastern Mysticism" in 
which he explains the importance of comprehending the phenomena in sub-
atomic physics, natural ecological systems and civilizations from a holistic 
perspective as opposed to a reductionist approach.  
Likewise, he does mention that since the 17th century, the predominant method of 
scientific experimentations and observation is rooted within Newtonian and 
Cartesian paradigms that are closer to reductionism rather than a more holistic 
approach towards evaluating sub-atomic physics and complex phenomena that 
occur in sociology, ecology and economics. The Newtonian and Cartesian 
paradigms are known to perceive every phenomena and entity in existence to be 
decipherable, predictable and controllable in nature that as Fritjof Capra (2010) 
points out is quite different from complex phenomena and sub-atomic physics.  
However, a reductionism centric approach is not entirely erroneous but in fact 
limited only up to a certain extent. For instance, the design, testing and validation 
of a medical device comprising of various sub-systems in which each sub-system 
is developed separately in a modular fashion with a lower degree of dependency 
on other sub-systems only to be integrated into a single system. Meanwhile, 
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developing a bone tissue engineering implant that entails cells, bone minerals and 
other biochemical cannot be developed in a modular approach. As each of the 
mentioned entities are strongly interconnected/interdependent to each other 
wherein the ‘whole’ is indeed more than just a sum of all the entities connected 
together. 
Moreover, Fritjof Capra (2010) also stated that since the 17th century the method 
of scientific experimentations and observation that is based Newtonian and 
Cartesian paradigms has also manifested into economic theories and policies of 
our industrialized society. Furthermore, Fritjof Capra (2010) critiques that such 
theories and policies founded upon Newtonian and Cartesian paradigms 
invariably possess a strong focus on ‘control or dominance’ of natural ecosystems 
and societies for sustaining our human civilization. Consequently, the emanating 
social and environmental externalities lead to undesired outcomes that negatively 
impact economic growth (Eichstaedt, 2011).   
Similarly, the triple bottom line approach towards sustainability has been 
appropriately criticized to be reductionist in nature as it implicitly considers the 
economic dimension with higher priority compared to environmental and social 
domains are externalities which have to be minimized (Magee & Scerri, 2012). 
Whereas, in reality the social sustainability and ecological stability governs the 
success at the frontier of economic growth (Stiglitz, 2007). Furthermore, any 
attempt to undermine the crucial role of natural ecosystems in sustaining our 
human civilization by the implementing initiatives based on the ethical paradigm 
of ‘man attempting to control nature and engineer the climate’ is anticipated to 
result in catastrophic outcomes for which policy makers across the globe would be 
unprepared (Capra, 2010; Costanza et al., 1998; Hermele, 2009; Hamilton, 2013).  
The existing form of industrial growth that is also founded upon Newtonian and 
Cartesian paradigms is undergoing a gradual shift from the linear centric ‘cradle 
to grave’ approach to the cyclical and harmonious ‘cradle to cradle’ approach, 
which is more holistic in nature and centred around overall sustainable growth. 
To explain further in simple words, the ‘cradle-to-grave’ approach of product 
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development entails the disposal of the product at the end of the life cycle as 
opposed to ‘cradle-to-cradle’ in which end-of-life options are adopted and ‘closing 
the loop of materials and energy’ (Nasr & Thurston, 2006; Styring  & Jansen, 2011). 
However, the transformation towards a ‘cradle-to-cradle’ is not entirely 
sustainable for continuing a resource intensive economic growth. The 
shortcomings are not only based on the 2nd law of thermodynamics as stated by 
Huesemann & Huesemann (2011) in which 100% efficiency associated with 
‘closing the loop of materials and energy’ is almost impossible to accomplish. In 
addition, the ideology of an expansionism centric perpetual economic growth has 
been criticized as the ‘Myth of Progress’ because industrial and technological 
advancements have not entirely lead to a higher degree of happiness within the 
human society and better sustainability of the environment in general (Wessels, 
2006).    
The goal of discussing the philosophical and perceptual underpinnings is not 
meant to discourage the users of the multifaceted framework and the decision 
models discussed in the thesis. On the contrary, the aim is to provide a more 
holistic perspective on the current paradigms, which define overall sustainability 
and even inspire senior management of medical device companies to engage in 
partnerships with their industrial contemporaries and public institutions to 
materialize a more sustainable human society.  
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